<?xml version="1.0" encoding="UTF-8" standalone="no"?>
<!DOCTYPE article PUBLIC "-//NLM//DTD Journal Publishing DTD v2.3 20070202//EN" "journalpublishing.dtd">
<article xmlns:mml="http://www.w3.org/1998/Math/MathML" xmlns:xlink="http://www.w3.org/1999/xlink" article-type="research-article">
<front>
<journal-meta>
<journal-id journal-id-type="publisher-id">Front. Cell. Infect. Microbiol.</journal-id>
<journal-title>Frontiers in Cellular and Infection Microbiology</journal-title>
<abbrev-journal-title abbrev-type="pubmed">Front. Cell. Infect. Microbiol.</abbrev-journal-title>
<issn pub-type="epub">2235-2988</issn>
<publisher>
<publisher-name>Frontiers Media S.A.</publisher-name>
</publisher>
</journal-meta>
<article-meta>
<article-id pub-id-type="doi">10.3389/fcimb.2020.00343</article-id>
<article-categories>
<subj-group subj-group-type="heading">
<subject>Cellular and Infection Microbiology</subject>
<subj-group>
<subject>Original Research</subject>
</subj-group>
</subj-group>
</article-categories>
<title-group>
<article-title>Influence of the MUC1 Cell Surface Mucin on Gastric Mucosal Gene Expression Profiles in Response to <italic>Helicobacter pylori</italic> Infection in Mice</article-title>
</title-group>
<contrib-group>
<contrib contrib-type="author">
<name><surname>Sheng</surname> <given-names>Yong H.</given-names></name>
<xref ref-type="aff" rid="aff1"><sup>1</sup></xref>
<uri xlink:href="http://loop.frontiersin.org/people/932929/overview"/>
</contrib>
<contrib contrib-type="author">
<name><surname>Ng</surname> <given-names>Garrett Z.</given-names></name>
<xref ref-type="aff" rid="aff2"><sup>2</sup></xref>
<uri xlink:href="http://loop.frontiersin.org/people/974302/overview"/>
</contrib>
<contrib contrib-type="author">
<name><surname>Summers</surname> <given-names>Kim M.</given-names></name>
<xref ref-type="aff" rid="aff3"><sup>3</sup></xref>
<uri xlink:href="http://loop.frontiersin.org/people/730346/overview"/>
</contrib>
<contrib contrib-type="author">
<name><surname>Every</surname> <given-names>Alison L.</given-names></name>
<xref ref-type="aff" rid="aff2"><sup>2</sup></xref>
<xref ref-type="author-notes" rid="fn002"><sup>&#x02020;</sup></xref>
</contrib>
<contrib contrib-type="author">
<name><surname>Price</surname> <given-names>Gareth</given-names></name>
<xref ref-type="aff" rid="aff4"><sup>4</sup></xref>
</contrib>
<contrib contrib-type="author">
<name><surname>Hasnain</surname> <given-names>Sumaira Z.</given-names></name>
<xref ref-type="aff" rid="aff1"><sup>1</sup></xref>
<uri xlink:href="http://loop.frontiersin.org/people/755314/overview"/>
</contrib>
<contrib contrib-type="author">
<name><surname>Sutton</surname> <given-names>Philip</given-names></name>
<xref ref-type="aff" rid="aff5"><sup>5</sup></xref>
<xref ref-type="aff" rid="aff6"><sup>6</sup></xref>
<uri xlink:href="http://loop.frontiersin.org/people/25449/overview"/>
</contrib>
<contrib contrib-type="author" corresp="yes">
<name><surname>McGuckin</surname> <given-names>Michael A.</given-names></name>
<xref ref-type="aff" rid="aff1"><sup>1</sup></xref>
<xref ref-type="aff" rid="aff7"><sup>7</sup></xref>
<xref ref-type="corresp" rid="c001"><sup>&#x0002A;</sup></xref>
<uri xlink:href="http://loop.frontiersin.org/people/67681/overview"/>
</contrib>
</contrib-group>
<aff id="aff1"><sup>1</sup><institution>Inflammatory Disease Biology and Therapeutics Group, Mater Research Institute &#x02013; The University of Queensland, Translational Research Institute</institution>, <addr-line>Woolloongabba, QLD</addr-line>, <country>Australia</country></aff>
<aff id="aff2"><sup>2</sup><institution>Centre for Animal Biotechnology, Faculty of Veterinary and Agricultural Sciences, The University of Melbourne</institution>, <addr-line>Parkville, VIC</addr-line>, <country>Australia</country></aff>
<aff id="aff3"><sup>3</sup><institution>Genetics, Genomics &#x00026; Transcriptomics of Disease Group, Mater Research Institute &#x02013; The University of Queensland, Translational Research Institute</institution>, <addr-line>Woolloongabba, QLD</addr-line>, <country>Australia</country></aff>
<aff id="aff4"><sup>4</sup><institution>QCIF Facility for Advanced Bioinformatics, Institute of Molecular Bioscience, The University of Queensland</institution>, <addr-line>St Lucia, QLD</addr-line>, <country>Australia</country></aff>
<aff id="aff5"><sup>5</sup><institution>Mucosal Immunology, Murdoch Children&#x00027;s Research Institute, Royal Children&#x00027;s Hospital</institution>, <addr-line>Parkville, VIC</addr-line>, <country>Australia</country></aff>
<aff id="aff6"><sup>6</sup><institution>Department of Paediatrics, Faculty of Medicine Dentistry and Health Sciences, The University of Melbourne</institution>, <addr-line>Parkville, VIC</addr-line>, <country>Australia</country></aff>
<aff id="aff7"><sup>7</sup><institution>Faculty of Medicine Dentistry and Health Sciences, The University of Melbourne</institution>, <addr-line>Parkville, VIC</addr-line>, <country>Australia</country></aff>
<author-notes>
<fn fn-type="edited-by"><p>Edited by: David Proud, University of Calgary, Canada</p></fn>
<fn fn-type="edited-by"><p>Reviewed by: Zhongming Ge, Massachusetts Institute of Technology, United States; Marguerite Clyne, University College Dublin, Ireland</p></fn>
<corresp id="c001">&#x0002A;Correspondence: Michael A. McGuckin <email>michael.mcguckin&#x00040;unimelb.edu.au</email></corresp>
<fn fn-type="other" id="fn001"><p>This article was submitted to Microbes and Innate Immunity, a section of the journal Frontiers in Cellular and Infection Microbiology</p></fn>
<fn fn-type="present-address" id="fn002"><p>&#x02020;Present address: Alison L. Every, College of Science, Health and Engineering, La Trobe University, Bundoora, VIC, Australia</p></fn></author-notes>
<pub-date pub-type="epub">
<day>24</day>
<month>07</month>
<year>2020</year>
</pub-date>
<pub-date pub-type="collection">
<year>2020</year>
</pub-date>
<volume>10</volume>
<elocation-id>343</elocation-id>
<history>
<date date-type="received">
<day>19</day>
<month>03</month>
<year>2020</year>
</date>
<date date-type="accepted">
<day>04</day>
<month>06</month>
<year>2020</year>
</date>
</history>
<permissions>
<copyright-statement>Copyright &#x000A9; 2020 Sheng, Ng, Summers, Every, Price, Hasnain, Sutton and McGuckin.</copyright-statement>
<copyright-year>2020</copyright-year>
<copyright-holder>Sheng, Ng, Summers, Every, Price, Hasnain, Sutton and McGuckin</copyright-holder>
<license xlink:href="http://creativecommons.org/licenses/by/4.0/"><p>This is an open-access article distributed under the terms of the Creative Commons Attribution License (CC BY). The use, distribution or reproduction in other forums is permitted, provided the original author(s) and the copyright owner(s) are credited and that the original publication in this journal is cited, in accordance with accepted academic practice. No use, distribution or reproduction is permitted which does not comply with these terms.</p></license>
</permissions>
<abstract><p>The cell surface mucin MUC1 is an important host factor limiting <italic>Helicobacter pylori (H. pylori</italic>) pathogenesis in both humans and mice by providing a protective barrier and modulating mucosal epithelial and leukocyte responses. The aim of this study was to establish the time-course of molecular events in MUC1-modulated gene expression profiles in response to <italic>H. pylori</italic> infection in wild type (WT) and MUC1-deficient mice using microarray-determined mRNA expression, gene network analysis and Ingenuity Pathway Analysis (IPA). A time-course over the first 72 h of infection showed significantly higher mucosal loads of bacteria at 8 h of infection in <italic>Muc1</italic><sup>&#x02212;/&#x02212;</sup> mice compared with WT, confirming its importance in the early stages of infection (<italic>P</italic> = 0.0003). Microarray analysis revealed 266 differentially expressed genes at one or more time-points over 72 h in the gastric mucosa of <italic>Muc1</italic><sup>&#x02212;/&#x02212;</sup> mice compared with WT control using a threshold of 2-fold change. The SPINK1 pancreatic cancer canonical pathway was strongly inhibited in <italic>Muc1</italic><sup>&#x02212;/&#x02212;</sup> mice compared with WT at sham and 8 h infection (<italic>P</italic> = 6.08E-14 and <italic>P</italic> = 2.25 E-19, respectively) but potently activated at 24 and 72 h post-infection (<italic>P</italic> = 1.38E-22 and <italic>P</italic> = 5.87E-13, respectively). The changes in this pathway are reflective of higher expression of genes mediating digestion and absorption of lipids, carbohydrates, and proteins at sham and 8 h infection in the absence of MUC1, but that this transcriptional signature is highly down regulated as infection progresses in the absence of MUC1. Uninfected <italic>Muc1</italic><sup>&#x02212;/&#x02212;</sup> gastric tissue was highly enriched for expression of factors involved in lipid metabolism and 8 h infection further activated this network compared with WT. As infection progressed, a network of antimicrobial and anti-inflammatory response genes was more highly activated in <italic>Muc1</italic><sup>&#x02212;/&#x02212;</sup> than WT mice. Key target genes identified by time-course microarrays were independently validated using RT-qPCR. These results highlight the dynamic interplay between the host and <italic>H. pylori</italic>, and the role of MUC1 in host defense, and provide a general picture of changes in cellular gene expression modulated by MUC1 in a time-dependent manner in response to <italic>H. pylori</italic> infection.</p></abstract>
<kwd-group>
<kwd>MUC1</kwd>
<kwd><italic>Helicobacter pylori</italic></kwd>
<kwd>infection</kwd>
<kwd>gene expression</kwd>
<kwd>lipid metabolism</kwd>
<kwd>SPINK1</kwd>
</kwd-group>
<contract-num rid="cn001">1164141</contract-num>
<contract-num rid="cn001">1060698</contract-num>
<contract-sponsor id="cn001">National Health and Medical Research Council<named-content content-type="fundref-id">10.13039/501100000925</named-content></contract-sponsor>
<counts>
<fig-count count="9"/>
<table-count count="6"/>
<equation-count count="0"/>
<ref-count count="44"/>
<page-count count="19"/>
<word-count count="13029"/>
</counts>
</article-meta>
</front>
<body>
<sec sec-type="intro" id="s1">
<title>Introduction</title>
<p>Chronic infection with the gram-negative bacterium <italic>Helicobacter pylori (H. pylori)</italic> induces a chronic gastritis in susceptible individuals, which can lead to gastric ulcers, and adenocarcinoma, a malignancy of the glandular epithelium of the stomach. Despite declining prevalence of infection in the Western world, gastric cancer remains one of the most common and deadly cancers worldwide, and is the 5th most common neoplasm and the 3rd most deadly cancer, with an estimated 783,000 deaths in 2018 (Rawla and Barsouk, <xref ref-type="bibr" rid="B29">2019</xref>). Only a fraction of individuals infected with <italic>H. pylori</italic> will develop these associated pathologies, and this variability is attributed to a mixture of environmental, bacterial, and host factors.</p>
<p>One host factor linked with susceptibility to <italic>Helicobacter</italic>-associated gastritis and gastric cancer is allelic variation in the gene that encodes the MUC1 mucin. MUC1 cell surface-mucin is densely present on the apical membrane of most mucosal epithelial cells, including the gastric mucosa where it is very highly expressed. MUC1 is a dominant constituent of the glycocalyx (McGuckin et al., <xref ref-type="bibr" rid="B22">2011</xref>; Sheng et al., <xref ref-type="bibr" rid="B32">2012</xref>), with the full-length form of MUC1 consisting of two non-covalently-bound subunits: a long N-terminal extracellular domain and a short C-terminal cytoplasmic domain. MUC1 is also expressed by some leukocytes, including monocyte/macrophages, dendritic cells, and activated T cells (Wykes et al., <xref ref-type="bibr" rid="B43">2002</xref>). Several epidemiologic studies have linked <italic>MUC1</italic> polymorphisms in humans with susceptibility to <italic>H. pylori</italic>-induced disease (Carvalho et al., <xref ref-type="bibr" rid="B4">1997</xref>; Vinall et al., <xref ref-type="bibr" rid="B40">2002</xref>), suggesting a direct effect of <italic>MUC1</italic> polymorphisms on the development of <italic>Helicobacter</italic>-associated pathology. We have shown that mice deficient in MUC1 are more susceptible to infection by <italic>H. pylori</italic> and that differences emerge very early in infection and are sustained, with characteristically more severe chronic inflammation (McGuckin et al., <xref ref-type="bibr" rid="B21">2007</xref>). Mechanistically, we have shown that MUC1 in gastric epithelial cells limits <italic>H. pylori</italic> infection both by steric hindrance and by acting as a releasable decoy (Linden et al., <xref ref-type="bibr" rid="B17">2009</xref>), and that MUC1 in macrophages suppresses inflammation by negatively regulating the inflammasome (Ng et al., <xref ref-type="bibr" rid="B26">2016</xref>). However, the molecular network pathway by which this mucin limits bacterial pathogenesis has not been fully elucidated, and differences in the very early stages of infection have not been explored. Therefore, the aim of this study was to elucidate the time-course of molecular events and dynamic networks in gastric tissue from <italic>Muc1</italic><sup>&#x02212;/&#x02212;</sup> and wild type (WT) mice in response to the very early stages of <italic>H. pylori</italic> infection, and to validate key target genes involved in the molecular changes in gastric tissue during <italic>H. pylori</italic> infection.</p>
</sec>
<sec sec-type="materials and methods" id="s2">
<title>Materials and Methods</title>
<sec>
<title><italic>H. pylori</italic> Culture</title>
<p><italic>H. pylori</italic> strain SS1 (Lee et al., <xref ref-type="bibr" rid="B16">1997</xref>), was initially cultured on horse blood agar plates [Blood Agar Base No. 2, 0.02% Amphostat, and Skirrow&#x00027;s Selective Supplements [Oxoid, Basingstoke, United Kingdom] and 5% horse blood [Biolab, Clayton, Australia]] in an anaerobic jar with a microaerophilic gas generating kit (Oxoid) for 2 days at 37&#x000B0;C. Prior to infection of mice, <italic>H. pylori</italic> were cultured in brain heart infusion broth (BHI; Oxoid) containing 5% horse serum (Sigma, Castle Hill, Australia), 0.02% Amphostat, and Skirrow&#x00027;s Selective Supplements under microaerophilic conditions for 24 h at 37&#x000B0;C.</p>
</sec>
<sec>
<title>Murine Infection Experiments</title>
<p><italic>Muc1</italic><sup>&#x02212;/&#x02212;</sup> [derived and kindly provided by Sandra Gendler, Mayo Clinic Spicer et al., <xref ref-type="bibr" rid="B34">1995</xref>] and wild-type (WT) mice, all on a 129/SvJ background, were bred within the Veterinary Science animal house, University of Melbourne, and genotyped as described (Spicer et al., <xref ref-type="bibr" rid="B34">1995</xref>). All experiments involved age-matched female mice and were performed under Animal Ethics Committee approval (University of Melbourne; AEEC No. 06205). Mice were infected intragastrically once with 10<sup>7</sup> <italic>H. pylori</italic> SS1 suspended in 0.1 mL BHI and groups (<italic>n</italic> = 3 of each genotype) were euthanased after 8, 24, and 72 h for collection of gastric tissues to determine bacterial abundance and gastric gene expression. Control uninfected (sham) mice were mock-infected with 0.1 mL sterile BHI and sampled after 8, 24, and 72 h mock-infection (<italic>n</italic> = 3 of each genotype).</p>
</sec>
<sec>
<title>Determination of Infection Levels</title>
<p><italic>H. pylori</italic> infection levels within mouse gastric tissues were quantified by colony-forming assay. Briefly, stomachs were opened along the inner curvature and bisected longitudinally. One half was placed in BHI and homogenized (GmbH Polytron homogeniser, Kinematica, Switzerland) and the other half rapidly frozen for RNA extraction. Ten-fold serial dilutions were prepared in BHI broth and aliquots spread over GSSA selective agar plates [Blood Agar Base No. 2 with 5% horse blood, vancomycin (12 mg/mL), polymyxin B (0.40 mg/mL), bacitracin (24 mg/mL), nalidixic acid (1.3 mg/mL), and amphotericin B (3.75 mg/mL), all from Sigma]. After 5 days culture as above, colonies were counted, and the number of colony-forming units was calculated per stomach (McGuckin et al., <xref ref-type="bibr" rid="B21">2007</xref>). Colonies were confirmed to be <italic>H. pylori</italic> by the rapid urease test as previously described (Sutton et al., <xref ref-type="bibr" rid="B35">2000</xref>).</p>
</sec>
<sec>
<title>RNA Preparation and Quality Control</title>
<p>RNA was extracted from each longitudinally bisected half stomach of each mouse using Trizol (Invitrogen) and further purified on RNeasy columns (Qiagen). RNA integrity (RNA integrity number &#x0003E;8) was verified using a Bio-analyzer (Agilent) and RNA was stored at &#x02212;70&#x000B0;C prior to further analysis by microarray and reverse-transcription-quantitative PCR (RT-qPCR).</p>
</sec>
<sec>
<title>Time-Course Microarray Assays</title>
<p>Equal quantities of RNA from mice of the same genotype and time point were pooled for microarray assays. For sham-infected mice, equal quantities of RNA from mice of the same genotype and all three time points were pooled as control uninfected mice. Samples were labeled for GeneChip analysis using the One-Cycle Target Labeling and Control Reagents (Affymetrix). The gene expression array used was the Affymetrix Mouse Gene 1.0 ST array. All steps of target labeling, hybridization, and scanning were performed according to the manufacturer&#x00027;s protocol. The entire microarray dataset is available in <xref ref-type="supplementary-material" rid="SM1">Supplementary Table 1</xref>.</p>
</sec>
<sec>
<title>Molecular Network Analysis</title>
<p>We used several gene ontology-based databases-to examine expression of genes across the time course of response to infection as follows;</p>
<sec>
<title>Ingenuity Knowledge Base Network Analysis</title>
<p>Ingenuity Knowledge Base network analysis was conducted using Ingenuity Pathway Analysis (IPA) which is based on the QIAGEN Knowledge Base (QIAGEN Inc., <ext-link ext-link-type="uri" xlink:href="https://digitalinsights.qiagen.com/products-overview/discovery-insights-portfolio/analysis-and-visualization/qiagen-ipa/">https://digitalinsights.qiagen.com/products-overview/discovery-insights-portfolio/analysis-and-visualization/qiagen-ipa/</ext-link>), a large repository of biological interactions between proteins, RNAs, genes, isoforms, metabolites, complexes, cells, tissues, drugs and diseases, manually curated by experts based on over 3.58 million published studies. The Knowledge Base includes biological interaction data on 19,600 human and 14,700 mouse genes. For each time-point, IPA was used to construct molecular networks of direct physical, transcriptional and enzymatic interactions. Genes identified as differentially expressed were overlaid onto the interactome. Focus genes, which had direct interactions with other genes in IPA, were identified. For each focus gene, the specificity of connections was calculated by the percentage of its connections to other significant genes. Each network was constrained to a maximum of 35 genes. Network scores were calculated based on statistical likelihood (Calvano et al., <xref ref-type="bibr" rid="B3">2005</xref>). The score indicates the likelihood that the assembly of a set of focus genes in a network could not be explained by random chance alone. For each time-point, networks with a statistical likelihood score above 30 are presented.</p>
</sec>
<sec>
<title>Graphia Pro 1.4 Network Analysis</title>
<p>The network analysis tool Graphia Pro 1.4 (formerly BioLayout <italic>Express</italic><sup>3D</sup>; <ext-link ext-link-type="uri" xlink:href="http://biolayout.org">http://biolayout.org</ext-link>.) (Theocharidis et al., <xref ref-type="bibr" rid="B36">2009</xref>) was used to examine expression of genes across the time course of response to infection. Graphia Pro 1.4 clusters data based on similarity of gene expression pattern with nodes representing a data point and edges the relation between nodes. The results were filtered to remove genes with low dynamic range. 6016 genes where the maximum value across all samples was at least 1.5 times the minimum value across all samples were included in the final analysis. In a sample-to-sample analysis (similar to a principal components analysis) nodes represent samples and the network layout shows the similarity of samples based on the expression of all genes in the sample. A gene-to-gene analysis generates a gene coexpression network (GCN) (Wolfe et al., <xref ref-type="bibr" rid="B42">2005</xref>) in which nodes represent genes and edges the correlation between them at or above the chosen threshold. The network layout shows the similarity of gene expression patterns across all samples. The Markov clustering algorithm (MCL) (van Dongen and Abreu-Goodger, <xref ref-type="bibr" rid="B39">2012</xref>) identified groups of highly connected genes within the elements of the network. The inflation value was set at 1.7 to control the granularity of the clusters. GO term enrichment was assessed using Database for Annotation, Visualization and Integrated Discovery (DAVID v6.8; <ext-link ext-link-type="uri" xlink:href="http://david.ncifcrf.gov">http://david.ncifcrf.gov</ext-link>) (Huang da et al., <xref ref-type="bibr" rid="B11">2009a</xref>,<xref ref-type="bibr" rid="B12">b</xref>). Gene Annotation Tool to Help Explain Relationships (GATHER; <ext-link ext-link-type="uri" xlink:href="https://changlab.uth.tmc.edu/gather/">https://changlab.uth.tmc.edu/gather/</ext-link>) (Chang and Nevins, <xref ref-type="bibr" rid="B5">2006</xref>) and PANTHER (version of 3 January 2020; <ext-link ext-link-type="uri" xlink:href="http://geneontology.org/">http://geneontology.org/</ext-link>) (Mi et al., <xref ref-type="bibr" rid="B24">2019a</xref>,<xref ref-type="bibr" rid="B25">b</xref>). <italic>Mus musculus</italic> was used as the reference genome. GO terms were selected for biological processes (GOTERM_BP_DIRECT), cellular components (GOTERM_CC_DIRECT), and molecular function (GOTERM_MF_DIRECT).</p>
</sec>
</sec>
<sec>
<title>RT-qPCR Validation of Microarray</title>
<p>To validate microarray data, a selection of the most highly differentially expressed genes between <italic>Muc1</italic><sup>&#x02212;/&#x02212;</sup> mice and WT mice were measured independently by RT-qPCR using the same individual RNA samples. Total RNA (1 &#x003BC;g) from each individual sample was used for first strand cDNA synthesis using SuperScriptTM III reverse transcriptase (Life Technologies) following the manufacturer&#x00027;s instructions. Real-time PCR was performed on a Rotor-Gene 3000 cycler (Qiagen) by using SYBR &#x000AE; Green I fluorescence (Life Technologies). The cycling conditions were: denaturation for 10 min at 95&#x000B0;C, followed by 40 amplification cycles of 20 s of denaturation at 94&#x000B0;C, 30 s of annealing at 60&#x000B0;C, and 30 s of extension at 72&#x000B0;C. To confirm the specificity of the amplified DNA, a melting curve was determined at the end of each run. The reaction efficiency was determined with a dilution series of cDNA containing the PCR products. Expression of the target genes was normalized to that of <italic>Actb</italic> (encoding &#x003B2;-actin) and the results presented as their ratios (arbitrary units). Control experiments were also performed to ensure that housekeeping gene expression was not differentially regulated under the experimental conditions employed.</p>
<p>The primers used for PCR were designed from Primer Bank (<ext-link ext-link-type="uri" xlink:href="https://www.ncbi.nlm.nih.gov/tools/primer-blast/index.cgi">https://www.ncbi.nlm.nih.gov/tools/primer-blast/index.cgi</ext-link>) or using Oligoperfect Designer (Life Technologies), and their sequences to amplify the target genes are shown in <xref ref-type="supplementary-material" rid="SM2">Supplementary Table 2</xref>.</p>
</sec>
<sec>
<title>Statistical Analysis</title>
<p>For microarray studies, statistical analysis was performed on the R platform using the limma package from Bioconductor. The False Discovery Rate (FDR) method and Fisher&#x00027;s Exact Test were used with a cut off for statistical significance of <italic>P</italic>-value of &#x0003C;0.05 and a fold expression change of 2. For the remainder of the study, statistical analyses were performed using Prism Software v5 (Graphpad) by using ordinary one-way ANOVA and <italic>post-hoc</italic> testing. No data were excluded from any analyses. The statistical test used and the sample sizes for individual analyses are provided within the figure legends.</p>
</sec>
</sec>
<sec sec-type="results" id="s3">
<title>Results</title>
<sec>
<title><italic>H. pylori</italic> Colonization Is Elevated Very Early in Infection in <italic>Muc1</italic><sup>-/-</sup> Mice</title>
<p>In wild type mice <italic>H. pylori</italic> colonization increased progressively over the first 3 days of infection (<xref ref-type="fig" rid="F1">Figure 1</xref>). Consistent with our previous finding of higher <italic>H. pylori</italic> colonization in <italic>Muc1</italic><sup>&#x02212;/&#x02212;</sup> mice 24 h after infection, we found that <italic>Muc1</italic><sup>&#x02212;/&#x02212;</sup> mice displayed &#x0007E;10-fold greater levels of <italic>H. pylori</italic> colonization in the stomach compared with wild-type (WT) mice as early as 8 h post-infection (<italic>P</italic> = 0.0003), consistent with a deficit in pre-existing or rapidly-induced innate defense. The higher CFU bacterial burden in the <italic>Muc1</italic><sup>&#x02212;/&#x02212;</sup> mice persisted, being 2.5- and 2.8-fold higher at 24 and 72 h post-infection (<xref ref-type="fig" rid="F1">Figure 1</xref>).</p>
<fig id="F1" position="float">
<label>Figure 1</label>
<caption><p><italic>H. pylori</italic> colonization levels are elevated in <italic>Muc1</italic><sup>&#x02212;/&#x02212;</sup> mice compared with wild-type (WT) controls. WT or <italic>Muc1</italic><sup>&#x02212;/&#x02212;</sup> mice were infected with a single challenge of <italic>H pylori</italic>-SS1. At each time point, stomachs were removed, and bacterial colonization was determined by colony-forming assay. Statistics: <italic>Muc1</italic><sup>&#x02212;/&#x02212;</sup> vs. wild-type controls at each time point (Ordinary one-way ANOVA corrected for multiple comparisons by controlling the False Discovery Rate (FDR) using &#x0201C;Two-stage step-up method of Benjamini, Krieger, and Yekutieli;&#x0201D; <italic>n</italic> = 3, &#x0002A;&#x0002A;&#x0002A;<italic>p</italic> &#x0003C; 0.001).</p></caption>
<graphic xlink:href="fcimb-10-00343-g0001.tif"/>
</fig>
</sec>
<sec>
<title>Identification and Categorization of Differentially Expressed Genes in the Gastric Tissue of <italic>Muc1<sup>&#x02212;/&#x02212;</sup></italic> Mice</title>
<p>To better understand the molecular mechanism by which MUC1 mediates the inhibition of gastric <italic>H. pylori</italic> colonization, we applied a microarray approach to examine the effect of <italic>Muc1</italic> gene ablation on gastric gene expression in the absence of infection. We identified 183 transcripts that were differentially expressed (using a threshold of 2-fold change) in the gastric mucosa of uninfected <italic>Muc1</italic><sup>&#x02212;/&#x02212;</sup> mice (<xref ref-type="fig" rid="F2">Figure 2A</xref>), and the top 10 differentially expressed genes are shown in <xref ref-type="table" rid="T1">Table 1</xref>. We further categorized the differentially expressed genes into specific functional groups according to gene ontology. Ingenuity Pathway Analysis (IPA) Entrez gene ontology annotation was used to determine the regulator effect network of MUC1-regulated genes (<xref ref-type="fig" rid="F3">Figure 3</xref>) and the top regulators with consistence score 4.536 were <italic>Hinf1a, Hinf4a</italic>, and <italic>Sox2</italic> (<xref ref-type="fig" rid="F3">Figure 3</xref>, <xref ref-type="table" rid="T2">Table 2</xref>). In line with the known functions of these upstream regulators, we found that their target genes in our data set were all increased in expression in <italic>Muc1</italic><sup>&#x02212;/&#x02212;</sup> gastric tissue, including <italic>Fabp2, Fabp1</italic>, <bold><italic>Alb</italic></bold><italic>, Abcc2</italic>, <bold><italic>Mttp</italic></bold><italic>, Abcg5</italic>, and <italic>Apoc3</italic> (<xref ref-type="fig" rid="F3">Figure 3</xref>, genes with &#x0003E;4.5-fold changes are highlighted in bold). Increased expression of these genes is likely to lead to increased transport and metabolism of lipids (<xref ref-type="fig" rid="F3">Figure 3</xref>, <xref ref-type="table" rid="T2">Table 2</xref>). Correspondingly, the top score (53) for network functions was attributed to digestive system development and function, humoral immune responses and organ development. This was followed by a score of 48 for network functions involved in lipid metabolism, molecular transport, and small molecule biochemistry (<xref ref-type="table" rid="T3">Table 3</xref>). These findings indicate that MUC1 modulates a lipid metabolic gene network, which is consistent with previous findings that MUC1 is a novel metabolic master regulator in human epithelial cancer cells (Mehla and Singh, <xref ref-type="bibr" rid="B23">2014</xref>). In <italic>Muc1</italic> deficiency, other mucin genes including <italic>Muc13, Muc2</italic>, and <italic>Muc3</italic> were increased in expression in gastric tissues (<xref ref-type="fig" rid="F4">Figure 4</xref>), although, given the other changes in gene expression and the differences in colonization, this was clearly unable to compensate functionally for loss of <italic>Muc1</italic>.</p>
<fig id="F2" position="float">
<label>Figure 2</label>
<caption><p>Differentially expressed (DE) genes in the gastric tissues across different time points of <italic>H. pylori</italic> infection. Control uninfected mice were sham-infected with 0.1 mL BHI and sampled after 8, 24, and 72 h mock-infection. Equal quantities of RNA from mice of the same genotype from the three time points were pooled as a single sham control for each of 8, 24, and 72 <italic>H. pylori</italic> infection. <bold>(A)</bold> DE genes between <italic>Muc1</italic><sup>&#x02212;/&#x02212;</sup> vs. wild type (WT) mice. <bold>(B)</bold> DE genes occurring in WT gastric tissues in response to <italic>H. pylori</italic> infection over the course of infection. <bold>(C)</bold> DE genes occurring in <italic>Muc1</italic><sup>&#x02212;/&#x02212;</sup> gastric tissues in response to <italic>H</italic>. pylori infection over the course of infection.</p></caption>
<graphic xlink:href="fcimb-10-00343-g0002.tif"/>
</fig>
<table-wrap position="float" id="T1">
<label>Table 1</label>
<caption><p>Differentially expressed 10 top genes in the Gastric Muc1<sup>&#x02212;/&#x02212;</sup> vs WT (KO/WT) or 72 h infection vs Sham (72h/0h) in WT or Muc1<sup>&#x02212;/&#x02212;</sup> (KO).</p></caption>
<table frame="hsides" rules="groups">
<thead>
<tr>
<th valign="top" align="center" colspan="3" style="border-bottom: thin solid #000000;"><bold>Sham (KO/WT)</bold></th>
<th valign="top" align="center" colspan="3" style="border-bottom: thin solid #000000;"><bold>8 h (KO/WT)</bold></th>
<th valign="top" align="center" colspan="3" style="border-bottom: thin solid #000000;"><bold>24 h (KO/WT)</bold></th>
<th valign="top" align="center" colspan="3" style="border-bottom: thin solid #000000;"><bold>72 h (KO/WT)</bold></th>
<th valign="top" align="center" colspan="3" style="border-bottom: thin solid #000000;"><bold>WT (72 h/0 h)</bold></th>
<th valign="top" align="center" colspan="3" style="border-bottom: thin solid #000000;"><bold>KO (72 h/0 h)</bold></th>
</tr>
<tr>
<th valign="top" align="left"><bold>Up molecules</bold></th>
<th valign="top" align="center"><bold>Expr log ratio</bold></th>
<th valign="top" align="left"><bold>Entrez gene name</bold></th>
<th valign="top" align="left"><bold>Up molecules</bold></th>
<th valign="top" align="left"><bold>Expr log ratio</bold></th>
<th valign="top" align="left"><bold>Entrez gene</bold><break/> <bold>name</bold></th>
<th valign="top" align="left"><bold>Up molecules</bold></th>
<th valign="top" align="left"><bold>Expr log ratio</bold></th>
<th valign="top" align="left"><bold>Entrez gene name</bold></th>
<th valign="top" align="left"><bold>Up molecules</bold></th>
<th valign="top" align="left"><bold>Expr log ratio</bold></th>
<th valign="top" align="left"><bold>Entrez gene</bold><break/> <bold>name</bold></th>
<th valign="top" align="left"><bold>Up molecules</bold></th>
<th valign="top" align="left"><bold>Expr log ratio</bold></th>
<th valign="top" align="left"><bold>Entrez gene name</bold></th>
<th valign="top" align="left"><bold>Up molecules</bold></th>
<th valign="top" align="left"><bold>Expr log ratio</bold></th>
<th valign="top" align="left"><bold>Entrez gene name</bold></th>
</tr>
</thead>
<tbody>
<tr>
<td valign="top" align="left">SI</td>
<td valign="top" align="center"><inline-formula><mml:math id="M1"><mml:mrow><mml:mstyle mathcolor="#ee1c23"><mml:mn>3.165</mml:mn></mml:mstyle></mml:mrow></mml:math></inline-formula></td>
<td valign="top" align="left">Sucrase<break/>-isomaltase</td>
<td valign="top" align="left">CPB1</td>
<td valign="top" align="left"><inline-formula><mml:math id="M2"><mml:mrow><mml:mstyle mathcolor="#ee1c23"><mml:mn>3.9</mml:mn></mml:mstyle></mml:mrow></mml:math></inline-formula></td>
<td valign="top" align="left">Carboxypeptidase B1</td>
<td valign="top" align="left">SLFN12L</td>
<td valign="top" align="left"><inline-formula><mml:math id="M3"><mml:mrow><mml:mstyle mathcolor="#ee1c23"><mml:mn>2.69</mml:mn></mml:mstyle></mml:mrow></mml:math></inline-formula></td>
<td valign="top" align="left">Schlafen family member 12 like</td>
<td valign="top" align="left">ALB</td>
<td valign="top" align="left"><inline-formula><mml:math id="M4"><mml:mrow><mml:mstyle mathcolor="#ee1c23"><mml:mn>3.67</mml:mn></mml:mstyle></mml:mrow></mml:math></inline-formula></td>
<td valign="top" align="left">Albumin</td>
<td valign="top" align="left">SI</td>
<td valign="top" align="left"><inline-formula><mml:math id="M5"><mml:mrow><mml:mstyle mathcolor="#ee1c23"><mml:mn>3.65</mml:mn></mml:mstyle></mml:mrow></mml:math></inline-formula></td>
<td valign="top" align="left">Sucrase<break/>-isomaltase</td>
<td valign="top" align="left">HSPA1A/1B</td>
<td valign="top" align="left"><inline-formula><mml:math id="M6"><mml:mrow><mml:mstyle mathcolor="#ee1c23"><mml:mn>1.75</mml:mn></mml:mstyle></mml:mrow></mml:math></inline-formula></td>
<td valign="top" align="left">Heat shock protein family A (Hsp70) member 1A</td>
</tr>
<tr>
<td valign="top" align="left">SLC13A1</td>
<td valign="top" align="center"><inline-formula><mml:math id="M7"><mml:mrow><mml:mstyle mathcolor="#ee1c23"><mml:mn>2.658</mml:mn></mml:mstyle></mml:mrow></mml:math></inline-formula></td>
<td valign="top" align="left">Solute carrier family 13 member 1</td>
<td valign="top" align="left">REG1B</td>
<td valign="top" align="left"><inline-formula><mml:math id="M8"><mml:mrow><mml:mstyle mathcolor="#ee1c23"><mml:mn>3.8</mml:mn></mml:mstyle></mml:mrow></mml:math></inline-formula></td>
<td valign="top" align="left">Regenerating family member 1 beta</td>
<td valign="top" align="left">Csprs</td>
<td valign="top" align="left"><inline-formula><mml:math id="M9"><mml:mrow><mml:mstyle mathcolor="#ee1c23"><mml:mn>2.42</mml:mn></mml:mstyle></mml:mrow></mml:math></inline-formula></td>
<td valign="top" align="left">Component of Sp100-rs</td>
<td valign="top" align="left">Csprs</td>
<td valign="top" align="left"><inline-formula><mml:math id="M10"><mml:mrow><mml:mstyle mathcolor="#ee1c23"><mml:mn>2.16</mml:mn></mml:mstyle></mml:mrow></mml:math></inline-formula></td>
<td valign="top" align="left">Component of Sp100-rs</td>
<td valign="top" align="left">SLC13A1</td>
<td valign="top" align="left"><inline-formula><mml:math id="M11"><mml:mrow><mml:mstyle mathcolor="#ee1c23"><mml:mn>2.48</mml:mn></mml:mstyle></mml:mrow></mml:math></inline-formula></td>
<td valign="top" align="left">Solute carrier family 13 member 1</td>
<td valign="top" align="left">Csprs</td>
<td valign="top" align="left"><inline-formula><mml:math id="M12"><mml:mrow><mml:mstyle mathcolor="#ee1c23"><mml:mn>1.55</mml:mn></mml:mstyle></mml:mrow></mml:math></inline-formula></td>
<td valign="top" align="left">Component of Sp100-rs</td>
</tr>
<tr>
<td valign="top" align="left">CYP3A11</td>
<td valign="top" align="center"><inline-formula><mml:math id="M13"><mml:mrow><mml:mstyle mathcolor="#ee1c23"><mml:mn>2.584</mml:mn></mml:mstyle></mml:mrow></mml:math></inline-formula></td>
<td valign="top" align="left">Cytochrome P450, family 3, subfamily a, polypeptide 11</td>
<td valign="top" align="left">CPA2</td>
<td valign="top" align="left"><inline-formula><mml:math id="M14"><mml:mrow><mml:mstyle mathcolor="#ee1c23"><mml:mn>3.8</mml:mn></mml:mstyle></mml:mrow></mml:math></inline-formula></td>
<td valign="top" align="left">Carboxypeptidase A2</td>
<td valign="top" align="left">IFI44</td>
<td valign="top" align="left"><inline-formula><mml:math id="M15"><mml:mrow><mml:mstyle mathcolor="#ee1c23"><mml:mn>2.12</mml:mn></mml:mstyle></mml:mrow></mml:math></inline-formula></td>
<td valign="top" align="left">Interferon induced protein 44</td>
<td valign="top" align="left">IDO1</td>
<td valign="top" align="left"><inline-formula><mml:math id="M16"><mml:mrow><mml:mstyle mathcolor="#ee1c23"><mml:mn>1.99</mml:mn></mml:mstyle></mml:mrow></mml:math></inline-formula></td>
<td valign="top" align="left">Indoleamine 2,3-dioxygenase 1</td>
<td valign="top" align="left">CPS1</td>
<td valign="top" align="left"><inline-formula><mml:math id="M17"><mml:mrow><mml:mstyle mathcolor="#ee1c23"><mml:mn>2.47</mml:mn></mml:mstyle></mml:mrow></mml:math></inline-formula></td>
<td valign="top" align="left">Carbamoyl-phosphate synthetase 1</td>
<td valign="top" align="left">IDO1</td>
<td valign="top" align="left"><inline-formula><mml:math id="M18"><mml:mrow><mml:mstyle mathcolor="#ee1c23"><mml:mn>1.47</mml:mn></mml:mstyle></mml:mrow></mml:math></inline-formula></td>
<td valign="top" align="left">Indoleamine 2,3-dioxygenase 1</td>
</tr>
<tr>
<td valign="top" align="left">SLC26A3</td>
<td valign="top" align="center"><inline-formula><mml:math id="M19"><mml:mrow><mml:mstyle mathcolor="#ee1c23"><mml:mn>2.554</mml:mn></mml:mstyle></mml:mrow></mml:math></inline-formula></td>
<td valign="top" align="left">Solute carrier family 26 member 3</td>
<td valign="top" align="left">CPA1</td>
<td valign="top" align="left"><inline-formula><mml:math id="M20"><mml:mrow><mml:mstyle mathcolor="#ee1c23"><mml:mn>3.7</mml:mn></mml:mstyle></mml:mrow></mml:math></inline-formula></td>
<td valign="top" align="left">Carboxypeptidase A1</td>
<td valign="top" align="left">IFIT1B</td>
<td valign="top" align="left"><inline-formula><mml:math id="M21"><mml:mrow><mml:mstyle mathcolor="#ee1c23"><mml:mn>1.75</mml:mn></mml:mstyle></mml:mrow></mml:math></inline-formula></td>
<td valign="top" align="left">Interferon induced protein with tetratricopeptide repeats 1B</td>
<td valign="top" align="left">TRDN</td>
<td valign="top" align="left"><inline-formula><mml:math id="M22"><mml:mrow><mml:mstyle mathcolor="#ee1c23"><mml:mn>1.9</mml:mn></mml:mstyle></mml:mrow></mml:math></inline-formula></td>
<td valign="top" align="left">Triadin</td>
<td valign="top" align="left">CDH17</td>
<td valign="top" align="left"><inline-formula><mml:math id="M23"><mml:mrow><mml:mstyle mathcolor="#ee1c23"><mml:mn>2.43</mml:mn></mml:mstyle></mml:mrow></mml:math></inline-formula></td>
<td valign="top" align="left">Cadherin 17</td>
<td valign="top" align="left">Gm5431</td>
<td valign="top" align="left"><inline-formula><mml:math id="M24"><mml:mrow><mml:mstyle mathcolor="#ee1c23"><mml:mn>1.28</mml:mn></mml:mstyle></mml:mrow></mml:math></inline-formula></td>
<td/>
</tr>
<tr>
<td valign="top" align="left">CPS1</td>
<td valign="top" align="center"><inline-formula><mml:math id="M25"><mml:mrow><mml:mstyle mathcolor="#ee1c23"><mml:mn>2.553</mml:mn></mml:mstyle></mml:mrow></mml:math></inline-formula></td>
<td valign="top" align="left">Carbamoyl- phosphate synthetase 1</td>
<td valign="top" align="left">CTRL1</td>
<td valign="top" align="left"><inline-formula><mml:math id="M26"><mml:mrow><mml:mstyle mathcolor="#ee1c23"><mml:mn>3.7</mml:mn></mml:mstyle></mml:mrow></mml:math></inline-formula></td>
<td valign="top" align="left">Chymotrypsin like 1</td>
<td valign="top" align="left">RSAD2</td>
<td valign="top" align="left"><inline-formula><mml:math id="M27"><mml:mrow><mml:mstyle mathcolor="#ee1c23"><mml:mn>1.64</mml:mn></mml:mstyle></mml:mrow></mml:math></inline-formula></td>
<td valign="top" align="left">Radical S-adenosyl methionine domain containing 2</td>
<td valign="top" align="left">FGG</td>
<td valign="top" align="left"><inline-formula><mml:math id="M28"><mml:mrow><mml:mstyle mathcolor="#ee1c23"><mml:mn>1.76</mml:mn></mml:mstyle></mml:mrow></mml:math></inline-formula></td>
<td valign="top" align="left">Fibrinogen gamma chain</td>
<td valign="top" align="left">MGAM</td>
<td valign="top" align="left"><inline-formula><mml:math id="M29"><mml:mrow><mml:mstyle mathcolor="#ee1c23"><mml:mn>2.35</mml:mn></mml:mstyle></mml:mrow></mml:math></inline-formula></td>
<td valign="top" align="left">Maltase-glucoamylase</td>
<td valign="top" align="left">HBA1/HAA2</td>
<td valign="top" align="left"><inline-formula><mml:math id="M30"><mml:mrow><mml:mstyle mathcolor="#ee1c23"><mml:mn>1.24</mml:mn></mml:mstyle></mml:mrow></mml:math></inline-formula></td>
<td valign="top" align="left">Hemoglobin subunit alpha 2</td>
</tr>
<tr>
<td valign="top" align="left">CDH17</td>
<td valign="top" align="center"><inline-formula><mml:math id="M31"><mml:mrow><mml:mstyle mathcolor="#ee1c23"><mml:mn>2.465</mml:mn></mml:mstyle></mml:mrow></mml:math></inline-formula></td>
<td valign="top" align="left">Cadherin 17</td>
<td valign="top" align="left">ALB</td>
<td valign="top" align="left"><inline-formula><mml:math id="M32"><mml:mrow><mml:mstyle mathcolor="#ee1c23"><mml:mn>3.5</mml:mn></mml:mstyle></mml:mrow></mml:math></inline-formula></td>
<td valign="top" align="left">Albumin</td>
<td valign="top" align="left">Trim30a/d</td>
<td valign="top" align="left"><inline-formula><mml:math id="M33"><mml:mrow><mml:mstyle mathcolor="#ee1c23"><mml:mn>1.6</mml:mn></mml:mstyle></mml:mrow></mml:math></inline-formula></td>
<td valign="top" align="left">Tripartite motif-containing 30A</td>
<td valign="top" align="left">SERPINA1</td>
<td valign="top" align="left"><inline-formula><mml:math id="M34"><mml:mrow><mml:mstyle mathcolor="#ee1c23"><mml:mn>1.72</mml:mn></mml:mstyle></mml:mrow></mml:math></inline-formula></td>
<td valign="top" align="left">Serpin family A member 1</td>
<td valign="top" align="left">SLC26A3</td>
<td valign="top" align="left"><inline-formula><mml:math id="M35"><mml:mrow><mml:mstyle mathcolor="#ee1c23"><mml:mn>2.31</mml:mn></mml:mstyle></mml:mrow></mml:math></inline-formula></td>
<td valign="top" align="left">Solute carrier family 26 member 3</td>
<td valign="top" align="left">Trav8-2</td>
<td valign="top" align="left"><inline-formula><mml:math id="M36"><mml:mrow><mml:mstyle mathcolor="#ee1c23"><mml:mn>1.2</mml:mn></mml:mstyle></mml:mrow></mml:math></inline-formula></td>
<td valign="top" align="left">T-cell receptor alpha variable 8-2</td>
</tr>
<tr>
<td valign="top" align="left">MGAM</td>
<td valign="top" align="center"><inline-formula><mml:math id="M37"><mml:mrow><mml:mstyle mathcolor="#ee1c23"><mml:mn>2.4</mml:mn></mml:mstyle></mml:mrow></mml:math></inline-formula></td>
<td valign="top" align="left">Maltase- glucoamylase</td>
<td valign="top" align="left">CELA3B</td>
<td valign="top" align="left"><inline-formula><mml:math id="M38"><mml:mrow><mml:mstyle mathcolor="#ee1c23"><mml:mn>3.5</mml:mn></mml:mstyle></mml:mrow></mml:math></inline-formula></td>
<td valign="top" align="left">Chymotrypsin like elastase 3B</td>
<td valign="top" align="left">USP18</td>
<td valign="top" align="left"><inline-formula><mml:math id="M39"><mml:mrow><mml:mstyle mathcolor="#ee1c23"><mml:mn>1.58</mml:mn></mml:mstyle></mml:mrow></mml:math></inline-formula></td>
<td valign="top" align="left">Ubiquitin specific peptidase 18</td>
<td valign="top" align="left">IFIT3</td>
<td valign="top" align="left"><inline-formula><mml:math id="M40"><mml:mrow><mml:mstyle mathcolor="#ee1c23"><mml:mn>1.65</mml:mn></mml:mstyle></mml:mrow></mml:math></inline-formula></td>
<td valign="top" align="left">Interferon induced protein with tetratricopeptide repeats 3</td>
<td valign="top" align="left">Igkv9-120</td>
<td valign="top" align="left"><inline-formula><mml:math id="M41"><mml:mrow><mml:mstyle mathcolor="#ee1c23"><mml:mn>2.22</mml:mn></mml:mstyle></mml:mrow></mml:math></inline-formula></td>
<td valign="top" align="left">Immunoglobulin kappa chain variable 9-120</td>
<td valign="top" align="left">Olfr1274-ps</td>
<td valign="top" align="left"><inline-formula><mml:math id="M42"><mml:mrow><mml:mstyle mathcolor="#ee1c23"><mml:mn>1.17</mml:mn></mml:mstyle></mml:mrow></mml:math></inline-formula></td>
<td valign="top" align="left">Olfactory receptor 1506</td>
</tr>
<tr>
<td valign="top" align="left">ALB</td>
<td valign="top" align="center"><inline-formula><mml:math id="M43"><mml:mrow><mml:mstyle mathcolor="#ee1c23"><mml:mn>2.4</mml:mn></mml:mstyle></mml:mrow></mml:math></inline-formula></td>
<td valign="top" align="left">Albumin</td>
<td valign="top" align="left">PNLIP</td>
<td valign="top" align="left"><inline-formula><mml:math id="M44"><mml:mrow><mml:mstyle mathcolor="#ee1c23"><mml:mn>3.4</mml:mn></mml:mstyle></mml:mrow></mml:math></inline-formula></td>
<td valign="top" align="left">Pancreatic lipase</td>
<td valign="top" align="left">Slfn2</td>
<td valign="top" align="left"><inline-formula><mml:math id="M45"><mml:mrow><mml:mstyle mathcolor="#ee1c23"><mml:mn>1.55</mml:mn></mml:mstyle></mml:mrow></mml:math></inline-formula></td>
<td valign="top" align="left">Schlafen 2</td>
<td valign="top" align="left">Svs3a/Svs3b</td>
<td valign="top" align="left"><inline-formula><mml:math id="M46"><mml:mrow><mml:mstyle mathcolor="#ee1c23"><mml:mn>1.6</mml:mn></mml:mstyle></mml:mrow></mml:math></inline-formula></td>
<td valign="top" align="left">Seminal vesicle secretory protein 3A</td>
<td valign="top" align="left">ALPP</td>
<td valign="top" align="left"><inline-formula><mml:math id="M47"><mml:mrow><mml:mstyle mathcolor="#ee1c23"><mml:mn>2.198</mml:mn></mml:mstyle></mml:mrow></mml:math></inline-formula></td>
<td valign="top" align="left">Alkaline phosphatase, placental</td>
<td valign="top" align="left">Igkv4-55</td>
<td valign="top" align="left"><inline-formula><mml:math id="M48"><mml:mrow><mml:mstyle mathcolor="#ee1c23"><mml:mn>1.16</mml:mn></mml:mstyle></mml:mrow></mml:math></inline-formula></td>
<td valign="top" align="left">Immunoglobulin kappa chain variable 4-55</td>
</tr>
<tr>
<td valign="top" align="left">CLCA4</td>
<td valign="top" align="center"><inline-formula><mml:math id="M49"><mml:mrow><mml:mstyle mathcolor="#ee1c23"><mml:mn>2.3</mml:mn></mml:mstyle></mml:mrow></mml:math></inline-formula></td>
<td valign="top" align="left">Chloride channel accessory 4</td>
<td valign="top" align="left">2210010C04Rik</td>
<td valign="top" align="left"><inline-formula><mml:math id="M50"><mml:mrow><mml:mstyle mathcolor="#ee1c23"><mml:mn>3.4</mml:mn></mml:mstyle></mml:mrow></mml:math></inline-formula></td>
<td valign="top" align="left">RIKEN cDNA 2210010C04 gene</td>
<td valign="top" align="left">LOC68395</td>
<td valign="top" align="left"><inline-formula><mml:math id="M51"><mml:mrow><mml:mstyle mathcolor="#ee1c23"><mml:mn>1.55</mml:mn></mml:mstyle></mml:mrow></mml:math></inline-formula></td>
<td valign="top" align="left">Histocompatibility 2, Q region locus 6-like</td>
<td valign="top" align="left">Trim30a/d</td>
<td valign="top" align="left"><inline-formula><mml:math id="M52"><mml:mrow><mml:mstyle mathcolor="#ee1c23"><mml:mn>1.59</mml:mn></mml:mstyle></mml:mrow></mml:math></inline-formula></td>
<td valign="top" align="left">Tripartite motif-containing 30A</td>
<td valign="top" align="left">CLCA4</td>
<td valign="top" align="left"><inline-formula><mml:math id="M53"><mml:mrow><mml:mstyle mathcolor="#ee1c23"><mml:mn>2.14</mml:mn></mml:mstyle></mml:mrow></mml:math></inline-formula></td>
<td valign="top" align="left">Chloride channel accessory 4</td>
<td valign="top" align="left">FGG</td>
<td valign="top" align="left"><inline-formula><mml:math id="M54"><mml:mrow><mml:mstyle mathcolor="#ee1c23"><mml:mn>1.15</mml:mn></mml:mstyle></mml:mrow></mml:math></inline-formula></td>
<td valign="top" align="left">Fibrinogen gamma chain</td>
</tr>
<tr>
<td valign="top" align="left">201010<break/>6E10Rik</td>
<td valign="top" align="center"><inline-formula><mml:math id="M55"><mml:mrow><mml:mstyle mathcolor="#ee1c23"><mml:mn>2.2</mml:mn></mml:mstyle></mml:mrow></mml:math></inline-formula></td>
<td/>
<td valign="top" align="left">CTRB2</td>
<td valign="top" align="left"><inline-formula><mml:math id="M56"><mml:mrow><mml:mstyle mathcolor="#ee1c23"><mml:mn>3.4</mml:mn></mml:mstyle></mml:mrow></mml:math></inline-formula></td>
<td valign="top" align="left">chymotrypsinogen B2</td>
<td valign="top" align="left">DHX58</td>
<td valign="top" align="left"><inline-formula><mml:math id="M57"><mml:mrow><mml:mstyle mathcolor="#ee1c23"><mml:mn>1.53</mml:mn></mml:mstyle></mml:mrow></mml:math></inline-formula></td>
<td valign="top" align="left">DExH-box helicase 58</td>
<td valign="top" align="left">Gm5662</td>
<td valign="top" align="left"><inline-formula><mml:math id="M58"><mml:mrow><mml:mstyle mathcolor="#ee1c23"><mml:mn>1.57</mml:mn></mml:mstyle></mml:mrow></mml:math></inline-formula></td>
<td/>
<td valign="top" align="left">Muc3</td>
<td valign="top" align="left"><inline-formula><mml:math id="M59"><mml:mrow><mml:mstyle mathcolor="#ee1c23"><mml:mn>2.12</mml:mn></mml:mstyle></mml:mrow></mml:math></inline-formula></td>
<td valign="top" align="left">Mucin 3, transmembrane</td>
<td valign="top" align="left">AHSG</td>
<td valign="top" align="left"><inline-formula><mml:math id="M60"><mml:mrow><mml:mstyle mathcolor="#ee1c23"><mml:mn>1.13</mml:mn></mml:mstyle></mml:mrow></mml:math></inline-formula></td>
<td valign="top" align="left">Alpha 2-HS glycoprotein</td>
</tr>
<tr style="border-top: thin solid #000000;">
<td valign="top" align="left"><bold>Down molecules</bold></td>
<td valign="top" align="center"><bold>Expr log ratio</bold></td>
<td valign="top" align="left"><bold>Entrez gene name</bold></td>
<td valign="top" align="left"><bold>Down molecules</bold></td>
<td valign="top" align="left"><bold>Expr log ratio</bold></td>
<td valign="top" align="left"><bold>Entrez gene name</bold></td>
<td valign="top" align="left"><bold>Down molecules</bold></td>
<td valign="top" align="left"><bold>Expr log ratio</bold></td>
<td valign="top" align="left"><bold>Entrez gene name</bold></td>
<td valign="top" align="left"><bold>Down molecules</bold></td>
<td valign="top" align="left"><bold>Expr log ratio</bold></td>
<td valign="top" align="left"><bold>Entrez gene name</bold></td>
<td valign="top" align="left"><bold>Down molecules</bold></td>
<td valign="top" align="left"><bold>Expr log ratio</bold></td>
<td valign="top" align="left"><bold>Entrez gene name</bold></td>
<td valign="top" align="left"><bold>Down molecules</bold></td>
<td valign="top" align="left"><bold>Expr log ratio</bold></td>
<td valign="top" align="left"><bold>Entrez gene name</bold></td>
</tr>
<tr style="border-top: thin solid #000000;">
<td valign="top" align="left">Muc1</td>
<td valign="top" align="center"><inline-formula><mml:math id="M61"><mml:mrow><mml:mstyle mathcolor="#336132"><mml:mn>3.9</mml:mn></mml:mstyle></mml:mrow></mml:math></inline-formula></td>
<td valign="top" align="left">Mucin 1, transmembrane</td>
<td valign="top" align="left">Muc1</td>
<td valign="top" align="left"><inline-formula><mml:math id="M62"><mml:mrow><mml:mstyle mathcolor="#336132"><mml:mn>3.96</mml:mn></mml:mstyle></mml:mrow></mml:math></inline-formula></td>
<td valign="top" align="left">Mucin 1, transmembrane</td>
<td valign="top" align="left">CPA1</td>
<td valign="top" align="left"><inline-formula><mml:math id="M63"><mml:mrow><mml:mstyle mathcolor="#336132"><mml:mn>3.94</mml:mn></mml:mstyle></mml:mrow></mml:math></inline-formula></td>
<td valign="top" align="left">Carboxypeptidase A1</td>
<td valign="top" align="left">CTRB2</td>
<td valign="top" align="left"><inline-formula><mml:math id="M64"><mml:mrow><mml:mstyle mathcolor="#436132"><mml:mn>4.27</mml:mn></mml:mstyle></mml:mrow></mml:math></inline-formula></td>
<td valign="top" align="left">Chymotrypsinogen B2</td>
<td valign="top" align="left">Olfr960</td>
<td valign="top" align="left"><inline-formula><mml:math id="M65"><mml:mrow><mml:mstyle mathcolor="#136132"><mml:mn>1.39</mml:mn></mml:mstyle></mml:mrow></mml:math></inline-formula></td>
<td valign="top" align="left">Olfactory receptor 960</td>
<td valign="top" align="left">PNLIP</td>
<td valign="top" align="left"><inline-formula><mml:math id="M66"><mml:mrow><mml:mstyle mathcolor="#536132"><mml:mn>5.68</mml:mn></mml:mstyle></mml:mrow></mml:math></inline-formula></td>
<td valign="top" align="left">Pancreatic lipase</td>
</tr>
<tr>
<td valign="top" align="left">Defb4</td>
<td valign="top" align="center"><inline-formula><mml:math id="M67"><mml:mrow><mml:mstyle mathcolor="#136132"><mml:mn>1.7</mml:mn></mml:mstyle></mml:mrow></mml:math></inline-formula></td>
<td valign="top" align="left">Defensin beta 4</td>
<td valign="top" align="left">UXT</td>
<td valign="top" align="left"><inline-formula><mml:math id="M68"><mml:mrow><mml:mstyle mathcolor="#136132"><mml:mn>1.61</mml:mn></mml:mstyle></mml:mrow></mml:math></inline-formula></td>
<td valign="top" align="left">Ubiquitously expressed prefoldin like chaperone</td>
<td valign="top" align="left">CPA2</td>
<td valign="top" align="left"><inline-formula><mml:math id="M69"><mml:mrow><mml:mstyle mathcolor="#336132"><mml:mn>3.898</mml:mn></mml:mstyle></mml:mrow></mml:math></inline-formula></td>
<td valign="top" align="left">Carboxypeptidase A2</td>
<td valign="top" align="left">CPB1</td>
<td valign="top" align="left"><inline-formula><mml:math id="M70"><mml:mrow><mml:mstyle mathcolor="#336132"><mml:mn>3.76</mml:mn></mml:mstyle></mml:mrow></mml:math></inline-formula></td>
<td valign="top" align="left">Carboxypeptidase B1</td>
<td valign="top" align="left">DGLUCY</td>
<td valign="top" align="left"><inline-formula><mml:math id="M71"><mml:mrow><mml:mstyle mathcolor="#136132"><mml:mn>1.36</mml:mn></mml:mstyle></mml:mrow></mml:math></inline-formula></td>
<td valign="top" align="left">D-glutamate cyclase</td>
<td valign="top" align="left">CPB1</td>
<td valign="top" align="left"><inline-formula><mml:math id="M72"><mml:mrow><mml:mstyle mathcolor="#536132"><mml:mn>5.45</mml:mn></mml:mstyle></mml:mrow></mml:math></inline-formula></td>
<td valign="top" align="left">Carboxypeptidase B1</td>
</tr>
<tr>
<td valign="top" align="left">Olfr591</td>
<td valign="top" align="center"><inline-formula><mml:math id="M73"><mml:mrow><mml:mstyle mathcolor="#136132"><mml:mn>1.6</mml:mn></mml:mstyle></mml:mrow></mml:math></inline-formula></td>
<td valign="top" align="left">Olfactory receptor 591</td>
<td valign="top" align="left">Gm10573</td>
<td valign="top" align="left"><inline-formula><mml:math id="M74"><mml:mrow><mml:mstyle mathcolor="#136132"><mml:mn>1.52</mml:mn></mml:mstyle></mml:mrow></mml:math></inline-formula></td>
<td valign="top" align="left">Palmitoyl-protein thioesterase 1 pseudogene</td>
<td valign="top" align="left">CPB1</td>
<td valign="top" align="left"><inline-formula><mml:math id="M75"><mml:mrow><mml:mstyle mathcolor="#336132"><mml:mn>3.856</mml:mn></mml:mstyle></mml:mrow></mml:math></inline-formula></td>
<td valign="top" align="left">Carboxypeptidase B1</td>
<td valign="top" align="left">PNLIP</td>
<td valign="top" align="left"><inline-formula><mml:math id="M76"><mml:mrow><mml:mstyle mathcolor="#336132"><mml:mn>3.76</mml:mn></mml:mstyle></mml:mrow></mml:math></inline-formula></td>
<td valign="top" align="left">Pancreatic lipase</td>
<td valign="top" align="left">Olfr591</td>
<td valign="top" align="left"><inline-formula><mml:math id="M77"><mml:mrow><mml:mstyle mathcolor="#136132"><mml:mn>1.36</mml:mn></mml:mstyle></mml:mrow></mml:math></inline-formula></td>
<td valign="top" align="left">Olfactory receptor591</td>
<td valign="top" align="left">CTRB2</td>
<td valign="top" align="left"><inline-formula><mml:math id="M78"><mml:mrow><mml:mstyle mathcolor="#536132"><mml:mn>5.45</mml:mn></mml:mstyle></mml:mrow></mml:math></inline-formula></td>
<td valign="top" align="left">Chymotrypsinogen B2</td>
</tr>
<tr>
<td valign="top" align="left">Acnat</td>
<td valign="top" align="center"><inline-formula><mml:math id="M79"><mml:mrow><mml:mstyle mathcolor="#136132"><mml:mn>1.6</mml:mn></mml:mstyle></mml:mrow></mml:math></inline-formula></td>
<td valign="top" align="left">Acyl-coenzyme A amino acid N-acyltransferase 2</td>
<td valign="top" align="left">27000<break/>79J08Rik</td>
<td valign="top" align="left"><inline-formula><mml:math id="M80"><mml:mrow><mml:mstyle mathcolor="#136132"><mml:mn>1.25</mml:mn></mml:mstyle></mml:mrow></mml:math></inline-formula></td>
<td/>
<td valign="top" align="left">PNLIP</td>
<td valign="top" align="left"><inline-formula><mml:math id="M81"><mml:mrow><mml:mstyle mathcolor="#336132"><mml:mn>3.8</mml:mn></mml:mstyle></mml:mrow></mml:math></inline-formula></td>
<td valign="top" align="left">Pancreatic lipase</td>
<td valign="top" align="left">Muc1</td>
<td valign="top" align="left"><inline-formula><mml:math id="M82"><mml:mrow><mml:mstyle mathcolor="#336132"><mml:mn>3.52</mml:mn></mml:mstyle></mml:mrow></mml:math></inline-formula></td>
<td valign="top" align="left">Mucin 1, transmembrane</td>
<td valign="top" align="left">Acnat1/2</td>
<td valign="top" align="left"><inline-formula><mml:math id="M83"><mml:mrow><mml:mstyle mathcolor="#136132"><mml:mn>1.33</mml:mn></mml:mstyle></mml:mrow></mml:math></inline-formula></td>
<td valign="top" align="left">Acyl-coenzyme A amino acid N-acyltransferase 2</td>
<td valign="top" align="left">CPA1</td>
<td valign="top" align="left"><inline-formula><mml:math id="M84"><mml:mrow><mml:mstyle mathcolor="#536132"><mml:mn>5.16</mml:mn></mml:mstyle></mml:mrow></mml:math></inline-formula></td>
<td valign="top" align="left">Carboxypeptidase A1</td>
</tr>
<tr>
<td valign="top" align="left">1700010D01<break/>Rik/Gm5941</td>
<td valign="top" align="center"><inline-formula><mml:math id="M85"><mml:mrow><mml:mstyle mathcolor="#136132"><mml:mn>1.5</mml:mn></mml:mstyle></mml:mrow></mml:math></inline-formula></td>
<td/>
<td valign="top" align="left">impdh2</td>
<td valign="top" align="left"><inline-formula><mml:math id="M86"><mml:mrow><mml:mstyle mathcolor="#136132"><mml:mn>1.14</mml:mn></mml:mstyle></mml:mrow></mml:math></inline-formula></td>
<td valign="top" align="left">Inosine monophosphate dehydrogenase 2</td>
<td valign="top" align="left">221001<break/>0C04Rik</td>
<td valign="top" align="left"><inline-formula><mml:math id="M87"><mml:mrow><mml:mstyle mathcolor="#336132"><mml:mn>3.5</mml:mn></mml:mstyle></mml:mrow></mml:math></inline-formula></td>
<td/>
<td valign="top" align="left">CPA1</td>
<td valign="top" align="left"><inline-formula><mml:math id="M88"><mml:mrow><mml:mstyle mathcolor="#336132"><mml:mn>3.48</mml:mn></mml:mstyle></mml:mrow></mml:math></inline-formula></td>
<td valign="top" align="left">Carboxypeptidase A1</td>
<td valign="top" align="left">OR5K1</td>
<td valign="top" align="left"><inline-formula><mml:math id="M89"><mml:mrow><mml:mstyle mathcolor="#136132"><mml:mn>1.31</mml:mn></mml:mstyle></mml:mrow></mml:math></inline-formula></td>
<td valign="top" align="left">Olfactory receptor family 5 subfamily K member 1</td>
<td valign="top" align="left">221001<break/>0C04Rik</td>
<td valign="top" align="left"><inline-formula><mml:math id="M90"><mml:mrow><mml:mstyle mathcolor="#536132"><mml:mn>5.05</mml:mn></mml:mstyle></mml:mrow></mml:math></inline-formula></td>
<td/>
</tr>
<tr>
<td valign="top" align="left">GJD2</td>
<td valign="top" align="center"><inline-formula><mml:math id="M91"><mml:mrow><mml:mstyle mathcolor="#136132"><mml:mn>1.5</mml:mn></mml:mstyle></mml:mrow></mml:math></inline-formula></td>
<td valign="top" align="left">Gap junction protein delta 2</td>
<td valign="top" align="left">Elobl</td>
<td valign="top" align="left"><inline-formula><mml:math id="M92"><mml:mrow><mml:mstyle mathcolor="#136132"><mml:mn>1.13</mml:mn></mml:mstyle></mml:mrow></mml:math></inline-formula></td>
<td valign="top" align="left">Elongin B-like</td>
<td valign="top" align="left">CTRL</td>
<td valign="top" align="left"><inline-formula><mml:math id="M93"><mml:mrow><mml:mstyle mathcolor="#336132"><mml:mn>3.49</mml:mn></mml:mstyle></mml:mrow></mml:math></inline-formula></td>
<td valign="top" align="left">Chymotrypsin like 1</td>
<td valign="top" align="left">2210010C04Rik</td>
<td valign="top" align="left"><inline-formula><mml:math id="M94"><mml:mrow><mml:mstyle mathcolor="#336132"><mml:mn>3.35</mml:mn></mml:mstyle></mml:mrow></mml:math></inline-formula></td>
<td/>
<td valign="top" align="left">Olfr469</td>
<td valign="top" align="left"><inline-formula><mml:math id="M95"><mml:mrow><mml:mstyle mathcolor="#136132"><mml:mn>1.31</mml:mn></mml:mstyle></mml:mrow></mml:math></inline-formula></td>
<td valign="top" align="left">Olfactory receptor 469</td>
<td valign="top" align="left">CTRL</td>
<td valign="top" align="left"><inline-formula><mml:math id="M96"><mml:mrow><mml:mstyle mathcolor="#436132"><mml:mn>4.5</mml:mn></mml:mstyle></mml:mrow></mml:math></inline-formula></td>
<td valign="top" align="left">Chymotrypsin like 1</td>
</tr>
<tr>
<td valign="top" align="left">Cym</td>
<td valign="top" align="center"><inline-formula><mml:math id="M97"><mml:mrow><mml:mstyle mathcolor="#136132"><mml:mn>1.5</mml:mn></mml:mstyle></mml:mrow></mml:math></inline-formula></td>
<td valign="top" align="left">Chymosin</td>
<td valign="top" align="left">Eppin</td>
<td valign="top" align="left"><inline-formula><mml:math id="M98"><mml:mrow><mml:mstyle mathcolor="#136132"><mml:mn>1.07</mml:mn></mml:mstyle></mml:mrow></mml:math></inline-formula></td>
<td valign="top" align="left">Epididymal peptidase inhibitor</td>
<td valign="top" align="left">Muc1</td>
<td valign="top" align="left"><inline-formula><mml:math id="M99"><mml:mrow><mml:mstyle mathcolor="#336132"><mml:mn>3.48</mml:mn></mml:mstyle></mml:mrow></mml:math></inline-formula></td>
<td valign="top" align="left">Mucin 1, transmembrane</td>
<td valign="top" align="left">CTRL</td>
<td valign="top" align="left"><inline-formula><mml:math id="M100"><mml:mrow><mml:mstyle mathcolor="#336132"><mml:mn>3.22</mml:mn></mml:mstyle></mml:mrow></mml:math></inline-formula></td>
<td valign="top" align="left">Chymotrypsin like 1</td>
<td valign="top" align="left">Olfr517</td>
<td valign="top" align="left"><inline-formula><mml:math id="M101"><mml:mrow><mml:mstyle mathcolor="#136132"><mml:mn>1.28</mml:mn></mml:mstyle></mml:mrow></mml:math></inline-formula></td>
<td valign="top" align="left">Olfactory receptor 517</td>
<td valign="top" align="left">CPA2</td>
<td valign="top" align="left"><inline-formula><mml:math id="M102"><mml:mrow><mml:mstyle mathcolor="#436132"><mml:mn>4.41</mml:mn></mml:mstyle></mml:mrow></mml:math></inline-formula></td>
<td valign="top" align="left">Carboxypeptidase A2</td>
</tr>
<tr>
<td valign="top" align="left">TRDN</td>
<td valign="top" align="center"><inline-formula><mml:math id="M103"><mml:mrow><mml:mstyle mathcolor="#136132"><mml:mn>1.4</mml:mn></mml:mstyle></mml:mrow></mml:math></inline-formula></td>
<td valign="top" align="left">Triadin</td>
<td valign="top" align="left">ZNF14</td>
<td valign="top" align="left"><inline-formula><mml:math id="M104"><mml:mrow><mml:mstyle mathcolor="#136132"><mml:mn>1.05</mml:mn></mml:mstyle></mml:mrow></mml:math></inline-formula></td>
<td valign="top" align="left">Zinc finger protein 14</td>
<td valign="top" align="left">CELA3b</td>
<td valign="top" align="left"><inline-formula><mml:math id="M105"><mml:mrow><mml:mstyle mathcolor="#336132"><mml:mn>3.47</mml:mn></mml:mstyle></mml:mrow></mml:math></inline-formula></td>
<td valign="top" align="left">Chymotrypsin like elastase 3B</td>
<td valign="top" align="left">CPA2</td>
<td valign="top" align="left"><inline-formula><mml:math id="M106"><mml:mrow><mml:mstyle mathcolor="#236132"><mml:mn>2.796</mml:mn></mml:mstyle></mml:mrow></mml:math></inline-formula></td>
<td valign="top" align="left">Carboxypeptidase A2</td>
<td valign="top" align="left">MRGPRX3</td>
<td valign="top" align="left"><inline-formula><mml:math id="M107"><mml:mrow><mml:mstyle mathcolor="#136132"><mml:mn>1.22</mml:mn></mml:mstyle></mml:mrow></mml:math></inline-formula></td>
<td valign="top" align="left">MAS related GPR family member X3</td>
<td valign="top" align="left">CEL</td>
<td valign="top" align="left"><inline-formula><mml:math id="M108"><mml:mrow><mml:mstyle mathcolor="#336132"><mml:mn>3.64</mml:mn></mml:mstyle></mml:mrow></mml:math></inline-formula></td>
<td valign="top" align="left">Carboxyl ester lipase</td>
</tr>
<tr>
<td valign="top" align="left">Zfp947/Zfp995</td>
<td valign="top" align="center"><inline-formula><mml:math id="M109"><mml:mrow><mml:mstyle mathcolor="#136132"><mml:mn>1.3</mml:mn></mml:mstyle></mml:mrow></mml:math></inline-formula></td>
<td valign="top" align="left">Zinc finger protein 995</td>
<td valign="top" align="left">SRGAP2</td>
<td valign="top" align="left"><inline-formula><mml:math id="M110"><mml:mrow><mml:mstyle mathcolor="#136132"><mml:mn>1.05</mml:mn></mml:mstyle></mml:mrow></mml:math></inline-formula></td>
<td valign="top" align="left">SLIT-ROBO Rho GTPase activating protein 2</td>
<td valign="top" align="left">CTRB2</td>
<td valign="top" align="left"><inline-formula><mml:math id="M111"><mml:mrow><mml:mstyle mathcolor="#336132"><mml:mn>3.44</mml:mn></mml:mstyle></mml:mrow></mml:math></inline-formula></td>
<td valign="top" align="left">Chymotrypsinogen B2</td>
<td valign="top" align="left">CEL</td>
<td valign="top" align="left"><inline-formula><mml:math id="M112"><mml:mrow><mml:mstyle mathcolor="#236132"><mml:mn>2.2</mml:mn></mml:mstyle></mml:mrow></mml:math></inline-formula></td>
<td valign="top" align="left">Carboxyl ester lipase</td>
<td valign="top" align="left">IDO1</td>
<td valign="top" align="left"><inline-formula><mml:math id="M113"><mml:mrow><mml:mstyle mathcolor="#136132"><mml:mn>1.21</mml:mn></mml:mstyle></mml:mrow></mml:math></inline-formula></td>
<td valign="top" align="left">Indoleamine 2,3-dioxygenase 1</td>
<td valign="top" align="left">CELA3b</td>
<td valign="top" align="left"><inline-formula><mml:math id="M114"><mml:mrow><mml:mstyle mathcolor="#336132"><mml:mn>3.43</mml:mn></mml:mstyle></mml:mrow></mml:math></inline-formula></td>
<td valign="top" align="left">Chymotrypsin like elastase 3B</td>
</tr>
<tr>
<td valign="top" align="left">Olfr1274</td>
<td valign="top" align="center"><inline-formula><mml:math id="M115"><mml:mrow><mml:mstyle mathcolor="#136132"><mml:mn>1.3</mml:mn></mml:mstyle></mml:mrow></mml:math></inline-formula></td>
<td valign="top" align="left">Olfactory receptor 1274</td>
<td valign="top" align="left">Psg18</td>
<td valign="top" align="left"><inline-formula><mml:math id="M116"><mml:mrow><mml:mstyle mathcolor="#136132"><mml:mn>1.01</mml:mn></mml:mstyle></mml:mrow></mml:math></inline-formula></td>
<td valign="top" align="left">Pregnancy specific glycoprotein 18</td>
<td valign="top" align="left">CEL</td>
<td valign="top" align="left"><inline-formula><mml:math id="M117"><mml:mrow><mml:mstyle mathcolor="#336132"><mml:mn>3.21</mml:mn></mml:mstyle></mml:mrow></mml:math></inline-formula></td>
<td valign="top" align="left">Carboxyl ester lipase</td>
<td valign="top" align="left">CELA3b</td>
<td valign="top" align="left"><inline-formula><mml:math id="M118"><mml:mrow><mml:mstyle mathcolor="#136132"><mml:mn>1.88</mml:mn></mml:mstyle></mml:mrow></mml:math></inline-formula></td>
<td valign="top" align="left">Chymotrypsin like elastase 3B</td>
<td valign="top" align="left">Klra7</td>
<td valign="top" align="left"><inline-formula><mml:math id="M119"><mml:mrow><mml:mstyle mathcolor="#136132"><mml:mn>1.2</mml:mn></mml:mstyle></mml:mrow></mml:math></inline-formula></td>
<td valign="top" align="left">Killer cell lectin-like receptor, subfamily A, member 4</td>
<td valign="top" align="left">PRSS2</td>
<td valign="top" align="left"><inline-formula><mml:math id="M120"><mml:mrow><mml:mstyle mathcolor="#336132"><mml:mn>3.01</mml:mn></mml:mstyle></mml:mrow></mml:math></inline-formula></td>
<td valign="top" align="left">Serine protease 2</td>
</tr>
</tbody>
</table>
<table-wrap-foot>
<p><italic>Citrate transport; ion transport; sodium ion transport; succinate transmembrane transport; sulfate transport; transmembrane transport. Number in green indicates decreased expression and red indicates increased expression</italic>.</p>
</table-wrap-foot>
</table-wrap>
<fig id="F3" position="float">
<label>Figure 3</label>
<caption><p>IPA regulator effect networks analysis of differentially expressed (DE) genes between Muc1<sup>&#x02212;/&#x02212;</sup> vs. wild type (WT) gastric tissues before infection (The highest Consistency Score of regulator effect networks is shown). Upstream regulators are located at the top of the network, target genes are in the middle of network and predicated disease or function in the bottom of network. Log ratio fold changes of DE genes in our data set is showed underneath each gene (red color symbol indicates increased expression). The concept of Regulator Effects in IPA is that The Regulator Effects algorithm connects upstream regulators, dataset molecules and downstream functions or diseases affected in your dataset to generate a hypothesis that can explain how the activation or inhibition of an upstream regulator affects the downstream target molecule expression and the impact of the molecular expression on functions and diseases. The algorithm goes through one or more iterations to merge upstream and downstream results from the Upstream Regulator. The networks are merged only if the overlap of targets has possible statistical significance (Fisher&#x00027;s Exact Test p-value of &#x0003C;0.05). For each network, a Consistency Score is calculated that rewards for paths from regulator-&#x0003E;target-&#x0003E;disease or function that are consistent. Higher scoring hypotheses are those with more consistent causal paths represented by a high Consistency Score.</p></caption>
<graphic xlink:href="fcimb-10-00343-g0003.tif"/>
</fig>
<table-wrap position="float" id="T2">
<label>Table 2</label>
<caption><p>Gastric Muc1<sup>&#x02212;/&#x02212;</sup> vs. WT (KO/WT) regulator effects<sup>&#x0002A;</sup> at different time points.</p></caption>
<table frame="hsides" rules="groups">
<thead>
<tr>
<th valign="top" align="left"><bold>Time</bold></th>
<th valign="top" align="left"><bold>Consistency score</bold></th>
<th valign="top" align="left"><bold>Node total</bold></th>
<th valign="top" align="left"><bold>Regulator total</bold></th>
<th valign="top" align="left"><bold>Regulators</bold></th>
<th valign="top" align="center"><bold>Target total</bold></th>
<th valign="top" align="left"><bold>Target molecules in dataset</bold></th>
<th valign="top" align="left"><bold>Diseases and functions</bold></th>
</tr>
</thead>
<tbody>
<tr>
<td valign="top" align="left">Sham (KO/WT)</td>
<td valign="top" align="left">4.536</td>
<td valign="top" align="left">11</td>
<td valign="top" align="left">3</td>
<td valign="top" align="left">HNF1A, HNF4A, SOX2</td>
<td valign="top" align="center">7</td>
<td valign="top" align="left">ABCC2, ABCG5, ALB, Apoc3, FABP1, FABP2, MTTP</td>
<td valign="top" align="left">Transport of lipid</td>
</tr>
<tr>
<td valign="top" align="left">8 h (KO/WT)</td>
<td valign="top" align="left">16.028</td>
<td valign="top" align="left">30</td>
<td valign="top" align="left">7</td>
<td valign="top" align="left">FOXA2, HNF1A, HNF4A, Ncoa-Nr1i2-Rxra, Ncoa-Nr1i3-Rxra, OSM, PXR ligand-PXR-Retinoic acid-RXR&#x003B1;</td>
<td valign="top" align="center">18</td>
<td valign="top" align="left">ABCC2, ALB, APOA4, APOC2, Apoc3, CXCL3, CYP2C8, CYP2C9, CYP2E1, CYP3A5, FABP1, FABP2, MTTP, MUC2, SCD, SLC5A1, SLPI, VDR</td>
<td valign="top" align="left">Abnormality of large intestine, conversion of lipid, enteritis, fatty acid metabolism, metabolism of vitamin</td>
</tr>
<tr>
<td valign="top" align="left">8 h (KO/WT)</td>
<td valign="top" align="left">15.718</td>
<td valign="top" align="left">40</td>
<td valign="top" align="left">8</td>
<td valign="top" align="left">FOXA2, miR-12201-5p (and other miRNAs w/seed GGAAGGA), miR-1293 (and other miRNAs w/seed GGGUGGU), Ncoa-Nr1i2-Rxra, Ncoa-Nr1i3-Rxra, NCOR-LXR-Oxysterol-RXR-9 cis RA, PPARGC1A, PXR ligand-PXR-Retinoic acid-RXR&#x003B1;</td>
<td valign="top" align="center">24</td>
<td valign="top" align="left">ABCC2, ADA, ALB, ALPI, APOA4, APOC2, Apoc3, CA3, CYP2C8, CYP2C9, CYP3A5, FABP1, GAL, GUCA2B, MME, MTTP, MUC2, PNLIPRP1, SCD, SERPINA1, SERPINB4, SLC2A2, SLC46A1, VDR</td>
<td valign="top" align="left">Disorder of blood pressure, fatty acid metabolism, inflammation of absolute anatomical region, inflammation of organ, metabolism of terpenoid, metabolism of vitamin, synthesis of lipid, transport of molecule</td>
</tr>
<tr>
<td valign="top" align="left">24 h (KO/WT)</td>
<td valign="top" align="left">165.333</td>
<td valign="top" align="left">75</td>
<td valign="top" align="left">63</td>
<td valign="top" align="left">ACKR2, BTK, CGAS, DDX58, DNASE2, DOCK8, FADD, FZD9, GAPDH, IFIH1, Ifn, IFN Beta, IFN type 1, IFNA1/IFNA13, IFNA2, IFNA4, Ifnar, IFNAR1, IFNB1, IFNE, IFNG, IFNL1, IFNL3, IFNL4, IL1B, IL1RN, IL21, IL4, Interferon alpha, IRF1, IRF3, IRF4, IRF5, IRF7, JAK, JAK1/2, MAPK1, MAVS, MYD88, NFATC2, NSD2, PAF1, PML, PNPT1, PRL, PTGER4, SAMSN1, SASH1, SOCS1, SP110, SPI1, STAT1, STAT2, STAT6, TGM2, TICAM1, TLR3, TLR4, TLR7, TLR9, TMEM173, TNF, TRIM24</td>
<td valign="top" align="center">9</td>
<td valign="top" align="left">CEL, Igtp, ISG15, Mx1, OAS1, OAS3, Oasl2, RSAD2, ZBP1</td>
<td valign="top" align="left">Relapsing-remitting multiple sclerosis, replication of viral replicon, replication of virus</td>
</tr>
<tr>
<td valign="top" align="left">24 h (KO/WT)</td>
<td valign="top" align="left">1.000</td>
<td valign="top" align="left">6</td>
<td valign="top" align="left">4</td>
<td valign="top" align="left">IFNB1</td>
<td valign="top" align="center">4</td>
<td valign="top" align="left">DHX58, Igtp, Irgm1, STAT1</td>
<td valign="top" align="left">Quantity of IL-12 in blood</td>
</tr>
<tr>
<td valign="top" align="left">72 h (KO/WT)</td>
<td valign="top" align="left">10.156</td>
<td valign="top" align="left">22</td>
<td valign="top" align="left">6</td>
<td valign="top" align="left">DNASE2, IKBKG, IL17A, SNCA, STAT2, TLR3</td>
<td valign="top" align="center">14</td>
<td valign="top" align="left">Defb3, DHX58, GBP2, IFIT3, IL33, IRF7, ISG15, Mx1, OAS2, OAS3, Oasl2, RSAD2, USP18, ZBP1</td>
<td valign="top" align="left">Infection of mammalia, viral infection</td>
</tr>
<tr>
<td valign="top" align="left">72 h (KO/WT)</td>
<td valign="top" align="left">4.333</td>
<td valign="top" align="left">14</td>
<td valign="top" align="left">4</td>
<td valign="top" align="left">IFNB1, IKBKG, IL17A, SNCA</td>
<td valign="top" align="center">9</td>
<td valign="top" align="left">Defb3, DHX58, GBP2, Igtp, IL33, IRF7, Irgm1, ISG15, USP18</td>
<td valign="top" align="left">Infection of mammalia</td>
</tr>
</tbody>
</table>
<table-wrap-foot>
<p><italic>Regulator effects<sup>&#x0002A;</sup>: The concept of Regulator Effects in IPA is that The Regulator Effects algorithm connects upstream regulators, dataset molecules, and downstream functions or diseases affected in your dataset to generate a hypothesis that can explain how the activation or inhibition of an upstream regulator affects the downstream target molecule expression and the impact of the molecular expression on functions and diseases. The algorithm goes through one or more iterations to merge upstream and downstream results from the Upstream Regulator. The networks are merged only if the overlap of targets has possible statistical significance (Fisher&#x00027;s Exact Test p-value of &#x0003C;0.05). For each network, a Consistency Score is calculated that rewards for paths from regulator-&#x0003E;target-&#x0003E;disease or function that are consistent. Higher scoring hypotheses are those with more consistent causal paths represented by a high Consistency Score</italic>.</p>
</table-wrap-foot>
</table-wrap>
<table-wrap position="float" id="T3">
<label>Table 3</label>
<caption><p>Gastric <italic>Muc1</italic><sup>&#x02212;/&#x02212;</sup> vs. WT (KO/WT) molecule networks<sup>&#x0002A;</sup> at different time points.</p></caption>
<table frame="hsides" rules="groups">
<thead>
<tr>
<th valign="top" align="left"><bold>Time</bold></th>
<th valign="top" align="left"><bold>Molecules in network</bold></th>
<th valign="top" align="center"><bold>Score</bold></th>
<th valign="top" align="center"><bold>Focus molecules</bold></th>
<th valign="top" align="left"><bold>Top diseases and functions</bold></th>
</tr>
</thead>
<tbody>
<tr>
<td valign="top" align="left">Sham (KO/WT)</td>
<td valign="top" align="left">ALB, Alphacatenin, AOC1, CDH17, Ces2e, CFD, chymotrypsin, CTRB2, ERK1/2, GAL, Gm21596/Hmgb1, GOT, H19, Iga, IgG, Igh, Igm, JCHAIN, MTTP, Muc1, MUC13, MUC2, Muc3, Mucin, PIGR, PRSS3, PTPRZ1, REG3G, Secretase gamma, SLC6A19, TDGF1, TFF3, UGT, UGT2B28, UGT2B7</td>
<td valign="top" align="center">53</td>
<td valign="top" align="center">25</td>
<td valign="top" align="left">Digestive System Development and Function, Humoral Immune Response, Organ Development</td>
</tr>
<tr>
<td valign="top" align="left">Sham (KO/WT)</td>
<td valign="top" align="left">2210010C04Rik, ABCG5, Akt, ALDOB, Apoc3, carboxypeptidase, CPA1, CPA2, CPB1, CYP2E1, Cyp3a25 (includes others), CYP3A5, DBP, Defa3 (includes others), Defa6, FABP1, FABP2, Growth hormone, HDL, HDL-cholesterol, hemoglobin, HNF4&#x003B1; dimer, IL23, LDL-cholesterol, MEP1B, Nr1h, PRAP1, REG3A, SLC13A1, SLC2A2, SLC40A1, SLC5A1, TM4SF20, trypsin, Trypsinogen</td>
<td valign="top" align="center">48</td>
<td valign="top" align="center">23</td>
<td valign="top" align="left">Carbohydrate Metabolism, Lipid Metabolism, Small Molecule Biochemistry</td>
</tr>
<tr>
<td valign="top" align="left">Sham (KO/WT)</td>
<td valign="top" align="left">Ap1, ARG2, CCN3, CELA3B, CG, Collagen type I (complex), Creb, CTRC, CTRL, Defb4, elastase, ENPP3, GGT1, GJD2, Iglv1, IL1, KLK3, LDL, LYZ, MHC Class II (complex), MME, Mmp, Mug1/Mug2, NFkB (complex), P38 MAPK, Pro-inflammatory Cytokine, PRSS2, S100G, Serine Protease, SERPINA1, SERPINB10, SI, TAC1, TCF, Tnf (family)</td>
<td valign="top" align="center">39</td>
<td valign="top" align="center">20</td>
<td valign="top" align="left">Post-Translational Modification, Protein Degradation, Protein Synthesis</td>
</tr>
<tr>
<td valign="top" align="left">8 h (KO/WT)</td>
<td valign="top" align="left">1810009J06Rik/Gm2663, 2210010C04Rik, carboxypeptidase, chymotrypsin, Collagen type I (complex), CPA1, CPA2, CPB1, Crisp1/Crisp3, CTRB2, CTRC, CTRL, estrogen receptor, FABP1, Growth hormone, Iglv1, KLK3, MEP1B, NFkB (complex), PRAP1, Prss1 (includes others), PRSS2, PRSS3, S100G, Serine Protease, SERPINA1, SI, SLC7A9, TCF, TM4SF20, Tnf (family), trypsin, Trypsinogen, UXT, VDR</td>
<td valign="top" align="center">50</td>
<td valign="top" align="center">24</td>
<td valign="top" align="left">Post-Translational Modification, Protein Degradation, Protein Synthesis</td>
</tr>
<tr>
<td valign="top" align="left">8 h (KO/WT)</td>
<td valign="top" align="left">ADA, AHSG, Akt, ALB, CELA1, CELA3B, Ces2e, CPS1, Defa3 (includes others), Defa6, elastase, ENPP3, GOT, hemoglobin, Ige, IgG, Igm, IL12 (complex), LDL, MHC Class II (complex), Muc1, MUC13, MUC2, Muc3, Mucin, PIGR, SCD, Secretase gamma, Serpinb3b/Serpinb3c, SLC13A1, SLC40A1, SLC6A19, SLPI, Sos, TFF3</td>
<td valign="top" align="center">45</td>
<td valign="top" align="center">22</td>
<td valign="top" align="left">Cancer, Dermatological Diseases and Conditions, Organismal Injury and Abnormalities</td>
</tr>
<tr>
<td valign="top" align="left">8 h (KO/WT)</td>
<td valign="top" align="left">ABCC2, ALDOB, ALT, AOC1, APOA4, APOC2, Apoc3, ARG2, BHMT, CAR ligand-CAR-Retinoic acid-RXR&#x003B1;, CDH17, CUZD1, CYP2C8, CYP2C9, CYP2E1, CYP3A5, ERK1/2, GAL, HDL, HDL-cholesterol, Hnf3, HNF4&#x003B1; dimer, LDL-cholesterol, MAT1A, MTTP, Ncoa-Nr1i2-Rxra, Ncoa-Nr1i3-Rxra, NCOR-LXR-Oxysterol-RXR-9 cis RA, Nr1h, PXR ligand-PXR-Retinoic acid-RXR&#x003B1;, Rxr, triacylglycerol lipase, unspecific monooxygenase, VLDL, VLDL-cholesterol</td>
<td valign="top" align="center">32</td>
<td valign="top" align="center">17</td>
<td valign="top" align="left">Drug Metabolism, Lipid Metabolism, Small Molecule Biochemistry</td>
</tr>
<tr>
<td valign="top" align="left">24 h (KO/WT)</td>
<td valign="top" align="left">2210010C04Rik, 3830403N18Rik/Xlr, ABCC2, Akt, ALDOB, CAR ligand-CAR-Retinoic acid-RXR&#x003B1;, carboxypeptidase, chymotrypsin, CPA1, CPA2, CPB1, CTRB2, CTRC, CTRL, CYP2B6, Cyp3a25 (includes others), CYP3A5, FABP1, FABP2, HNF4&#x003B1; dimer, Igtp, Ncoa-Nr1i2-Rxra, Ncoa-Nr1i3-Rxra, P glycoprotein, PRSS1, Prss1 (includes others), PRSS2, PRSS3, PXR ligand-PXR-Retinoic acid-RXR&#x003B1;, Rxr, SLC13A1, TMPRSS15, trypsin, Trypsinogen, TTPA</td>
<td valign="top" align="center">47</td>
<td valign="top" align="center">23</td>
<td valign="top" align="left">Drug Metabolism, Endocrine System Development and Function, Lipid Metabolism</td>
</tr>
<tr>
<td valign="top" align="left">24 h (KO/WT)</td>
<td valign="top" align="left">ACE2, Alp, ALPI, ALPP, AMPK, Ap1, APOC2, ARG2, Collagen type I (complex), Collagen(s), ERK, G6PC, GBP4, Gm10768, Growth hormone, Immunoglobulin, Interferon alpha, LDL, MEP1B, Mup1 (includes others), Nr1h, Oasl2, PHF11, PRAP1, RNF213, RTP4, S100G, SI, SLFN12L, Slfn2, SPINK1, STAT1, Tgf beta, TM4SF20, UBE2F</td>
<td valign="top" align="center">47</td>
<td valign="top" align="center">23</td>
<td valign="top" align="left">Developmental Disorder, Gastrointestinal Disease, Hereditary Disorder</td>
</tr>
<tr>
<td valign="top" align="left">24 h (KO/WT)</td>
<td valign="top" align="left">2&#x00027; 5&#x00027; oas, AOC1, CCL25, CDH17, CUZD1, DHX58, ERK1/2, IDO1, IFI44, IFIT1B, IFIT3, Ifn, IFN alpha/beta, IFN Beta, IFN type 1, Ifnar, Interferon-&#x003B1; Induced, IRF, IRF7, Irgm1, Isg, ISG15, ISGF3, JAK1/2, Mx1, Mx2, Oas, OAS1, OAS2, OAS3, RSAD2, Sp100, Stat1-Stat2, TCF, ZBP1</td>
<td valign="top" align="center">39</td>
<td valign="top" align="center">20</td>
<td valign="top" align="left">Antimicrobial Response, Dermatological Diseases and Conditions, Inflammatory Response</td>
</tr>
<tr>
<td valign="top" align="left">72 h (KO/WT)</td>
<td valign="top" align="left">DHX58, ERK1/2, IDO1, Ifi202b, IFI44, IFIT1B, IFIT3, Ifn, IFN alpha/beta, IFN Beta, IFN type 1, Ifnar, Igtp, Interferon alpha, Interferon-&#x003B1; Induced, IRF, IRF7, Irgm1, Isg, ISG15, ISGF3, JAK, JAK1/2, Mx1, Mx2, NLRC5, OAS2, OAS3, Oasl2, RSAD2, RTP4, Sp100, TAP1, USP18, ZBP1</td>
<td valign="top" align="center">50</td>
<td valign="top" align="center">22</td>
<td valign="top" align="left">Antimicrobial Response, Connective Tissue Disorders, Inflammatory Response</td>
</tr>
<tr>
<td valign="top" align="left">72 h (KO/WT)</td>
<td valign="top" align="left">2210010C04Rik, AHSG, Akt, ALB, AMY2B, amylase, carboxypeptidase, CEL, CPA1, CPA2, CPB1, CTRB2, CTRL, Fibrinogen, GBP2, GBP3, HDL, KNG1, LDL, MHC Class II (complex), Mug1/Mug2, Nr1h, PNLIP, PNLIPRP1, Pro-inflammatory Cytokine, PRSS2, PRSS3, Pzp, Serine Protease, SERPINA1, SLFN12L, Tnf (family), triacylglycerol lipase, trypsin, Trypsinogen</td>
<td valign="top" align="center">47</td>
<td valign="top" align="center">21</td>
<td valign="top" align="left">Endocrine System Disorders, Gastrointestinal Disease, Immunological Disease</td>
</tr>
<tr>
<td valign="top" align="left">72 h (KO/WT)</td>
<td valign="top" align="left">2&#x00027; 5&#x00027; oas, Apol7e (includes others), Apol9a/Apol9b, APP, beta-estradiol, C2orf49, CELA3B, CFB, CPA2, CYP2C18, dehydroepiandrosterone sulfate, DGLUCY, DHX58, GBP4, Gm5662 (includes others), GP2, GRIN2A, GSDMC, IFNAR1, IL10RA, IRF1, Mcpt1, Muc1, Mx2, nitrogen, NR5A2, Oasl2, PPP2CA, RBPJL, RNASE1, Rnu5g, SYCN, Tlr11, Tlr12, TNF</td>
<td valign="top" align="center">36</td>
<td valign="top" align="center">17</td>
<td valign="top" align="left">Cellular Assembly and Organization, Molecular Transport, Small Molecule Biochemistry</td>
</tr>
</tbody>
</table>
<table-wrap-foot>
<p><italic>Molecule Networks<sup>&#x0002A;</sup>: Molecule Networks in IPA is that Analysis Ready molecules which interact with other molecules in the Ingenuity Knowledge Base are considered &#x0201C;network eligible&#x0201D; and serve as &#x0201C;seeds&#x0201D; for generating networks. There may be some Analysis Ready molecules that will pass all the filtering criteria you set for your analysis but may not be network eligible because there is no known scientific evidence of these molecules directly or indirectly interacting with other molecules in the Ingenuity Knowledge base. The score is a numerical value used to rank networks according to their degree of relevance to the Network Eligible molecules in your dataset. The score takes into account the number of Network Eligible molecules in the network and its size, as well as the total number of Network Eligible molecules analyzed and the total number of molecules in the Ingenuity Knowledge Base that could potentially be included in networks. In the Networks view, networks are ordered according to their score, with the highest scoring network displayed at the top of the page</italic>.</p>
</table-wrap-foot>
</table-wrap>
<fig id="F4" position="float">
<label>Figure 4</label>
<caption><p>IPA molecular networks analysis of differentially expressed (DE) genes between <italic>Muc1</italic><sup>&#x02212;/&#x02212;</sup> vs. wild type gastric tissues before infection. Log ratio fold changes of DE genes in our data set is shown underneath each gene (- number or green symbol indicates decreased expression and otherwise/red indicates increased expression).</p></caption>
<graphic xlink:href="fcimb-10-00343-g0004.tif"/>
</fig>
</sec>
<sec>
<title>Differences in Activation of Molecular Networks Between WT and <italic>Muc1<sup>&#x02212;/&#x02212;</sup></italic> Mice in Response to <italic>H. pylori</italic> Infection</title>
<p>Next a transcriptomic analysis was performed at 8, 24, and 72 h post-infection. For this purpose, we analyzed each time point individually, as well as in various combinations. A comparative analysis using a threshold of 2-fold difference identified a total of 174 differentially expressed (DE) genes in WT and 326 in <italic>Muc1</italic><sup>&#x02212;/&#x02212;</sup> mice in response to infection (<xref ref-type="fig" rid="F2">Figures 2B,C</xref>). The number of DE genes was higher in <italic>Muc1</italic><sup>&#x02212;/&#x02212;</sup> mice than WT mice at 8 h post infection (<xref ref-type="fig" rid="F2">Figures 2B,C</xref>); the higher number of DE genes could be a consequence of the higher colonization levels of <italic>H. pylori</italic> in <italic>Muc1</italic><sup>&#x02212;/&#x02212;</sup> mice. At 24 h infection, there were fewer up-regulated genes (20) in <italic>Muc1</italic><sup>&#x02212;/&#x02212;</sup> compared to WT gastric mucosa (80), despite the higher colonization levels of <italic>H. pylori</italic> (<xref ref-type="fig" rid="F2">Figures 2B,C</xref>). A similar trend was observed for up-regulated genes at 72 h infection. In contrast, <italic>Muc1</italic><sup>&#x02212;/&#x02212;</sup> mice showed a greater number of down-regulated genes (173) than WT (20) after 24 h infection, and the number of down-regulated genes surpassed the number of up-regulated genes throughout the time course in <italic>Muc1</italic><sup>&#x02212;/&#x02212;</sup> mice (<xref ref-type="fig" rid="F2">Figures 2B,C</xref>). A list of the top 10 DE genes is provided in <xref ref-type="table" rid="T1">Table 1</xref>. The number of DE genes at each time point in comparison to uninfected controls is illustrated in <xref ref-type="fig" rid="F2">Figures 2B,C</xref>. The number of DE genes at each time point in the gastric tissue of <italic>Muc1</italic><sup>&#x02212;/&#x02212;</sup> compared with WT mice is illustrated in <xref ref-type="fig" rid="F2">Figure 2A</xref>.</p>
</sec>
<sec>
<title>Pathway and Network Functional Categories</title>
<p>In this section, rather than discussing genes individually, we have grouped differentially regulated genes into canonical pathways and associated network functions, identified the upstream factors likely to drive the differentially expressed genes in the network, and focused on the most highly statistically significant changes in the pathway and network.</p>
</sec>
<sec>
<title>Temporal Changes in the SPINK 1 Pancreatic Cancer Pathway in WT and <italic>Muc1<sup>&#x02212;/&#x02212;</sup></italic> Mice in Response to <italic>H. pylori</italic> Infection</title>
<p>In uninfected mice and at 8 h post-infection, there was significantly inhibition of the Serine Protease Inhibitor Kazal type 1 (SPINK1) pancreatic cancer pathway in the gastric tissue of <italic>Muc1</italic><sup>&#x02212;/&#x02212;</sup> mice compared with WT mice uninfected or at 8 h post-infection (<italic>P</italic> = 6.08E-14 and <italic>P</italic> = 2.25E-19, respectively, <xref ref-type="fig" rid="F5">Figure 5</xref>), but at 24 and 72 h post-infection, we detected a strong activation of this pathway in <italic>Muc1</italic><sup>&#x02212;/&#x02212;</sup> mice (<italic>P</italic> = 1.38E-22 and <italic>P</italic> = 5.87E-13, respectively, <xref ref-type="fig" rid="F5">Figure 5</xref>). The main physiological role of SPINK1 is to serve as a first line inhibitor of trypsin in the event of premature trypsinogen activation (<xref ref-type="supplementary-material" rid="SM6">Supplementary Figure 1</xref>). In addition, severe infections and tissue destruction cause elevation of SPINK1 in serum and urine, suggesting that it is an acute phase protein of the immune system. SPINK1 is highly expressed by the mucus-producing cells of the normal gastric mucosa and has been hypothesized to suppress proteolytic digestion of secreted mucus and promote gastric healing after injury (Marchbank et al., <xref ref-type="bibr" rid="B18">1996</xref>, <xref ref-type="bibr" rid="B19">1998</xref>; Konturek et al., <xref ref-type="bibr" rid="B14">1998</xref>). In mouse, the homologous gene is designated <italic>Spink3</italic> (Wang and Xu, <xref ref-type="bibr" rid="B41">2010</xref>).</p>
<fig id="F5" position="float">
<label>Figure 5</label>
<caption><p>Ingenuity Pathway Analysis (IPA) showing the identified top canonical pathways of differentially expressed genes between <italic>Muc1</italic><sup>&#x02212;/&#x02212;</sup> vs. wild type (WT) gastric tissues in sham or in response to <italic>H. pylori</italic> infection over time. Significance <italic>P</italic>-values were calculated based on the Fisher&#x00027;s right tailed exact test. The-log (<italic>p</italic>-value) are shown on the top x-axis of the bar chart. The orange and blue colored bars indicate predicted pathway activation, or predicted inhibition, respectively (<italic>z</italic>-score). White bars are those with a <italic>z</italic>-score at or very close to 0. Gray bars indicate pathways, where no prediction can currently be made. IPA applies a-log (<italic>p</italic>-value) cutoff of 1.3 (threshold). SPC, SPINK1 Pancreatic Cancer Pathway; UC, Urea Cycle; NRTAZ, Neuroprotective Role of THOP1 in Alzheimer&#x00027;s Disease; MODYS, Maturity Onset Diabetes of Young Signaling; SCM, Superpathway of Citrulline Metabolism; MDI, Melatonin Degradation I; NDIII, Nicotine Degradation III; SMD, Superpathway of Melatonin Degradation; LXR/RXR, LXR/RXR Activation; FXR/RXR, FXR/RXR Activation; BD, Bupropion Degradation; AD, Acetone Degradation I (to Methylglyoxal); EB, Estrogen Biosynthesis; SGC, SPINK1 General Cancer Pathway; AICPRR, Activation of IRF by Cytosolic Pattern Recognition Receptors; INFS, Interferon Signaling; TD, Triacylglycerol Degradation; CS, Coagulation System; APRS, Acute Phase Response Signaling; RB, Retinol Biosynthesis.</p></caption>
<graphic xlink:href="fcimb-10-00343-g0005.tif"/>
</fig>
<p>The significant change in expression of genes related to the SPINK1 pathway included genes encoding proteins involved with digestion, absorption and secretion. Examples include chymotrypsin like elastase family (Cea1, Cela3b), carboxypeptidase (members Cpa1, Cpa2, Cpb1), chymotrypsin (members Ctrb2, Ctrc, Ctrl), Kallikrein related peptidase 3 (Klk3), and serine protease (Prss2, Prss3) (<xref ref-type="table" rid="T4">Table 4</xref> and <xref ref-type="supplementary-material" rid="SM6">Supplementary Figure 2</xref>). In WT mice, the focal genes in the SPINK1 pathway were up-regulated most at 24 h post-infection and appeared to be switched off and were no longer differentially expressed at 72 h infection (<xref ref-type="table" rid="T4">Table 4</xref>), whereas in Muc1<sup>&#x02212;/&#x02212;</sup> mice, the focal genes were up-regulated as early as 8 h after infection and their expression levels switched to 4&#x02013;8-fold decreased expression toward 24 h and continuing to be further down-regulated at 72 h post-infection (most of the genes were decreased in expression by 8&#x02013;32-fold, <xref ref-type="table" rid="T4">Table 4</xref>). In addition, there was higher expression of Spink3 in Muc1<sup>&#x02212;/&#x02212;</sup> mice compared with WT mice at sham and 8 h infection, but Spink3 was downregulated at 24 and 72 h post-infection (<xref ref-type="supplementary-material" rid="SM6">Supplementary Figure 4</xref>).</p>
<table-wrap position="float" id="T4">
<label>Table 4</label>
<caption><p>SPINK1 pancreatic cancer pathway.</p></caption>
<table frame="hsides" rules="groups">
<thead>
<tr>
<th/>
<th/>
<th valign="top" align="center" colspan="10" style="border-bottom: thin solid #000000;"><bold>Expr log ratio</bold></th>
<th/>
<th/>
</tr>
<tr>
<th valign="top" align="left"><bold>Symbol</bold></th>
<th valign="top" align="left"><bold>Entrez gene name</bold></th>
<th valign="top" align="center"><bold>Sham (KO/WT)</bold></th>
<th valign="top" align="center"><bold>8 h (KO/WT)</bold></th>
<th valign="top" align="center"><bold>24 h (KO/WT)</bold></th>
<th valign="top" align="center"><bold>72 h (KO/WT)</bold></th>
<th valign="top" align="center"><bold>WT (8 h/0)</bold></th>
<th valign="top" align="center"><bold>WT (24 h/0)</bold></th>
<th valign="top" align="center"><bold>WT (72 h/0)</bold></th>
<th valign="top" align="center"><bold>KO (8 h/0)</bold></th>
<th valign="top" align="center"><bold>KO (24 h/0)</bold></th>
<th valign="top" align="center"><bold>KO (72 h/0)</bold></th>
<th valign="top" align="left"><bold>Location</bold></th>
<th valign="top" align="left"><bold>Type(s)</bold></th>
</tr>
</thead>
<tbody>
<tr>
<td valign="top" align="left">1810009J06Rik/Gm2663</td>
<td valign="top" align="left">Trypsinogen 4</td>
<td valign="top" align="center">&#x02212;0.056</td>
<td valign="top" align="center" style="background-color:#f9c6ce">1.466</td>
<td valign="top" align="center">0.098</td>
<td valign="top" align="center">&#x02212;0.2</td>
<td valign="top" align="center">&#x02212;0.32</td>
<td valign="top" align="center">0.155</td>
<td valign="top" align="center">&#x02212;0.25</td>
<td valign="top" align="center" style="background-color:#f9c6ce">1.201</td>
<td valign="top" align="center">0.309</td>
<td valign="top" align="center">&#x02212;0.4</td>
<td valign="top" align="left">Other</td>
<td valign="top" align="left">Other</td>
</tr>
<tr>
<td valign="top" align="left">2210010C04Rik</td>
<td valign="top" align="left">Trypsinogen 7</td>
<td valign="top" align="center" style="background-color:#f9c6ce">1.471</td>
<td valign="top" align="center" style="background-color:#f9c6ce">3.431</td>
<td valign="top" align="center" style="background-color:#c8e5ca">&#x02212;3.51</td>
<td valign="top" align="center" style="background-color:#c8e5ca">&#x02212;3.354</td>
<td valign="top" align="center">&#x02212;0.83</td>
<td valign="top" align="center" style="background-color:#f9c6ce">1.839</td>
<td valign="top" align="center">&#x02212;0.23</td>
<td valign="top" align="center" style="background-color:#f9c6ce">1.127</td>
<td valign="top" align="center" style="background-color:#c8e5ca">&#x02212;3.14</td>
<td valign="top" align="center" style="background-color:#c8e5ca">&#x02212;5.05</td>
<td valign="top" align="left">Extracellular space</td>
<td valign="top" align="left">Other</td>
</tr>
<tr>
<td valign="top" align="left">CELA1</td>
<td valign="top" align="left">Chymotrypsin like elastase 1</td>
<td valign="top" align="center">0.836</td>
<td valign="top" align="center" style="background-color:#f9c6ce">2.245</td>
<td valign="top" align="center" style="background-color:#c8e5ca">&#x02212;1.95</td>
<td valign="top" align="center">&#x02212;0.808</td>
<td valign="top" align="center">&#x02212;0.37</td>
<td valign="top" align="center" style="background-color:#f9c6ce">1.141</td>
<td valign="top" align="center">&#x02212;0.23</td>
<td valign="top" align="center" style="background-color:#f9c6ce">1.04</td>
<td valign="top" align="center" style="background-color:#c8e5ca">&#x02212;1.65</td>
<td valign="top" align="center" style="background-color:#c8e5ca">&#x02212;1.87</td>
<td valign="top" align="left">Extracellular space</td>
<td valign="top" align="left">Peptidase</td>
</tr>
<tr>
<td valign="top" align="left">CELA3B</td>
<td valign="top" align="left">Chymotrypsin like elastase 3B</td>
<td valign="top" align="center" style="background-color:#f9c6ce">1.603</td>
<td valign="top" align="center" style="background-color:#f9c6ce">3.467</td>
<td valign="top" align="center" style="background-color:#c8e5ca">&#x02212;3.466</td>
<td valign="top" align="center" style="background-color:#c8e5ca">&#x02212;1.881</td>
<td valign="top" align="center">&#x02212;0.46</td>
<td valign="top" align="center" style="background-color:#f9c6ce">2.183</td>
<td valign="top" align="center">0.058</td>
<td valign="top" align="center" style="background-color:#f9c6ce">1.403</td>
<td valign="top" align="center" style="background-color:#c8e5ca">&#x02212;2.89</td>
<td valign="top" align="center" style="background-color:#c8e5ca">&#x02212;3.43</td>
<td valign="top" align="left">Other</td>
<td valign="top" align="left">Peptidase</td>
</tr>
<tr>
<td valign="top" align="left">CPA1</td>
<td valign="top" align="left">Carboxypeptidase A1</td>
<td valign="top" align="center" style="background-color:#f9c6ce">1.363</td>
<td valign="top" align="center" style="background-color:#f9c6ce">3.742</td>
<td valign="top" align="center" style="background-color:#c8e5ca">&#x02212;3.94</td>
<td valign="top" align="center" style="background-color:#c8e5ca">&#x02212;3.481</td>
<td valign="top" align="center" style="background-color:#c8e5ca">&#x02212;1.15</td>
<td valign="top" align="center" style="background-color:#f9c6ce">1.743</td>
<td valign="top" align="center">&#x02212;0.32</td>
<td valign="top" align="center" style="background-color:#f9c6ce">1.233</td>
<td valign="top" align="center" style="background-color:#c8e5ca">&#x02212;3.56</td>
<td valign="top" align="center" style="background-color:#c8e5ca">&#x02212;5.16</td>
<td valign="top" align="left">Extracellular space</td>
<td valign="top" align="left">Peptidase</td>
</tr>
<tr>
<td valign="top" align="left">CPA2</td>
<td valign="top" align="left">Carboxypeptidase A2</td>
<td valign="top" align="center" style="background-color:#f9c6ce">1.888</td>
<td valign="top" align="center" style="background-color:#f9c6ce">3.815</td>
<td valign="top" align="center" style="background-color:#c8e5ca">&#x02212;3.898</td>
<td valign="top" align="center" style="background-color:#c8e5ca">&#x02212;2.796</td>
<td valign="top" align="center">&#x02212;0.79</td>
<td valign="top" align="center" style="background-color:#f9c6ce">2.522</td>
<td valign="top" align="center">0.277</td>
<td valign="top" align="center" style="background-color:#f9c6ce">1.133</td>
<td valign="top" align="center" style="background-color:#c8e5ca">&#x02212;3.26</td>
<td valign="top" align="center" style="background-color:#c8e5ca">&#x02212;4.41</td>
<td valign="top" align="left">Extracellular space</td>
<td valign="top" align="left">Peptidase</td>
</tr>
<tr>
<td valign="top" align="left">CPB1</td>
<td valign="top" align="left">Carboxypeptidase B1</td>
<td valign="top" align="center" style="background-color:#f9c6ce">1.639</td>
<td valign="top" align="center" style="background-color:#f9c6ce">3.857</td>
<td valign="top" align="center" style="background-color:#c8e5ca">&#x02212;3.856</td>
<td valign="top" align="center" style="background-color:#c8e5ca">&#x02212;3.764</td>
<td valign="top" align="center" style="background-color:#c8e5ca">&#x02212;1.21</td>
<td valign="top" align="center" style="background-color:#f9c6ce">2.028</td>
<td valign="top" align="center">&#x02212;0.05</td>
<td valign="top" align="center" style="background-color:#f9c6ce">1.008</td>
<td valign="top" align="center" style="background-color:#c8e5ca">&#x02212;3.47</td>
<td valign="top" align="center" style="background-color:#c8e5ca">&#x02212;5.45</td>
<td valign="top" align="left">Extracellular space</td>
<td valign="top" align="left">Peptidase</td>
</tr>
<tr>
<td valign="top" align="left">CTRB2</td>
<td valign="top" align="left">Chymotrypsinogen B2</td>
<td valign="top" align="center" style="background-color:#f9c6ce">1.532</td>
<td valign="top" align="center" style="background-color:#f9c6ce">3.417</td>
<td valign="top" align="center" style="background-color:#c8e5ca">&#x02212;3.444</td>
<td valign="top" align="center" style="background-color:#c8e5ca">&#x02212;4.267</td>
<td valign="top" align="center">&#x02212;0.62</td>
<td valign="top" align="center" style="background-color:#f9c6ce">2.177</td>
<td valign="top" align="center">0.353</td>
<td valign="top" align="center" style="background-color:#f9c6ce">1.269</td>
<td valign="top" align="center" style="background-color:#c8e5ca">&#x02212;2.8</td>
<td valign="top" align="center" style="background-color:#c8e5ca">&#x02212;5.45</td>
<td valign="top" align="left">Cytoplasm</td>
<td valign="top" align="left">Peptidase</td>
</tr>
<tr>
<td valign="top" align="left">CTRC</td>
<td valign="top" align="left">Chymotrypsin C</td>
<td valign="top" align="center" style="background-color:#f9c6ce">1.088</td>
<td valign="top" align="center" style="background-color:#f9c6ce">2.284</td>
<td valign="top" align="center" style="background-color:#c8e5ca">&#x02212;2.321</td>
<td valign="top" align="center">&#x02212;0.605</td>
<td valign="top" align="center">&#x02212;0.47</td>
<td valign="top" align="center" style="background-color:#f9c6ce">1.236</td>
<td valign="top" align="center">&#x02212;0.14</td>
<td valign="top" align="center">0.723</td>
<td valign="top" align="center" style="background-color:#c8e5ca">&#x02212;2.17</td>
<td valign="top" align="center" style="background-color:#c8e5ca">&#x02212;1.83</td>
<td valign="top" align="left">Extracellular space</td>
<td valign="top" align="left">Peptidase</td>
</tr>
<tr>
<td valign="top" align="left">CTRL</td>
<td valign="top" align="left">Chymotrypsin like</td>
<td valign="top" align="center" style="background-color:#f9c6ce">1.575</td>
<td valign="top" align="center" style="background-color:#f9c6ce">3.656</td>
<td valign="top" align="center" style="background-color:#c8e5ca">&#x02212;3.485</td>
<td valign="top" align="center" style="background-color:#c8e5ca">&#x02212;3.223</td>
<td valign="top" align="center">&#x02212;0.72</td>
<td valign="top" align="center" style="background-color:#f9c6ce">2.125</td>
<td valign="top" align="center">0.283</td>
<td valign="top" align="center" style="background-color:#f9c6ce">1.364</td>
<td valign="top" align="center" style="background-color:#c8e5ca">&#x02212;2.94</td>
<td valign="top" align="center" style="background-color:#c8e5ca">&#x02212;4.51</td>
<td valign="top" align="left">Extracellular space</td>
<td valign="top" align="left">Peptidase</td>
</tr>
<tr>
<td valign="top" align="left">KLK3</td>
<td valign="top" align="left">Kallikrein related peptidase 3</td>
<td valign="top" align="center" style="background-color:#f9c6ce">1.102</td>
<td valign="top" align="center" style="background-color:#f9c6ce">1.304</td>
<td valign="top" align="center" style="background-color:#c8e5ca">&#x02212;1.047</td>
<td valign="top" align="center">0.584</td>
<td valign="top" align="center">0.468</td>
<td valign="top" align="center" style="background-color:#f9c6ce">1.084</td>
<td valign="top" align="center">&#x02212;0.86</td>
<td valign="top" align="center">&#x02212;0.58</td>
<td valign="top" align="center" style="background-color:#c8e5ca">&#x02212;1.07</td>
<td valign="top" align="center" style="background-color:#c8e5ca">&#x02212;1.18</td>
<td valign="top" align="left">Extracellular space</td>
<td valign="top" align="left">Peptidase</td>
</tr>
<tr>
<td valign="top" align="left">Prss1 (includes others)</td>
<td valign="top" align="left">Protease, serine 1 (trypsin 1)</td>
<td valign="top" align="center">&#x02212;0.283</td>
<td valign="top" align="center" style="background-color:#f9c6ce">1.296</td>
<td valign="top" align="center" style="background-color:#c8e5ca">&#x02212;1.273</td>
<td valign="top" align="center">0.212</td>
<td valign="top" align="center">&#x02212;0.09</td>
<td valign="top" align="center">0.986</td>
<td valign="top" align="center">&#x02212;0.39</td>
<td valign="top" align="center" style="background-color:#f9c6ce">1.669</td>
<td valign="top" align="center">0.152</td>
<td valign="top" align="center">0.11</td>
<td valign="top" align="left">Extracellular space</td>
<td valign="top" align="left">Peptidase</td>
</tr>
<tr>
<td valign="top" align="left">PRSS2</td>
<td valign="top" align="left">Serine protease 2</td>
<td valign="top" align="center" style="background-color:#f9c6ce">1.486</td>
<td valign="top" align="center" style="background-color:#f9c6ce">3.177</td>
<td valign="top" align="center" style="background-color:#c8e5ca">&#x02212;2.882</td>
<td valign="top" align="center" style="background-color:#c8e5ca">&#x02212;1.491</td>
<td valign="top" align="center">&#x02212;0.49</td>
<td valign="top" align="center" style="background-color:#f9c6ce">2.044</td>
<td valign="top" align="center">&#x02212;0.03</td>
<td valign="top" align="center" style="background-color:#f9c6ce">1.197</td>
<td valign="top" align="center" style="background-color:#c8e5ca">&#x02212;2.32</td>
<td valign="top" align="center" style="background-color:#c8e5ca">&#x02212;3.01</td>
<td valign="top" align="left">Extracellular space</td>
<td valign="top" align="left">Peptidase</td>
</tr>
<tr>
<td valign="top" align="left">PRSS3</td>
<td valign="top" align="left">Serine protease 3</td>
<td valign="top" align="center" style="background-color:#f9c6ce">1.397</td>
<td valign="top" align="center" style="background-color:#f9c6ce">3.224</td>
<td valign="top" align="center" style="background-color:#c8e5ca">&#x02212;2.96</td>
<td valign="top" align="center" style="background-color:#c8e5ca">&#x02212;1.316</td>
<td valign="top" align="center">&#x02212;0.32</td>
<td valign="top" align="center" style="background-color:#f9c6ce">1.654</td>
<td valign="top" align="center">&#x02212;0.29</td>
<td valign="top" align="center" style="background-color:#f9c6ce">1.503</td>
<td valign="top" align="center" style="background-color:#c8e5ca">&#x02212;2.7</td>
<td valign="top" align="center" style="background-color:#c8e5ca">&#x02212;3.01</td>
<td valign="top" align="left">Extracellular space</td>
<td valign="top" align="left">Peptidase</td>
</tr>
</tbody>
</table>
<table-wrap-foot>
<p><italic>Greater than 2 fold changes are highlight; &#x02013;number in green with green filled indicates decreased expression and otherwise/red indicates increased expression. Number in green indicates decreased expression and red indicates increased expression</italic>.</p>
</table-wrap-foot>
</table-wrap>
</sec>
<sec>
<title>Lipid Metabolism and Transport of Molecules</title>
<p>Consistent with observation of MUC1-suppressed lipid metabolism in uninfected mice, 8 h infection further induced expression of a wide range of lipid transporters in the gastric tissue of Muc1<sup>&#x02212;/&#x02212;</sup> mice compared with WT (<xref ref-type="fig" rid="F6">Figure 6</xref>). The IPA regulator effect analysis revealed that the categories most impacted by MUC1 deficiency were fatty acid metabolism, lipid conversion and metabolism of vitamin with consistence score = 16,028, followed by transport molecule (<xref ref-type="table" rid="T2">Table 2</xref>). In addition to increased expression of the genes leading to activated fatty acid metabolism that we observed in the uninfected mucosa (<bold><italic>Alb</italic></bold>, <bold><italic>Abcc2</italic></bold>, Mttp, Apoc3, Fabp2, Fabp1), we also observed the increased expression of genes involved in the conversion of lipid and metabolism of vitamins (Cxcl3, Apoa2, Scd, and Vdr) and cytochrome P450 members (Cyp2c8, Cyp2c9, Cyp2e1) (<xref ref-type="fig" rid="F6">Figure 6</xref>). For example, stearoyl-coA desaturase (Scd) is an endoplasmic reticulum (ER) enzyme that catalyzes the biosynthesis of monounsaturated fatty acids from saturated fatty acids. Cytochrome P450 encompasses a family of enzymes which oxidize steroids, fatty acids, and xenobiotics, and are important for the clearance of various compounds, as well as for hormone synthesis and breakdown. The expression of these genes is regulated by nuclear hormone receptors of the pregnane X receptor (PXR) family (<xref ref-type="fig" rid="F6">Figure 6</xref>).</p>
<fig id="F6" position="float">
<label>Figure 6</label>
<caption><p>Ingenuity Pathway Analysis (IPA) top regulator effect networks analysis of differentially expressed (DE) genes between Muc1<sup>&#x02212;/&#x02212;</sup> vs. wild type gastric tissues at 8 h H. pylori infection. Log ratio fold changes of DE genes is shown underneath each gene (red color symbol indicates increased expression). Prediction legend is the same as for <xref ref-type="fig" rid="F3">Figure 3</xref>.</p></caption>
<graphic xlink:href="fcimb-10-00343-g0006.tif"/>
</fig>
<p>Some of the up-regulated genes in the fatty acid metabolism function category were also assigned to the transport molecule category, such as <italic>Fabp1, Scd</italic>, and <italic>Cxcl3</italic> plus additional genes <italic>Slc2a2, Vdr, Fabp2</italic> and microsomal triglyceride transfer protein gene (<italic>Mttp</italic>) (<xref ref-type="fig" rid="F7">Figure 7</xref>). IPA indicated that expression of this set of genes is likely to be controlled by PPARG at 8 h post-infection (<xref ref-type="fig" rid="F7">Figure 7</xref>). In addition, higher expression of solute carrier family genes (<italic>Slc13a1, Slc26a3, Slc2a2, Slc40a1, Slc5a1</italic>, and <italic>Slc6a19</italic>) was seen in the gastric tissue of <italic>Muc1</italic><sup>&#x02212;/&#x02212;</sup> mice compared with WT at sham and 8 h infection (<xref ref-type="table" rid="T5">Table 5</xref>). This family of genes plays a pivotal role in transport of a wide variety of solutes, including glucose and amino acids. However, <italic>H. pylori</italic> infection resulted in &#x0007E;2&#x02013;6-fold induction of most of these genes in WT at 24 h, vs. a &#x0007E;2-fold decreased expression in <italic>Muc1</italic><sup>&#x02212;/&#x02212;</sup> gastric tissues (<xref ref-type="table" rid="T5">Table 5</xref>), and a similar trend was seen at 72 h infection (<xref ref-type="table" rid="T5">Table 5</xref>).</p>
<fig id="F7" position="float">
<label>Figure 7</label>
<caption><p>Ingenuity Pathway Analysis regulator effect networks analysis of differentially expressed (DE) genes between Muc1<sup>&#x02212;/&#x02212;</sup> vs. wild type gastric tissues at 8 h H. pylori infection showed PPARG up-regulated transport of molecule pathway. Log ratio fold changes of DE genes is shown underneath each gene (red color symbol indicates increased expression). Prediction legend is the same as for <xref ref-type="fig" rid="F3">Figure 3</xref>.</p></caption>
<graphic xlink:href="fcimb-10-00343-g0007.tif"/>
</fig>
<table-wrap position="float" id="T5">
<label>Table 5</label>
<caption><p>Transport molecules.</p></caption>
<table frame="hsides" rules="groups">
<thead>
<tr>
<th/>
<th/>
<th valign="top" align="center" colspan="10" style="border-bottom: thin solid #000000;"><bold>Expr log ratio</bold></th>
<th/>
<th/>
</tr>
<tr>
<th valign="top" align="left"><bold>Symbol</bold></th>
<th valign="top" align="left"><bold>Entrez gene name</bold></th>
<th valign="top" align="center"><bold>Sham (KO/WT)</bold></th>
<th valign="top" align="center"><bold>8 h (KO/WT)</bold></th>
<th valign="top" align="center"><bold>24 h (KO/WT)</bold></th>
<th valign="top" align="center"><bold>72 h (KO/WT)</bold></th>
<th valign="top" align="center"><bold>WT (8 h/0)</bold></th>
<th valign="top" align="center"><bold>WT (24 h/0)</bold></th>
<th valign="top" align="center"><bold>WT (72 h/0)</bold></th>
<th valign="top" align="center"><bold>KO (8 h/0)</bold></th>
<th valign="top" align="center"><bold>KO (24 h/0)</bold></th>
<th valign="top" align="center"><bold>KO (72 h/0)</bold></th>
<th valign="top" align="left"><bold>Location</bold></th>
<th valign="top" align="left"><bold>Type(s)</bold></th>
</tr>
</thead>
<tbody>
<tr>
<td valign="top" align="left">A1CF</td>
<td valign="top" align="left">APOBEC1 complementation factor</td>
<td valign="top" align="center" style="background-color:#f9c6ce">1.347</td>
<td valign="top" align="center">0.698</td>
<td valign="top" align="center" style="background-color:#c8e5ca">&#x02212;1.079</td>
<td valign="top" align="center">0.132</td>
<td valign="top" align="center">0.394</td>
<td valign="top" align="center" style="background-color:#f9c6ce">1.555</td>
<td valign="top" align="center" style="background-color:#f9c6ce">1.253</td>
<td valign="top" align="center">&#x02212;0.378</td>
<td valign="top" align="center">&#x02212;0.871</td>
<td valign="top" align="center">&#x02212;0.134</td>
<td valign="top" align="left">Nucleus</td>
<td valign="top" align="left">Other</td>
</tr>
<tr>
<td valign="top" align="left">ABCC2</td>
<td valign="top" align="left">ATP binding cassette subfamily C member 2</td>
<td valign="top" align="center" style="background-color:#f9c6ce">1.725</td>
<td valign="top" align="center" style="background-color:#f9c6ce">2.228</td>
<td valign="top" align="center" style="background-color:#c8e5ca">&#x02212;1.332</td>
<td valign="top" align="center">&#x02212;0.11</td>
<td valign="top" align="center">0.678</td>
<td valign="top" align="center" style="background-color:#f9c6ce">1.936</td>
<td valign="top" align="center" style="background-color:#f9c6ce">1.631</td>
<td valign="top" align="center" style="background-color:#f9c6ce">1.181</td>
<td valign="top" align="center" style="background-color:#c8e5ca">&#x02212;1.122</td>
<td valign="top" align="center">&#x02212;0.205</td>
<td valign="top" align="left">Plasma membrane</td>
<td valign="top" align="left">Transporter</td>
</tr>
<tr>
<td valign="top" align="left">ABCG5</td>
<td valign="top" align="left">ATP binding cassette subfamily G member 5</td>
<td valign="top" align="center" style="background-color:#f9c6ce">1.371</td>
<td valign="top" align="center">0.438</td>
<td valign="top" align="center">&#x02212;0.871</td>
<td valign="top" align="center">0.167</td>
<td valign="top" align="center">0.708</td>
<td valign="top" align="center" style="background-color:#f9c6ce">1.321</td>
<td valign="top" align="center" style="background-color:#f9c6ce">1.128</td>
<td valign="top" align="center">&#x02212;0.225</td>
<td valign="top" align="center">&#x02212;0.921</td>
<td valign="top" align="center">&#x02212;0.075</td>
<td valign="top" align="left">Plasma membrane</td>
<td valign="top" align="left">Transporter</td>
</tr>
<tr>
<td valign="top" align="left">ALB</td>
<td valign="top" align="left">Albumin</td>
<td valign="top" align="center" style="background-color:#f9c6ce">2.375</td>
<td valign="top" align="center" style="background-color:#f9c6ce">3.505</td>
<td valign="top" align="center">&#x02212;0.39</td>
<td valign="top" align="center" style="background-color:#f9c6ce">3.673</td>
<td valign="top" align="center">0.071</td>
<td valign="top" align="center">&#x02212;0.36</td>
<td valign="top" align="center">&#x02212;0.396</td>
<td valign="top" align="center" style="background-color:#f9c6ce">1.201</td>
<td valign="top" align="center" style="background-color:#c8e5ca">&#x02212;3.125</td>
<td valign="top" align="center">0.902</td>
<td valign="top" align="left">Extracellular space</td>
<td valign="top" align="left">Transporter</td>
</tr>
<tr>
<td valign="top" align="left">Apoc3</td>
<td valign="top" align="left">Apolipoprotein C&#x02013;III</td>
<td valign="top" align="center" style="background-color:#f9c6ce">1.006</td>
<td valign="top" align="center" style="background-color:#f9c6ce">1.144</td>
<td valign="top" align="center">&#x02212;0.592</td>
<td valign="top" align="center">&#x02212;0.095</td>
<td valign="top" align="center">0.266</td>
<td valign="top" align="center">0.968</td>
<td valign="top" align="center">0.912</td>
<td valign="top" align="center">0.404</td>
<td valign="top" align="center">&#x02212;0.63</td>
<td valign="top" align="center">&#x02212;0.189</td>
<td valign="top" align="left">Extracellular space</td>
<td valign="top" align="left">Transporter</td>
</tr>
<tr>
<td valign="top" align="left">CDH17</td>
<td valign="top" align="left">Cadherin 17</td>
<td valign="top" align="center" style="background-color:#f9c6ce">2.465</td>
<td valign="top" align="center" style="background-color:#f9c6ce">1.963</td>
<td valign="top" align="center" style="background-color:#c8e5ca">&#x02212;1.423</td>
<td valign="top" align="center">&#x02212;0.191</td>
<td valign="top" align="center">0.639</td>
<td valign="top" align="center" style="background-color:#f9c6ce">2.572</td>
<td valign="top" align="center" style="background-color:#f9c6ce">2.432</td>
<td valign="top" align="center">0.137</td>
<td valign="top" align="center" style="background-color:#c8e5ca">&#x02212;1.316</td>
<td valign="top" align="center">&#x02212;0.223</td>
<td valign="top" align="left">Plasma membrane</td>
<td valign="top" align="left">Transporter</td>
</tr>
<tr>
<td valign="top" align="left">CLCA4</td>
<td valign="top" align="left">Chloride channel accessory 4</td>
<td valign="top" align="center" style="background-color:#f9c6ce">2.268</td>
<td valign="top" align="center" style="background-color:#f9c6ce">1.933</td>
<td valign="top" align="center" style="background-color:#c8e5ca">&#x02212;1.586</td>
<td valign="top" align="center">&#x02212;0.171</td>
<td valign="top" align="center">&#x02212;0.464</td>
<td valign="top" align="center" style="background-color:#f9c6ce">2.362</td>
<td valign="top" align="center" style="background-color:#f9c6ce">2.144</td>
<td valign="top" align="center">0.187</td>
<td valign="top" align="center" style="background-color:#c8e5ca">&#x02212;1.492</td>
<td valign="top" align="center">&#x02212;0.442</td>
<td valign="top" align="left">Plasma membrane</td>
<td valign="top" align="left">Ion channel</td>
</tr>
<tr>
<td valign="top" align="left">Defa3 (includes others)</td>
<td valign="top" align="left">Defensin, alpha, 3</td>
<td valign="top" align="center" style="background-color:#f9c6ce">2.169</td>
<td valign="top" align="center" style="background-color:#f9c6ce">1.852</td>
<td valign="top" align="center">&#x02212;0.539</td>
<td valign="top" align="center">0.925</td>
<td valign="top" align="center">0.342</td>
<td valign="top" align="center" style="background-color:#f9c6ce">1.624</td>
<td valign="top" align="center" style="background-color:#f9c6ce">1.615</td>
<td valign="top" align="center">&#x02212;0.189</td>
<td valign="top" align="center" style="background-color:#c8e5ca">&#x02212;1.152</td>
<td valign="top" align="center">0.52</td>
<td valign="top" align="left">Extracellular space</td>
<td valign="top" align="left">Other</td>
</tr>
<tr>
<td valign="top" align="left">FABP1</td>
<td valign="top" align="left">Fatty acid binding protein 1</td>
<td valign="top" align="center" style="background-color:#f9c6ce">1.75</td>
<td valign="top" align="center" style="background-color:#f9c6ce">1.521</td>
<td valign="top" align="center" style="background-color:#c8e5ca">&#x02212;1.483</td>
<td valign="top" align="center">0.244</td>
<td valign="top" align="center">0.102</td>
<td valign="top" align="center" style="background-color:#f9c6ce">1.613</td>
<td valign="top" align="center" style="background-color:#f9c6ce">1.52</td>
<td valign="top" align="center">&#x02212;0.126</td>
<td valign="top" align="center" style="background-color:#c8e5ca">&#x02212;1.619</td>
<td valign="top" align="center">0.015</td>
<td valign="top" align="left">Cytoplasm</td>
<td valign="top" align="left">Transporter</td>
</tr>
<tr>
<td valign="top" align="left">FABP2</td>
<td valign="top" align="left">Fatty acid binding protein 2</td>
<td valign="top" align="center" style="background-color:#f9c6ce">1.492</td>
<td valign="top" align="center" style="background-color:#f9c6ce">1.903</td>
<td valign="top" align="center" style="background-color:#c8e5ca">&#x02212;1.491</td>
<td valign="top" align="center">&#x02212;0.29</td>
<td valign="top" align="center">0.032</td>
<td valign="top" align="center" style="background-color:#f9c6ce">1.513</td>
<td valign="top" align="center" style="background-color:#f9c6ce">1.557</td>
<td valign="top" align="center">0.444</td>
<td valign="top" align="center" style="background-color:#c8e5ca">&#x02212;1.469</td>
<td valign="top" align="center">&#x02212;0.225</td>
<td valign="top" align="left">Cytoplasm</td>
<td valign="top" align="left">Transporter</td>
</tr>
<tr>
<td valign="top" align="left">GAL</td>
<td valign="top" align="left">Galanin and GMAP prepropeptide</td>
<td valign="top" align="center" style="background-color:#f9c6ce">1.15</td>
<td valign="top" align="center" style="background-color:#f9c6ce">1.07</td>
<td valign="top" align="center">&#x02212;0.396</td>
<td valign="top" align="center">&#x02212;0.221</td>
<td valign="top" align="center">&#x02212;0.265</td>
<td valign="top" align="center">0.879</td>
<td valign="top" align="center">0.218</td>
<td valign="top" align="center">&#x02212;0.346</td>
<td valign="top" align="center">&#x02212;0.668</td>
<td valign="top" align="center" style="background-color:#c8e5ca">&#x02212;1.153</td>
<td valign="top" align="left">Extracellular space</td>
<td valign="top" align="left">Other</td>
</tr>
<tr>
<td valign="top" align="left">GRP</td>
<td valign="top" align="left">Gastrin releasing peptide</td>
<td valign="top" align="center" style="background-color:#f9c6ce">1.312</td>
<td valign="top" align="center">0.395</td>
<td valign="top" align="center">&#x02212;0.562</td>
<td valign="top" align="center">&#x02212;0.013</td>
<td valign="top" align="center">0.216</td>
<td valign="top" align="center" style="background-color:#f9c6ce">1.143</td>
<td valign="top" align="center">0.769</td>
<td valign="top" align="center">&#x02212;0.7</td>
<td valign="top" align="center">&#x02212;0.731</td>
<td valign="top" align="center">&#x02212;0.556</td>
<td valign="top" align="left">Extracellular space</td>
<td valign="top" align="left">Growth factor</td>
</tr>
<tr>
<td valign="top" align="left">GUCA2B</td>
<td valign="top" align="left">Guanylate cyclase activator 2B</td>
<td valign="top" align="center" style="background-color:#f9c6ce">1.281</td>
<td valign="top" align="center" style="background-color:#f9c6ce">1.412</td>
<td valign="top" align="center">&#x02212;0.757</td>
<td valign="top" align="center">&#x02212;0.231</td>
<td valign="top" align="center">&#x02212;0.402</td>
<td valign="top" align="center" style="background-color:#f9c6ce">1.132</td>
<td valign="top" align="center">0.976</td>
<td valign="top" align="center">&#x02212;0.272</td>
<td valign="top" align="center">&#x02212;0.907</td>
<td valign="top" align="center">&#x02212;0.537</td>
<td valign="top" align="left">Extracellular space</td>
<td valign="top" align="left">Other</td>
</tr>
<tr>
<td valign="top" align="left">MTTP</td>
<td valign="top" align="left">Microsomal triglyceride transfer protein</td>
<td valign="top" align="center" style="background-color:#f9c6ce">2.007</td>
<td valign="top" align="center" style="background-color:#f9c6ce">1.583</td>
<td valign="top" align="center" style="background-color:#c8e5ca">&#x02212;1.268</td>
<td valign="top" align="center">&#x02212;0.242</td>
<td valign="top" align="center">0.597</td>
<td valign="top" align="center" style="background-color:#f9c6ce">2.024</td>
<td valign="top" align="center" style="background-color:#f9c6ce">2.076</td>
<td valign="top" align="center">0.173</td>
<td valign="top" align="center" style="background-color:#c8e5ca">&#x02212;1.25</td>
<td valign="top" align="center">&#x02212;0.173</td>
<td valign="top" align="left">Cytoplasm</td>
<td valign="top" align="left">Transporter</td>
</tr>
<tr>
<td valign="top" align="left">PIGR</td>
<td valign="top" align="left">Polymeric immunoglobulin receptor</td>
<td valign="top" align="center" style="background-color:#f9c6ce">1.184</td>
<td valign="top" align="center" style="background-color:#f9c6ce">1.073</td>
<td valign="top" align="center">&#x02212;0.166</td>
<td valign="top" align="center">0.283</td>
<td valign="top" align="center">0.138</td>
<td valign="top" align="center">0.852</td>
<td valign="top" align="center" style="background-color:#f9c6ce">1.143</td>
<td valign="top" align="center">0.027</td>
<td valign="top" align="center">&#x02212;0.498</td>
<td valign="top" align="center">0.242</td>
<td valign="top" align="left">Plasma membrane</td>
<td valign="top" align="left">Transporter</td>
</tr>
<tr>
<td valign="top" align="left">SLC13A1</td>
<td valign="top" align="left">Solute carrier family 13 member 1</td>
<td valign="top" align="center" style="background-color:#f9c6ce">2.658</td>
<td valign="top" align="center" style="background-color:#f9c6ce">3</td>
<td valign="top" align="center" style="background-color:#c8e5ca">&#x02212;1.167</td>
<td valign="top" align="center">&#x02212;0.373</td>
<td valign="top" align="center">0.124</td>
<td valign="top" align="center" style="background-color:#f9c6ce">2.391</td>
<td valign="top" align="center" style="background-color:#f9c6ce">2.478</td>
<td valign="top" align="center">0.466</td>
<td valign="top" align="center" style="background-color:#c8e5ca">&#x02212;1.434</td>
<td valign="top" align="center">&#x02212;0.553</td>
<td valign="top" align="left">Plasma membrane</td>
<td valign="top" align="left">Transporter</td>
</tr>
<tr>
<td valign="top" align="left">SLC22A25</td>
<td valign="top" align="left">Solute carrier family 22 member 25</td>
<td valign="top" align="center" style="background-color:#f9c6ce">1.192</td>
<td valign="top" align="center">0.586</td>
<td valign="top" align="center">0.501</td>
<td valign="top" align="center">0.575</td>
<td valign="top" align="center">0.473</td>
<td valign="top" align="center">0.198</td>
<td valign="top" align="center">0.401</td>
<td valign="top" align="center">&#x02212;0.353</td>
<td valign="top" align="center">&#x02212;0.656</td>
<td valign="top" align="center">&#x02212;0.501</td>
<td valign="top" align="left">Other</td>
<td valign="top" align="left">Other</td>
</tr>
<tr>
<td valign="top" align="left">SLC26A3</td>
<td valign="top" align="left">Solute carrier family 26 member 3</td>
<td valign="top" align="center" style="background-color:#f9c6ce">2.554</td>
<td valign="top" align="center" style="background-color:#f9c6ce">1.924</td>
<td valign="top" align="center" style="background-color:#c8e5ca">&#x02212;1.685</td>
<td valign="top" align="center">&#x02212;0.189</td>
<td valign="top" align="center">0.473</td>
<td valign="top" align="center" style="background-color:#f9c6ce">2.415</td>
<td valign="top" align="center" style="background-color:#f9c6ce">2.315</td>
<td valign="top" align="center">&#x02212;0.157</td>
<td valign="top" align="center" style="background-color:#c8e5ca">&#x02212;1.823</td>
<td valign="top" align="center">&#x02212;0.428</td>
<td valign="top" align="left">Plasma membrane</td>
<td valign="top" align="left">Transporter</td>
</tr>
<tr>
<td valign="top" align="left">SLC2A2</td>
<td valign="top" align="left">Solute carrier family 2 member 2</td>
<td valign="top" align="center" style="background-color:#f9c6ce">1.008</td>
<td valign="top" align="center" style="background-color:#f9c6ce">1.556</td>
<td valign="top" align="center">&#x02212;0.645</td>
<td valign="top" align="center">&#x02212;0.138</td>
<td valign="top" align="center">0.328</td>
<td valign="top" align="center" style="background-color:#f9c6ce">1.118</td>
<td valign="top" align="center" style="background-color:#f9c6ce">1.199</td>
<td valign="top" align="center">0.876</td>
<td valign="top" align="center">&#x02212;0.535</td>
<td valign="top" align="center">0.053</td>
<td valign="top" align="left">Plasma membrane</td>
<td valign="top" align="left">Transporter</td>
</tr>
<tr>
<td valign="top" align="left">SLC40A1</td>
<td valign="top" align="left">Solute carrier family 40 member 1</td>
<td valign="top" align="center" style="background-color:#f9c6ce">1.099</td>
<td valign="top" align="center" style="background-color:#f9c6ce">1.363</td>
<td valign="top" align="center" style="background-color:#c8e5ca">&#x02212;1.16</td>
<td valign="top" align="center">&#x02212;0.335</td>
<td valign="top" align="center">0.176</td>
<td valign="top" align="center" style="background-color:#f9c6ce">1.39</td>
<td valign="top" align="center" style="background-color:#f9c6ce">1.11</td>
<td valign="top" align="center">0.441</td>
<td valign="top" align="center">&#x02212;0.868</td>
<td valign="top" align="center">&#x02212;0.324</td>
<td valign="top" align="left">Plasma membrane</td>
<td valign="top" align="left">Transporter</td>
</tr>
<tr>
<td valign="top" align="left">SLC5A1</td>
<td valign="top" align="left">Solute carrier family 5 member 1</td>
<td valign="top" align="center" style="background-color:#f9c6ce">1.212</td>
<td valign="top" align="center" style="background-color:#f9c6ce">1.814</td>
<td valign="top" align="center">&#x02212;0.525</td>
<td valign="top" align="center">&#x02212;0.029</td>
<td valign="top" align="center">0.432</td>
<td valign="top" align="center">0.995</td>
<td valign="top" align="center" style="background-color:#f9c6ce">1.107</td>
<td valign="top" align="center" style="background-color:#f9c6ce">1.035</td>
<td valign="top" align="center">&#x02212;0.742</td>
<td valign="top" align="center">&#x02212;0.134</td>
<td valign="top" align="left">Plasma membrane</td>
<td valign="top" align="left">Transporter</td>
</tr>
<tr>
<td valign="top" align="left">SLC6A19</td>
<td valign="top" align="left">Solute carrier family 6 member 19</td>
<td valign="top" align="center" style="background-color:#f9c6ce">1.151</td>
<td valign="top" align="center" style="background-color:#f9c6ce">1.207</td>
<td valign="top" align="center" style="background-color:#c8e5ca">&#x02212;1.227</td>
<td valign="top" align="center">&#x02212;0.405</td>
<td valign="top" align="center">0.376</td>
<td valign="top" align="center" style="background-color:#f9c6ce">1.321</td>
<td valign="top" align="center" style="background-color:#f9c6ce">1.11</td>
<td valign="top" align="center">0.432</td>
<td valign="top" align="center" style="background-color:#c8e5ca">&#x02212;1.058</td>
<td valign="top" align="center">&#x02212;0.446</td>
<td valign="top" align="left">Plasma membrane</td>
<td valign="top" align="left">Transporter</td>
</tr>
<tr>
<td valign="top" align="left">TAC1</td>
<td valign="top" align="left">Tachykinin precursor 1</td>
<td valign="top" align="center" style="background-color:#f9c6ce">1.132</td>
<td valign="top" align="center">&#x02212;0.012</td>
<td valign="top" align="center">&#x02212;0.687</td>
<td valign="top" align="center">0.059</td>
<td valign="top" align="center">0.417</td>
<td valign="top" align="center" style="background-color:#f9c6ce">1.136</td>
<td valign="top" align="center">0.681</td>
<td valign="top" align="center">&#x02212;0.727</td>
<td valign="top" align="center">&#x02212;0.683</td>
<td valign="top" align="center">&#x02212;0.392</td>
<td valign="top" align="left">Extracellular space</td>
<td valign="top" align="left">Other</td>
</tr>
<tr>
<td valign="top" align="left">ZG16</td>
<td valign="top" align="left">Zymogen granule protein 16</td>
<td valign="top" align="center" style="background-color:#f9c6ce">1.697</td>
<td valign="top" align="center" style="background-color:#f9c6ce">2.714</td>
<td valign="top" align="center" style="background-color:#c8e5ca">&#x02212;2.265</td>
<td valign="top" align="center">&#x02212;0.733</td>
<td valign="top" align="center">&#x02212;0.141</td>
<td valign="top" align="center" style="background-color:#f9c6ce">2.164</td>
<td valign="top" align="center" style="background-color:#f9c6ce">1.229</td>
<td valign="top" align="center">0.876</td>
<td valign="top" align="center" style="background-color:#c8e5ca">&#x02212;1.798</td>
<td valign="top" align="center" style="background-color:#c8e5ca">&#x02212;1.202</td>
<td valign="top" align="left">Extracellular space</td>
<td valign="top" align="left">Other</td>
</tr>
</tbody>
</table>
<table-wrap-foot>
<p><italic>Greater than 2 fold changes are highlight; &#x02013;number in green with green filled indicates decreased expression and otherwise/red indicates increased expression. Number in green indicates decreased expression and red indicates increased expression</italic>.</p>
</table-wrap-foot>
</table-wrap>
</sec>
<sec>
<title>Antimicrobial Response and Inflammatory Response</title>
<p>One of the hallmarks of <italic>H. pylori</italic> colonization is the induction of a strong local antimicrobial and proinflammatory response by the infected epithelium. This initiates the mucosal infiltration of monocytes, neutrophils, and lymphocytes and the development of gastritis (McGuckin et al., <xref ref-type="bibr" rid="B21">2007</xref>). Analysis of the DE genes between <italic>Muc1</italic><sup>&#x02212;/&#x02212;</sup> vs. WT in response to the infection revealed significant enrichment of functional clusters that were associated with antimicrobial and inflammatory responses.</p>
<p><italic>H. pylori</italic> infection for 8 h resulted in &#x0007E;4-fold induction of the regenerating islet-derived (REG) gene family 1B (<italic>Reg1b</italic>) mRNA in <italic>Muc1</italic><sup>&#x02212;/&#x02212;</sup> vs. no change in WT gastric tissues (<xref ref-type="table" rid="T1">Table 1</xref>). REG1B protein is highly expressed in several human pathologies, such as inflammatory bowel disease, many of which are associated with epithelial inflammation (van Beelen Granlund et al., <xref ref-type="bibr" rid="B38">2013</xref>), indicating that the gastric mucosa of <italic>Muc1</italic><sup>&#x02212;/&#x02212;</sup> mice is more inflamed than WT mice within 8 h of infection. <italic>H. pylori</italic> infection for 24 h resulted in &#x0007E;2.5-fold induction of mRNA for <italic>Slfn12</italic>, a schlafen family member, in <italic>Muc1</italic><sup>&#x02212;/&#x02212;</sup> vs. no change in WT gastric tissues. SLFN12 functions as an inducer of immune responses and is implicated in enterocyte differentiation (<xref ref-type="table" rid="T1">Table 1</xref>).</p>
<p>As infection progressed (24 and 72 h), we observed interferon gamma (IFNG)- regulated pathways were more strongly activated in <italic>Muc1</italic><sup>&#x02212;/&#x02212;</sup> vs. WT gastric tissues (<italic>Z</italic>-score 4.12, <italic>P</italic> = 1.65-E7, and <italic>Z</italic>-score 4.96, <italic>P</italic> = 5.7-E15, respectively, highlighted in bold in <xref ref-type="table" rid="T6">Table 6</xref>) characterized by the higher expression of many proinflammatory genes. Altered genes included: <italic>Cmpk2, Defb3, Duoxa2, Fgg, Gbp2, Gbp3, Gbp4, Hspa1a/Hspa1b, Ido1, Ifi202b, Ifi44, Ifit1b, Ifit3, Igtp, Irf7, Irgm1, Isg15, Mx1, Mx2, Nlrc5, Oas2, Oas3, Rsad2, Rtp4, Serpina1, Slfn12l, Tap1, and Usp18</italic> (<xref ref-type="supplementary-material" rid="SM3">Supplementary Table 3</xref>). Some of these genes are controlled by <italic>Dnase2, Ikbkg, Il17a, Snca, Stat2, Tlr3</italic> and their induction is associated with suppression of infection (<xref ref-type="table" rid="T2">Table 2</xref> and <xref ref-type="fig" rid="F8">Figure 8</xref>).</p>
<table-wrap position="float" id="T6">
<label>Table 6</label>
<caption><p>Gastric <italic>Muc1</italic><sup>&#x02212;/&#x02212;</sup> vs. WT (KO/WT) upstream regulators<sup>&#x0002A;</sup> at different time points.</p></caption>
<table frame="hsides" rules="groups">
<thead>
<tr>
<th valign="top" align="left"><bold>Time</bold></th>
<th valign="top" align="left"><bold>Upstream regulator</bold></th>
<th valign="top" align="left"><bold>Expr log ratio</bold></th>
<th valign="top" align="center"><bold>Molecule type</bold></th>
<th valign="top" align="left"><bold>Predicted activation state</bold></th>
<th valign="top" align="center"><bold>Activation <italic>z</italic>-score</bold></th>
<th valign="top" align="center"><bold><italic>p</italic>-value of overlap</bold></th>
</tr>
</thead>
<tbody>
<tr>
<td valign="top" align="left">Sham (KO/WT)</td>
<td valign="top" align="left">HNF4A</td>
<td valign="top" align="left">0.235</td>
<td valign="top" align="center">Transcription regulator</td>
<td valign="top" align="left">Activated</td>
<td valign="top" align="center">3.443</td>
<td valign="top" align="center">0.00228</td>
</tr>
<tr>
<td valign="top" align="left">8 h (KO/WT)</td>
<td valign="top" align="left">HNF4A</td>
<td valign="top" align="left">0.075</td>
<td valign="top" align="center">Transcription regulator</td>
<td valign="top" align="left">Activated</td>
<td valign="top" align="center">3.477</td>
<td valign="top" align="center">0.0000242</td>
</tr>
<tr>
<td valign="top" align="left">8 h (KO/WT)</td>
<td valign="top" align="left">HNF1A</td>
<td valign="top" align="left">&#x02212;0.122</td>
<td valign="top" align="center">Transcription regulator</td>
<td valign="top" align="left">Activated</td>
<td valign="top" align="center">3.791</td>
<td valign="top" align="center">2.62E-10</td>
</tr>
<tr>
<td valign="top" align="left">24 (KO/WT)</td>
<td valign="top" align="left">IRF7</td>
<td valign="top" align="left">1.178</td>
<td valign="top" align="center">Transcription regulator</td>
<td valign="top" align="left">Activated</td>
<td valign="top" align="center">4.874</td>
<td valign="top" align="center">6.48E-29</td>
</tr>
<tr>
<td valign="top" align="left">24 (KO/WT)</td>
<td valign="top" align="left">Interferon alpha</td>
<td/>
<td valign="top" align="center">Group</td>
<td valign="top" align="left">Activated</td>
<td valign="top" align="center">4.386</td>
<td valign="top" align="center">6.02E-14</td>
</tr>
<tr>
<td valign="top" align="left"><bold>24 (KO/WT)</bold></td>
<td valign="top" align="left"><bold>IFNG</bold></td>
<td valign="top" align="left"><bold>0.105</bold></td>
<td valign="top" align="center"><bold>Cytokine</bold></td>
<td valign="top" align="left"><bold>Activated</bold></td>
<td valign="top" align="center"><bold>4.121</bold></td>
<td valign="top" align="center"><bold>1.65E-07</bold></td>
</tr>
<tr>
<td valign="top" align="left">24 (KO/WT)</td>
<td valign="top" align="left">IRF3</td>
<td valign="top" align="left">&#x02212;0.089</td>
<td valign="top" align="center">Transcription regulator</td>
<td valign="top" align="left">Activated</td>
<td valign="top" align="center">4.007</td>
<td valign="top" align="center">6.07E-24</td>
</tr>
<tr>
<td valign="top" align="left">24 (KO/WT)</td>
<td valign="top" align="left">TNF</td>
<td valign="top" align="left">&#x02212;0.625</td>
<td valign="top" align="center">Cytokine</td>
<td valign="top" align="left">Activated</td>
<td valign="top" align="center">3.9</td>
<td valign="top" align="center">0.00368</td>
</tr>
<tr>
<td valign="top" align="left">24 (KO/WT)</td>
<td valign="top" align="left">IFN Beta</td>
<td/>
<td valign="top" align="center">Group</td>
<td valign="top" align="left">Activated</td>
<td valign="top" align="center">3.81</td>
<td valign="top" align="center">8.62E-16</td>
</tr>
<tr>
<td valign="top" align="left">24 (KO/WT)</td>
<td valign="top" align="left">STAT1</td>
<td valign="top" align="left">1.008</td>
<td valign="top" align="center">Transcription regulator</td>
<td valign="top" align="left">Activated</td>
<td valign="top" align="center">3.982</td>
<td valign="top" align="center">9.03E-21</td>
</tr>
<tr>
<td valign="top" align="left"><bold>72 (KO/WT)</bold></td>
<td valign="top" align="left"><bold>IFNG</bold></td>
<td valign="top" align="left"><bold>&#x02212;0.328</bold></td>
<td valign="top" align="center"><bold>Cytokine</bold></td>
<td valign="top" align="left"><bold>Activated</bold></td>
<td valign="top" align="center"><bold>4.956</bold></td>
<td valign="top" align="center"><bold>5.7E-15</bold></td>
</tr>
<tr>
<td valign="top" align="left">72 (KO/WT)</td>
<td valign="top" align="left">Interferon alpha</td>
<td/>
<td valign="top" align="center">Group</td>
<td valign="top" align="left">Activated</td>
<td valign="top" align="center">4.269</td>
<td valign="top" align="center">9.96E-18</td>
</tr>
<tr>
<td valign="top" align="left">72 (KO/WT)</td>
<td valign="top" align="left">IFN Beta</td>
<td/>
<td valign="top" align="center">Group</td>
<td valign="top" align="left">Activated</td>
<td valign="top" align="center">3.54</td>
<td valign="top" align="center">3.91E-16</td>
</tr>
<tr>
<td valign="top" align="left">72 (KO/WT)</td>
<td valign="top" align="left">Ifn</td>
<td/>
<td valign="top" align="center">Group</td>
<td valign="top" align="left">Activated</td>
<td valign="top" align="center">3.384</td>
<td valign="top" align="center">4.15E-17</td>
</tr>
<tr>
<td valign="top" align="left">72 (KO/WT)</td>
<td valign="top" align="left">Ifnar</td>
<td/>
<td valign="top" align="center">Group</td>
<td valign="top" align="left">Activated</td>
<td valign="top" align="center">3.937</td>
<td valign="top" align="center">1.37E-22</td>
</tr>
<tr>
<td valign="top" align="left">72 (KO/WT)</td>
<td valign="top" align="left">STAT1</td>
<td valign="top" align="left">0.834</td>
<td valign="top" align="center">Transcription regulator</td>
<td valign="top" align="left">Activated</td>
<td valign="top" align="center">4.233</td>
<td valign="top" align="center">1.83E-24</td>
</tr>
<tr>
<td valign="top" align="left">72 (KO/WT)</td>
<td valign="top" align="left">IL21</td>
<td valign="top" align="left">0.094</td>
<td valign="top" align="center">Cytokine</td>
<td valign="top" align="left">Activated</td>
<td valign="top" align="center">3.606</td>
<td valign="top" align="center">3.41E-14</td>
</tr>
<tr>
<td valign="top" align="left">72 (KO/WT)</td>
<td valign="top" align="left">APP</td>
<td valign="top" align="left">0.143</td>
<td valign="top" align="center">Other</td>
<td valign="top" align="left">Activated</td>
<td valign="top" align="center">3.484</td>
<td valign="top" align="center">2.7E-07</td>
</tr>
<tr>
<td valign="top" align="left">72 (KO/WT)</td>
<td valign="top" align="left">IRF7</td>
<td valign="top" align="left">1.119</td>
<td valign="top" align="center">Transcription regulator</td>
<td valign="top" align="left">Activated</td>
<td valign="top" align="center">4.794</td>
<td valign="top" align="center">1.32E-33</td>
</tr>
<tr>
<td valign="top" align="left">72 (KO/WT)</td>
<td valign="top" align="left">TLR9</td>
<td valign="top" align="left">0.095</td>
<td valign="top" align="center">Transmembrane receptor</td>
<td valign="top" align="left">Activated</td>
<td valign="top" align="center">3.341</td>
<td valign="top" align="center">1.24E-12</td>
</tr>
<tr>
<td valign="top" align="left">72 (KO/WT)</td>
<td valign="top" align="left">IRF3</td>
<td valign="top" align="left">0.291</td>
<td valign="top" align="center">Transcription regulator</td>
<td valign="top" align="left">Activated</td>
<td valign="top" align="center">4.383</td>
<td valign="top" align="center">1.07E-24</td>
</tr>
<tr>
<td valign="top" align="left">72 (KO/WT)</td>
<td valign="top" align="left">IFNB1</td>
<td valign="top" align="left">0.126</td>
<td valign="top" align="center">Cytokine</td>
<td valign="top" align="left">Activated</td>
<td valign="top" align="center">3.65</td>
<td valign="top" align="center">7.79E-21</td>
</tr>
<tr>
<td valign="top" align="left">72 (KO/WT)</td>
<td valign="top" align="left">IFNA2</td>
<td/>
<td valign="top" align="center">Cytokine</td>
<td valign="top" align="left">Activated</td>
<td valign="top" align="center">3.772</td>
<td valign="top" align="center">1.11E-15</td>
</tr>
<tr>
<td valign="top" align="left">72 (KO/WT)</td>
<td valign="top" align="left">TLR3</td>
<td valign="top" align="left">0.306</td>
<td valign="top" align="center">Transmembrane receptor</td>
<td valign="top" align="left">Activated</td>
<td valign="top" align="center">3.526</td>
<td valign="top" align="center">2.21E-16</td>
</tr>
<tr>
<td valign="top" align="left">24 (KO/WT)</td>
<td valign="top" align="left">ACKR2</td>
<td valign="top" align="left">0.246</td>
<td valign="top" align="center">G-protein coupled receptor</td>
<td valign="top" align="left">Inhibited</td>
<td valign="top" align="center">&#x02212;3.606</td>
<td valign="top" align="center">9.71E-19</td>
</tr>
<tr>
<td valign="top" align="left">24 (KO/WT)</td>
<td valign="top" align="left">IL4</td>
<td valign="top" align="left">&#x02212;0.108</td>
<td valign="top" align="center">Cytokine</td>
<td valign="top" align="left">Inhibited</td>
<td valign="top" align="center">&#x02212;3.861</td>
<td valign="top" align="center">6.65E-08</td>
</tr>
<tr>
<td valign="top" align="left">24 (KO/WT)</td>
<td valign="top" align="left">SOCS1</td>
<td valign="top" align="left">0.136</td>
<td valign="top" align="center">Other</td>
<td valign="top" align="left">Inhibited</td>
<td valign="top" align="center">&#x02212;3.41</td>
<td valign="top" align="center">1.73E-12</td>
</tr>
<tr>
<td valign="top" align="left">24 (KO/WT)</td>
<td valign="top" align="left">PTGER4</td>
<td valign="top" align="left">0.021</td>
<td valign="top" align="center">G-protein coupled receptor</td>
<td valign="top" align="left">Inhibited</td>
<td valign="top" align="center">&#x02212;3.729</td>
<td valign="top" align="center">1.41E-12</td>
</tr>
<tr>
<td valign="top" align="left">24 (KO/WT)</td>
<td valign="top" align="left">TRIM24</td>
<td valign="top" align="left">&#x02212;0.025</td>
<td valign="top" align="center">Transcription regulator</td>
<td valign="top" align="left">Inhibited</td>
<td valign="top" align="center">&#x02212;3.627</td>
<td valign="top" align="center">2.93E-19</td>
</tr>
<tr>
<td valign="top" align="left">24 (KO/WT)</td>
<td valign="top" align="left">SIRT1</td>
<td valign="top" align="left">&#x02212;0.335</td>
<td valign="top" align="center">Transcription regulator</td>
<td valign="top" align="left">Inhibited</td>
<td valign="top" align="center">&#x02212;3.838</td>
<td valign="top" align="center">6.84E-19</td>
</tr>
<tr>
<td valign="top" align="left">24 (KO/WT)</td>
<td valign="top" align="left">PNPT1</td>
<td valign="top" align="left">0.491</td>
<td valign="top" align="center">Enzyme</td>
<td valign="top" align="left">Inhibited</td>
<td valign="top" align="center">&#x02212;4.123</td>
<td valign="top" align="center">5.54E-25</td>
</tr>
<tr>
<td valign="top" align="left">72 (KO/WT)</td>
<td valign="top" align="left">ACKR2</td>
<td valign="top" align="left">0.188</td>
<td valign="top" align="center">G-protein coupled receptor</td>
<td valign="top" align="left">Inhibited</td>
<td valign="top" align="center">&#x02212;3.317</td>
<td valign="top" align="center">8.73E-18</td>
</tr>
<tr>
<td valign="top" align="left">72 (KO/WT)</td>
<td valign="top" align="left">PTGER4</td>
<td valign="top" align="left">&#x02212;0.141</td>
<td valign="top" align="center">G-protein coupled receptor</td>
<td valign="top" align="left">Inhibited</td>
<td valign="top" align="center">&#x02212;3.44</td>
<td valign="top" align="center">5.67E-13</td>
</tr>
<tr>
<td valign="top" align="left">72 (KO/WT)</td>
<td valign="top" align="left">TRIM24</td>
<td valign="top" align="left">&#x02212;0.032</td>
<td valign="top" align="center">Transcription regulator</td>
<td valign="top" align="left">Inhibited</td>
<td valign="top" align="center">&#x02212;3.978</td>
<td valign="top" align="center">1.06E-21</td>
</tr>
<tr>
<td valign="top" align="left">72 (KO/WT)</td>
<td valign="top" align="left">SIRT1</td>
<td valign="top" align="left">0.232</td>
<td valign="top" align="center">Transcription regulator</td>
<td valign="top" align="left">Inhibited</td>
<td valign="top" align="center">&#x02212;4.243</td>
<td valign="top" align="center">2.51E-17</td>
</tr>
<tr>
<td valign="top" align="left">72 (KO/WT)</td>
<td valign="top" align="left">PNPT1</td>
<td valign="top" align="left">0.315</td>
<td valign="top" align="center">Enzyme</td>
<td valign="top" align="left">Inhibited</td>
<td valign="top" align="center">&#x02212;3.873</td>
<td valign="top" align="center">6.15E-25</td>
</tr>
</tbody>
</table>
<table-wrap-foot>
<p><italic>Upstream Regulators<sup>&#x0002A;</sup>: Use IPA Upstream Regulator Analysis to identify the upstream regulators that may be responsible for gene expression changes observed in your experimental dataset. IPA predicts which upstream regulators are activated or inhibited to explain the up-regulated and down-regulated genes observed in your dataset. Knowledge of this regulatory cascade can help you understand the biological activities occurring in the tissues or cells that you are studying. IPA uses a z-score algorithm to make predictions. The z-score algorithm is designed to reduce the chance that random data will generate significant predictions</italic>.</p>
</table-wrap-foot>
</table-wrap>
<fig id="F8" position="float">
<label>Figure 8</label>
<caption><p>Ingenuity Pathway Analysis regulator effect networks analysis of differentially expressed (DE) genes between <italic>Muc1</italic><sup>&#x02212;/&#x02212;</sup> vs. wild type gastric tissues at 72 h <italic>H</italic>. pylori infection. Log ratio fold changes of DE genes in our data set is shown underneath each gene (red color symbol indicates increased expression). Prediction legend is the same as for <xref ref-type="fig" rid="F3">Figure 3</xref>.</p></caption>
<graphic xlink:href="fcimb-10-00343-g0008.tif"/>
</fig>
</sec>
<sec>
<title>Verification of IPA Identified Canonical Pathways and Networks</title>
<p>To further compare the wild type and <italic>Muc1</italic><sup>&#x02212;/&#x02212;</sup> response to infection, we also performed a sample-to-sample analysis using Graphia Pro network analysis software, with the filtered set of 6016 probesets showing at least 1.5-fold difference between highest and lowest across the eight samples (representing 4,448 unique genes as well as 1,305 unannotated probesets). A Pearson correlation coefficient threshold of 0.95 was used as it was the highest value to include all eight samples in the network. <xref ref-type="supplementary-material" rid="SM6">Supplementary Figure 3</xref> shows that the <italic>Muc1</italic><sup>&#x02212;/&#x02212;</sup> 24 and 72 h samples were separated from all other samples on the basis of gene expression patterns, and that the earlier <italic>Muc1</italic><sup>&#x02212;/&#x02212;</sup> samples were more similar to the wild type 24 and 72 h samples that than earlier wild type samples. This suggested that there were distinct gene expression patterns differentiating the response of the <italic>Muc1</italic><sup>&#x02212;/&#x02212;</sup> animals from that of the wild type animals, consistent with the DE gene analysis. We therefore constructed a GCN using a Pearson correlation coefficient threshold of 0.87 which included all 6016 probesets of the filtered list (making 78,064 edges) in the analysis. A summary of the expression patterns of the largest clusters is shown in <xref ref-type="supplementary-material" rid="SM4">Supplementary Table 4</xref> and a full list of clusters and histograms showing the average expression pattern of clusters with 10 or more nodes is available in <xref ref-type="supplementary-material" rid="SM5">Supplementary Table 5</xref>.</p>
<p>We searched the GCN for known proliferation markers, mitochondrial genes and protein synthesis genes and found no indication that these functions were disrupted in the <italic>Muc1</italic><sup>&#x02212;/&#x02212;</sup> response to the infection.</p>
<p>The DE genes described above were concentrated in three clusters of the GCN. The genes which were upregulated in the <italic>Muc1</italic><sup>&#x02212;/&#x02212;</sup> sham infected animals compared to the wild type sham infected and also in the wild type at 72 h post infection compared to the wild type sham infected were predominantly in Cluster004 (<xref ref-type="supplementary-material" rid="SM6">Supplementary Figure 4</xref>). Genes in this cluster showed enrichment of GO terms relating to digestion, transport, intestinal absorption, microvillus, brush border membrane. DE genes which were upregulated in 24 and 72 h <italic>Muc1</italic><sup>&#x02212;/&#x02212;</sup> samples compared with the corresponding wild type samples, and some of the genes that were higher in <italic>Muc1</italic><sup>&#x02212;/&#x02212;</sup> at 72 h compared with <italic>Muc1</italic><sup>&#x02212;/&#x02212;</sup> sham infected, were mainly in Cluster005 (<xref ref-type="supplementary-material" rid="SM6">Supplementary Figure 4</xref>), enriched for GO terms associated with innate immune response and response to pathogen. The set of DE genes which were higher in <italic>Muc1</italic><sup>&#x02212;/&#x02212;</sup> 8 h than wild type 8 h, but lower in <italic>Muc1</italic><sup>&#x02212;/&#x02212;</sup> 24 and 72 h compared to the corresponding wild type time points and also lower in <italic>Muc1</italic><sup>&#x02212;/&#x02212;</sup> 72 h compared to <italic>Muc1</italic><sup>&#x02212;/&#x02212;</sup> sham were in Cluster008 (<xref ref-type="supplementary-material" rid="SM6">Supplementary Figure 4</xref>). This showed enrichment for GO terms related to catabolism, digestion and extracellular space. This cluster also included <italic>Spink3</italic>, identified as a key regulator by the IPA analysis (<xref ref-type="supplementary-material" rid="SM6">Supplementary Figure 4</xref>), and genes encoding many members of the SPINK1 pathway, including <italic>Cela3b, Cpa1, Cpa2, Cpb1, Ctrc, Ctrl, Prss2</italic>, and <italic>Prss3</italic> (<xref ref-type="supplementary-material" rid="SM6">Supplementary Figure 1</xref>). This cluster also contained a number of other proteases and protease inhibitors.</p>
<p>Analysis of the expression pattern of Muc1 showed that the Muc1<sup>&#x02212;/&#x02212;</sup> samples had very low levels of Muc1 mRNA, as expected. Muc1 was found in Cluster020 where the average expression across all cluster genes of the Muc1<sup>&#x02212;/&#x02212;</sup> samples was half that of the wild type and there was no change during the infection in either WT or Muc1<sup>&#x02212;/&#x02212;</sup> (<xref ref-type="supplementary-material" rid="SM6">Supplementary Figure 4</xref>). This cluster contains genes potentially directly affected by the lack of MUC1, and includes the Srp54b and Srp54c genes, encoding signal recognition particles involved in the export of proteins and both reduced to about 50% of their wild type expression, Rfx6 (regulatory factor X, 6), and sodium channel genes Scn2a and Scn7a. This cluster was enriched for the GO MF term receptor regulatory activity and the GO CC terms vesicle and extracellular region.</p>
<p>In the GCN analysis, Cluster007 showed reduced expression overall in Muc1<sup>&#x02212;/&#x02212;</sup> compared to wild type sham and also reduced further as the infection progressed (<xref ref-type="supplementary-material" rid="SM6">Supplementary Figure 4</xref>). This cluster contained Acta1, encoding smooth muscle actin, as well as the actin crosslinking protein gene Actn3 and two myosin genes (Myo1h and Myh2), suggesting that both infection and Muc1 knockout disrupt the cytoskeleton. The role of H. pylori in actin rearrangement has been described (Tohidpour et al., <xref ref-type="bibr" rid="B37">2017</xref>) and this observation warrants further investigation.</p>
</sec>
<sec>
<title>Selected DE Genes From Diverse Gene Ontologies Showed Consistent Trends in RT-qPCR Assay</title>
<p>Several genes identified as highly DE at one or more time-points over 72 h based on microarray analysis and which were also part of significantly altered pathways and networks identified by IPA were independently validated by RT-qPCR (<xref ref-type="fig" rid="F9">Figure 9</xref>). Overall, most genes measured by qPCR confirmed the changes in gene expression identified by microarray (<xref ref-type="fig" rid="F9">Figure 9</xref>).</p>
<fig id="F9" position="float">
<label>Figure 9</label>
<caption><p>RT qPCR validation of transcripts selected as the most highly differentially expressed genes between <italic>Muc1</italic><sup>&#x02212;/&#x02212;</sup> vs. wild type (WT) gastric tissues. Statistics: Ordinary one-way ANOVA corrected for multiple comparisons by controlling the False Discovery Rate (FDR) using &#x0201C;Two-stage step-up method of Benjamini, Krieger, and Yekutieli;&#x0201D; <italic>n</italic> = 3, &#x0002A; vs. WT at each time point, &#x0002A;<italic>P</italic> &#x0003C; 0.05, &#x0002A;&#x0002A;<italic>P</italic> &#x0003C; 0.01, &#x0002A;&#x0002A;&#x0002A;<italic>P</italic> &#x0003C; 0.001).</p></caption>
<graphic xlink:href="fcimb-10-00343-g0009.tif"/>
</fig>
</sec>
</sec>
<sec sec-type="discussion" id="s4">
<title>Discussion</title>
<p>In this study we first identified a specific set of MUC1-regulated gastric genes by performing microarray analysis of the gastric transcriptome of <italic>Muc1</italic> knockout mice under physiological conditions. Gene categorization analysis (using both IPA and GO term enrichment) indicated that in the uninfected state MUC1-associated genes are involved in a wide range of cellular functions, with the most highly impacted network related to lipid transport and regulated via the transcription factors HINF1A, HINF4A, and SOX2 (<xref ref-type="fig" rid="F3">Figures 3</xref>, <xref ref-type="fig" rid="F4">4</xref>). The Sry-containing protein SOX2 was initially shown to regulate the self-renewal of mouse and human embryonic stem cells (ESCs) and controls the formation of several cell types during fetal development, such as anterior foregut endoderm (Que et al., <xref ref-type="bibr" rid="B28">2007</xref>). SOX2 is also important for the maintenance of stem cells in multiple adult tissues, and it is one of the key transcription factors for establishing induced pluripotent stem cells (Boyer et al., <xref ref-type="bibr" rid="B2">2005</xref>). SOX2 has been shown to bind the <italic>MUC1</italic> promoter in human embryonic stem cells (Boyer et al., <xref ref-type="bibr" rid="B2">2005</xref>). In cancer cells, MUC1 has been shown to drive self-renewal capacity and promote stemness of cancer cells. Targeting the MUC1 cytoplasmic domain (MUC1-C) genetically or pharmacologically decreased: (i) expression of breast cancer stem cell markers including SOX2 (Hata et al., <xref ref-type="bibr" rid="B9">2019</xref>); and (ii) lung cancer stem cell generation associated with decreased levels of SOX2 (Ham et al., <xref ref-type="bibr" rid="B8">2016</xref>). Our study further demonstrates that MUC1 deficiency decreases the expression of <italic>Sox2</italic> in normal gastric tissue. Further studies will now be needed to define how Muc1 influences <italic>Sox2</italic> expression.</p>
<p>Knowledge of the gastric microbiota is evolving, and it is now appreciated that the stomach supports a bacterial community with possibly hundreds of bacterial species that influence stomach homeostasis (Sheh and Fox, <xref ref-type="bibr" rid="B31">2013</xref>). Most of these microbial residents will grow within the mucus layer that overlies the gut epithelium. The mucus layer in the stomach consists of a cell-associated layer (predominantly MUC1) and secreted mucins (mainly MUC5AC) (McGuckin et al., <xref ref-type="bibr" rid="B22">2011</xref>). Recent studies showed that the maturation and function of the mucus layer are strongly influenced by the gut microbiota. In turn, the glycan repertoire of mucins can select for distinct mucosa-associated bacteria that are able to bind or degrade specific mucin glycans as a nutrient source (Schroeder, <xref ref-type="bibr" rid="B30">2019</xref>). It is likely that gastric microbial ecosystems will differ between <italic>Muc1</italic><sup>&#x02212;/&#x02212;</sup> and WT mice. Alterations in the mucosa-associated microbiota could impact on host nutrient metabolism, thus explaining the higher expression of lipid transporter genes in <italic>Muc1</italic><sup>&#x02212;/&#x02212;</sup> gastric tissue. MUC1 has also previously been shown to be a metabolic master regulator in cancer cells in which it regulated metabolism flux at multiple levels, including: (i) directly regulating expression of metabolic genes by acting as co-transcriptional factor; (ii) regulating metabolic functions by modulating the activity/stability of enzymes and transcription factors; and (iii) modulating levels of reactive oxygen species and metabolite flux (Pitroda et al., <xref ref-type="bibr" rid="B27">2009</xref>; Mehla and Singh, <xref ref-type="bibr" rid="B23">2014</xref>). For example, MUC1-C has been shown to regulate glycolysis by directly modulating the functions of the metabolic enzyme, pyruvate kinase M2 (Kosugi et al., <xref ref-type="bibr" rid="B15">2011</xref>). Our results suggest that MUC1 also modulates epithelial metabolic function in the normal gastric mucosa with potential importance in both health and during mucosal infection.</p>
<p>In addition to providing the first-line defensive barrier against many pathogens, gastric mucus also protects the gastric mucosa from enzymatic autodigestion (e.g., by pepsin) and from erosion by acid, premature trypsinogen activation, and from ingested caustic materials. An intriguing and novel finding of MUC1 deficiency under physiological conditions is the inhibition of the SPINK pancreatic cancer pathway. SPINK1 or its homologous protein SPINK3 in mouse, originally isolated from the pancreas as an inhibitor of trypsin, is present throughout the gastrointestinal tract (with stomach having the 2nd highest expression behind pancreas) (Marchbank et al., <xref ref-type="bibr" rid="B18">1996</xref>), and it is the only protease inhibitor known to be secreted into the intestinal lumen. SPINK1 functions as an inhibitor of serine-proteinases, including trypsin, that prevents excessive digestion of the mucus by luminal proteases within the stomach and colon (Marchbank et al., <xref ref-type="bibr" rid="B18">1996</xref>). The inhibition of this pathway in <italic>Muc1</italic><sup>&#x02212;/&#x02212;</sup> mice might result in a thinner mucus layer due to the high uninhibited serine proteinase activity, and thereby predispose to increased penetration by <italic>H. pylori</italic>. This mucus defect could explain the &#x0007E;10-fold higher <italic>H. pylori</italic> colonization in <italic>Muc1</italic><sup>&#x02212;/&#x02212;</sup> mice compared with WT mice very early in infection at a time when innate responses to the bacteria would only be in the preliminary stages of activation and unlikely to impact on bacterial survival or replication. <italic>H. pylori</italic> secretes a serine protease, HtrA, that is involved in gastric colonization and pathogenesis (Zarzecka et al., <xref ref-type="bibr" rid="B44">2019</xref>), and another possibility is that SPINK1 inhibits this protease and MUC1 deficiency-induced reduction of SPINK1 also enhances HtrA activity and pathogenesis. In addition, SPINK1 has been shown to accelerate the healing of stress-induced gastric lesions by inhibiting gastric acid and pepsin outputs in rats (Konturek et al., <xref ref-type="bibr" rid="B14">1998</xref>). The greater bacterial burden in the MUC1-deficient mice continued at 24&#x02013;72 h of infection, and we observe this pathway to be potently activated at 24 and 72 h of infection in the gastric tissue of <italic>Muc1</italic><sup>&#x02212;/&#x02212;</sup> mice compared with WT mice. The higher bacterial burden could cause more tissue damage in the gastric mucosa of <italic>Muc1</italic><sup>&#x02212;/&#x02212;</sup> mice compared with WT mice, thus the activation of this pathway is likely to stimulate repair at sites of infection and epithelial injury in <italic>Muc1</italic><sup>&#x02212;/&#x02212;</sup> mice. Induction of the pathway could also represent a feedback loop to prevent further damage of mucus due to the higher colonization of <italic>H. pylori</italic>. We previously have demonstrated that both epithelial and leucocyte MUC1 mucin protect against <italic>H. pylori</italic> pathogenesis in mice by limiting pathogen contact with the host epithelium and by limiting activation of the NLRP3 inflammasome in macrophages, respectively. We now show that MUC1 may also limit <italic>H</italic>. <italic>pylori</italic> penetration by protecting mucus from enzymatic autodigestion. Together these findings suggest that MUC1 protects the host against pathogens via multiple distinct mechanisms involving multiple cell types.</p>
<p>The time course analysis of this study showed the induction of a potent anti-pathogen response within 24 h of <italic>H. pylori</italic> infection, with infection in <italic>Muc1</italic><sup>&#x02212;/&#x02212;</sup> mice characterized by higher induction of INFG-regulated target genes (<xref ref-type="supplementary-material" rid="SM3">Supplementary Table 3</xref>). For instance, we observed that the genes encoding interferon induced protein 44 (<italic>Ifi44</italic> gene) and schlafen family member 12 like (<italic>Slfn12l</italic> gene) are two of the most highly induced genes in <italic>Muc1</italic><sup>&#x02212;/&#x02212;</sup> mice vs. WT at 24 h post-infection. IFI44, was associated with multiple different viral infections (Honda et al., <xref ref-type="bibr" rid="B10">1990</xref>; Bochkov et al., <xref ref-type="bibr" rid="B1">2010</xref>; Kaczkowski et al., <xref ref-type="bibr" rid="B13">2012</xref>), and has been shown to induce an antiproliferative state in cells (Hallen et al., <xref ref-type="bibr" rid="B7">2007</xref>). SLFN12L also functions as a regulator of cell proliferation and differentiation, and in the induction of immune responses (Mavrommatis et al., <xref ref-type="bibr" rid="B20">2013</xref>). This finding suggested that there are more infected epithelial cells in the gastric mucosa of <italic>Muc1</italic><sup>&#x02212;/&#x02212;</sup> mice, and consequently a more robust response from the host to try to limit the infection by increased expression of immune response and antiproliferation genes and a higher IFNG-modulated anti-pathogen response. A higher number of infected cells is consistent with the higher <italic>H. pylori</italic> colonization in the gastric mucosa of <italic>Muc1</italic><sup>&#x02212;/&#x02212;</sup> mice throughout the first 3 days of infection. These data suggested that MUC1 has an anti-infection and anti-inflammatory function in response to <italic>H. pylori</italic> infection, which is consistent with our previous finding that MUC1 suppresses inflammation in response to <italic>H. pylori</italic> infection <italic>in vitro</italic> and <italic>in vivo</italic> (McGuckin et al., <xref ref-type="bibr" rid="B21">2007</xref>; Linden et al., <xref ref-type="bibr" rid="B17">2009</xref>; Sheng et al., <xref ref-type="bibr" rid="B33">2013</xref>) via negative regulation of NF-&#x003BA;B (Guang et al., <xref ref-type="bibr" rid="B6">2010</xref>; Sheng et al., <xref ref-type="bibr" rid="B33">2013</xref>) and the NLRP3 inflammasome (Ng et al., <xref ref-type="bibr" rid="B26">2016</xref>).</p>
<p>A sample-to-sample network of all samples in the analysis showed that the <italic>Muc1</italic><sup>&#x02212;/&#x02212;</sup> 24 and 72 h samples were separated from all others, indicating that they were substantially different from both the earlier <italic>Muc1</italic><sup>&#x02212;/&#x02212;</sup>samples and the same time points in WT. In addition, sham and 8 h infected <italic>Muc1</italic><sup>&#x02212;/&#x02212;</sup> samples were more similar to the WT 24 and 72 h infection samples than the earlier time points in WT. This association was substantiated by the GCN analysis which revealed clusters of genes in which expression patterns were distinct in <italic>Muc1</italic><sup>&#x02212;/&#x02212;</sup> mice at 24 and 72 h infection, and <italic>Muc1</italic><sup>&#x02212;/&#x02212;</sup> sham and 8 h expression was similar to WT 24 and 72 h expression. These results suggest that <italic>Muc1</italic><sup>&#x02212;/&#x02212;</sup>animals are poised to respond to the early stages of the infection, although by 72 h they are very different from the WT. These data highlight the importance of MUC1 for restriction of early <italic>H. pylori</italic> infection by alterations in the molecular network providing mucosal defense against infection.</p>
<p>In conclusion, we have reported a global overview of MUC1-regulated genes in response to <italic>H. pylori</italic> infection, it likely reflects the subsequent defensive response although this needs to be verified at the proteomic level.</p>
</sec>
<sec sec-type="data-availability-statement" id="s5">
<title>Data Availability Statement</title>
<p>The original contributions presented in the study are publicly available. This data can be found here: <ext-link ext-link-type="uri" xlink:href="https://www.ncbi.nlm.nih.gov/geo/query/acc.cgi?acc=GSE151418">https://www.ncbi.nlm.nih.gov/geo/query/acc.cgi?acc=GSE151418</ext-link>.</p>
</sec>
<sec id="s6">
<title>Ethics Statement</title>
<p>The animal study was reviewed and approved by The University of Melbourne Animal Ethics Committee approval (AEEC No. 06205).</p>
</sec>
<sec id="s7">
<title>Author Contributions</title>
<p>YS designed, performed and analyzed mouse, RNA extraction, microarray and QPCR experiments, and wrote the manuscript. GN and AE designed, performed, and analyzed mouse experiments. GP designed, performed, and analyzed microarray experiments. KS performed the GCN analysis. SH provided intellectual input to the experimental design and analysis. PS provided intellectual input to the project including experimental design, detailed comments, and suggestions on drafts of the manuscript. MM supervised the project, provided intellectual input to experimental planning and analysis, was involved in writing, and was responsible for the final version of the manuscript. All authors contributed to the article and approved the submitted version.</p>
</sec>
<sec id="s8">
<title>Conflict of Interest</title>
<p>The authors declare that the research was conducted in the absence of any commercial or financial relationships that could be construed as a potential conflict of interest.</p>
</sec>
</body>
<back>
<sec sec-type="supplementary-material" id="s9">
<title>Supplementary Material</title>
<p>The Supplementary Material for this article can be found online at: <ext-link ext-link-type="uri" xlink:href="https://www.frontiersin.org/articles/10.3389/fcimb.2020.00343/full#supplementary-material">https://www.frontiersin.org/articles/10.3389/fcimb.2020.00343/full#supplementary-material</ext-link></p>
<supplementary-material xlink:href="Table_1.XLS" id="SM1" mimetype="application/vnd.ms-excel" xmlns:xlink="http://www.w3.org/1999/xlink"/>
<supplementary-material xlink:href="Table_2.DOCX" id="SM2" mimetype="application/vnd.openxmlformats-officedocument.wordprocessingml.document" xmlns:xlink="http://www.w3.org/1999/xlink"/>
<supplementary-material xlink:href="Table_3.XLS" id="SM3" mimetype="application/vnd.ms-excel" xmlns:xlink="http://www.w3.org/1999/xlink"/>
<supplementary-material xlink:href="Table_4.DOCX" id="SM4" mimetype="application/vnd.openxmlformats-officedocument.wordprocessingml.document" xmlns:xlink="http://www.w3.org/1999/xlink"/>
<supplementary-material xlink:href="Table_5.XLSX" id="SM5" mimetype="application/vnd.openxmlformats-officedocument.spreadsheetml.sheet" xmlns:xlink="http://www.w3.org/1999/xlink"/>
<supplementary-material xlink:href="Data_Sheet_1.PDF" id="SM6" mimetype="application/pdf" xmlns:xlink="http://www.w3.org/1999/xlink"/>
</sec>
<ref-list>
<title>References</title>
<ref id="B1">
<citation citation-type="journal"><person-group person-group-type="author"><name><surname>Bochkov</surname> <given-names>Y. A.</given-names></name> <name><surname>Hanson</surname> <given-names>K. M.</given-names></name> <name><surname>Keles</surname> <given-names>S.</given-names></name> <name><surname>Brockman-Schneider</surname> <given-names>R. A.</given-names></name> <name><surname>Jarjour</surname> <given-names>N. N.</given-names></name> <name><surname>Gern</surname> <given-names>J. E.</given-names></name></person-group> (<year>2010</year>). <article-title>Rhinovirus-induced modulation of gene expression in bronchial epithelial cells from subjects with asthma</article-title>. <source>Mucosal Immunol.</source> <volume>3</volume>, <fpage>69</fpage>&#x02013;<lpage>80</lpage>. <pub-id pub-id-type="doi">10.1038/mi.2009.109</pub-id><pub-id pub-id-type="pmid">19710636</pub-id></citation></ref>
<ref id="B2">
<citation citation-type="journal"><person-group person-group-type="author"><name><surname>Boyer</surname> <given-names>L. A.</given-names></name> <name><surname>Lee</surname> <given-names>T. I.</given-names></name> <name><surname>Cole</surname> <given-names>M. F.</given-names></name> <name><surname>Johnstone</surname> <given-names>S. E.</given-names></name> <name><surname>Levine</surname> <given-names>S. S.</given-names></name> <name><surname>Zucker</surname> <given-names>J. P.</given-names></name> <etal/></person-group>. (<year>2005</year>). <article-title>Core transcriptional regulatory circuitry in human embryonic stem cells</article-title>. <source>Cell</source> <volume>122</volume>, <fpage>947</fpage>&#x02013;<lpage>956</lpage>. <pub-id pub-id-type="doi">10.1016/j.cell.2005.08.020</pub-id><pub-id pub-id-type="pmid">16153702</pub-id></citation></ref>
<ref id="B3">
<citation citation-type="journal"><person-group person-group-type="author"><name><surname>Calvano</surname> <given-names>S. E.</given-names></name> <name><surname>Xiao</surname> <given-names>W.</given-names></name> <name><surname>Richards</surname> <given-names>D. R.</given-names></name> <name><surname>Felciano</surname> <given-names>R. M.</given-names></name> <name><surname>Baker</surname> <given-names>H. V.</given-names></name> <name><surname>Cho</surname> <given-names>R. J.</given-names></name> <etal/></person-group>. (<year>2005</year>). <article-title>A network-based analysis of systemic inflammation in humans</article-title>. <source>Nature</source> <volume>437</volume>, <fpage>1032</fpage>&#x02013;<lpage>1037</lpage>. <pub-id pub-id-type="doi">10.1038/nature03985</pub-id><pub-id pub-id-type="pmid">16136080</pub-id></citation></ref>
<ref id="B4">
<citation citation-type="journal"><person-group person-group-type="author"><name><surname>Carvalho</surname> <given-names>F.</given-names></name> <name><surname>Seruca</surname> <given-names>R.</given-names></name> <name><surname>David</surname> <given-names>L.</given-names></name> <name><surname>Amorim</surname> <given-names>A.</given-names></name> <name><surname>Seixas</surname> <given-names>M.</given-names></name> <name><surname>Bennett</surname> <given-names>E.</given-names></name> <etal/></person-group>. (<year>1997</year>). <article-title>MUC1 gene polymorphism and gastric cancer&#x02013;an epidemiological study</article-title>. <source>Glycoconj J.</source> <volume>14</volume>, <fpage>107</fpage>&#x02013;<lpage>111</lpage>. <pub-id pub-id-type="doi">10.1023/A:1018573201347</pub-id><pub-id pub-id-type="pmid">9076520</pub-id></citation></ref>
<ref id="B5">
<citation citation-type="journal"><person-group person-group-type="author"><name><surname>Chang</surname> <given-names>J. T.</given-names></name> <name><surname>Nevins</surname> <given-names>J. R.</given-names></name></person-group> (<year>2006</year>). <article-title>GATHER: a systems approach to interpreting genomic signatures</article-title>. <source>Bioinformatics</source> <volume>22</volume>, <fpage>2926</fpage>&#x02013;<lpage>2933</lpage>. <pub-id pub-id-type="doi">10.1093/bioinformatics/btl483</pub-id><pub-id pub-id-type="pmid">17000751</pub-id></citation></ref>
<ref id="B6">
<citation citation-type="journal"><person-group person-group-type="author"><name><surname>Guang</surname> <given-names>W.</given-names></name> <name><surname>Ding</surname> <given-names>H.</given-names></name> <name><surname>Czinn</surname> <given-names>S. J.</given-names></name> <name><surname>Kim</surname> <given-names>K. C.</given-names></name> <name><surname>Blanchard</surname> <given-names>T. G.</given-names></name> <name><surname>Lillehoj</surname> <given-names>E. P.</given-names></name></person-group> (<year>2010</year>). <article-title>Muc1 cell surface mucin attenuates epithelial inflammation in response to a common mucosal pathogen</article-title>. <source>J. Biol. Chem.</source> <volume>285</volume>, <fpage>20547</fpage>&#x02013;<lpage>20557</lpage>. <pub-id pub-id-type="doi">10.1074/jbc.M110.121319</pub-id><pub-id pub-id-type="pmid">20430889</pub-id></citation></ref>
<ref id="B7">
<citation citation-type="journal"><person-group person-group-type="author"><name><surname>Hallen</surname> <given-names>L. C.</given-names></name> <name><surname>Burki</surname> <given-names>Y.</given-names></name> <name><surname>Ebeling</surname> <given-names>M.</given-names></name> <name><surname>Broger</surname> <given-names>C.</given-names></name> <name><surname>Siegrist</surname> <given-names>F.</given-names></name> <name><surname>Oroszlan-Szovik</surname> <given-names>K.</given-names></name> <etal/></person-group>. (<year>2007</year>). <article-title>Antiproliferative activity of the human IFN-alpha-inducible protein IFI44</article-title>. <source>J. Interferon Cytokine Res.</source> <volume>27</volume>, <fpage>675</fpage>&#x02013;<lpage>680</lpage>. <pub-id pub-id-type="doi">10.1089/jir.2007.0021</pub-id><pub-id pub-id-type="pmid">17784819</pub-id></citation></ref>
<ref id="B8">
<citation citation-type="journal"><person-group person-group-type="author"><name><surname>Ham</surname> <given-names>S. Y.</given-names></name> <name><surname>Kwon</surname> <given-names>T.</given-names></name> <name><surname>Bak</surname> <given-names>Y.</given-names></name> <name><surname>Yu</surname> <given-names>J. H.</given-names></name> <name><surname>Hong</surname> <given-names>J.</given-names></name> <name><surname>Lee</surname> <given-names>S. K.</given-names></name> <etal/></person-group>. (<year>2016</year>). <article-title>Mucin 1-mediated chemo-resistance in lung cancer cells</article-title>. <source>Oncogenesis</source> <volume>5</volume>:<fpage>e185</fpage>. <pub-id pub-id-type="doi">10.1038/oncsis.2015.47</pub-id><pub-id pub-id-type="pmid">26779808</pub-id></citation></ref>
<ref id="B9">
<citation citation-type="journal"><person-group person-group-type="author"><name><surname>Hata</surname> <given-names>T.</given-names></name> <name><surname>Rajabi</surname> <given-names>H.</given-names></name> <name><surname>Yamamoto</surname> <given-names>M.</given-names></name> <name><surname>Jin</surname> <given-names>C.</given-names></name> <name><surname>Ahmad</surname> <given-names>R.</given-names></name> <name><surname>Zhang</surname> <given-names>Y.</given-names></name> <etal/></person-group>. (<year>2019</year>). <article-title>Targeting MUC1-C inhibits TWIST1 signaling in triple-negative breast cancer</article-title>. <source>Mol. Cancer Ther.</source> <volume>18</volume>, <fpage>1744</fpage>&#x02013;<lpage>1754</lpage>. <pub-id pub-id-type="doi">10.1158/1535-7163.MCT-19-0156</pub-id><pub-id pub-id-type="pmid">31308076</pub-id></citation></ref>
<ref id="B10">
<citation citation-type="journal"><person-group person-group-type="author"><name><surname>Honda</surname> <given-names>Y.</given-names></name> <name><surname>Kondo</surname> <given-names>J.</given-names></name> <name><surname>Maeda</surname> <given-names>T.</given-names></name> <name><surname>Yoshiyama</surname> <given-names>Y.</given-names></name> <name><surname>Yamada</surname> <given-names>E.</given-names></name> <name><surname>Shimizu</surname> <given-names>Y. K.</given-names></name> <etal/></person-group>. (<year>1990</year>). <article-title>Isolation and purification of a non-A, non-B hepatitis-associated microtubular aggregates protein</article-title>. <source>J. Gen. Virol.</source> <volume>71</volume>(<issue>Pt 9</issue>), <fpage>1999</fpage>&#x02013;<lpage>2004</lpage>. <pub-id pub-id-type="doi">10.1099/0022-1317-71-9-1999</pub-id></citation></ref>
<ref id="B11">
<citation citation-type="journal"><person-group person-group-type="author"><name><surname>Huang da</surname> <given-names>W.</given-names></name> <name><surname>Sherman</surname> <given-names>B. T.</given-names></name> <name><surname>Lempicki</surname> <given-names>R. A.</given-names></name></person-group> (<year>2009a</year>). <article-title>Bioinformatics enrichment tools: paths toward the comprehensive functional analysis of large gene lists</article-title>. <source>Nucleic Acids Res.</source> <volume>37</volume>, <fpage>1</fpage>&#x02013;<lpage>13</lpage>. <pub-id pub-id-type="doi">10.1093/nar/gkn923</pub-id><pub-id pub-id-type="pmid">19033363</pub-id></citation></ref>
<ref id="B12">
<citation citation-type="journal"><person-group person-group-type="author"><name><surname>Huang da</surname> <given-names>W.</given-names></name> <name><surname>Sherman</surname> <given-names>B. T.</given-names></name> <name><surname>Lempicki</surname> <given-names>R. A.</given-names></name></person-group> (<year>2009b</year>). <article-title>Systematic and integrative analysis of large gene lists using DAVID bioinformatics resources</article-title>. <source>Nat. Protoc.</source> <volume>4</volume>, <fpage>44</fpage>&#x02013;<lpage>57</lpage>. <pub-id pub-id-type="doi">10.1038/nprot.2008.211</pub-id><pub-id pub-id-type="pmid">19131956</pub-id></citation></ref>
<ref id="B13">
<citation citation-type="journal"><person-group person-group-type="author"><name><surname>Kaczkowski</surname> <given-names>B.</given-names></name> <name><surname>Rossing</surname> <given-names>M.</given-names></name> <name><surname>Andersen</surname> <given-names>D. K.</given-names></name> <name><surname>Dreher</surname> <given-names>A.</given-names></name> <name><surname>Morevati</surname> <given-names>M.</given-names></name> <name><surname>Visser</surname> <given-names>M. A.</given-names></name> <etal/></person-group>. (<year>2012</year>). <article-title>Integrative analyses reveal novel strategies in HPV11,-16 and&#x02212;45 early infection</article-title>. <source>Sci. Rep.</source> <volume>2</volume>:<fpage>515</fpage>. <pub-id pub-id-type="doi">10.1038/srep00515</pub-id><pub-id pub-id-type="pmid">22808421</pub-id></citation></ref>
<ref id="B14">
<citation citation-type="journal"><person-group person-group-type="author"><name><surname>Konturek</surname> <given-names>P.</given-names></name> <name><surname>Brzozowski</surname> <given-names>T.</given-names></name> <name><surname>Konturek</surname> <given-names>S. J.</given-names></name> <name><surname>Taut</surname> <given-names>A.</given-names></name> <name><surname>Pierzchalski</surname> <given-names>P.</given-names></name> <name><surname>Elia</surname> <given-names>G.</given-names></name> <etal/></person-group>. (<year>1998</year>). <article-title>Base variant of human pancreatic secretory trypsin inhibitor in healing of stress-induced gastric lesions in rats</article-title>. <source>Regul. Pept.</source> <volume>77</volume>, <fpage>95</fpage>&#x02013;<lpage>103</lpage>. <pub-id pub-id-type="doi">10.1016/S0167-0115(98)00105-0</pub-id><pub-id pub-id-type="pmid">9809802</pub-id></citation></ref>
<ref id="B15">
<citation citation-type="journal"><person-group person-group-type="author"><name><surname>Kosugi</surname> <given-names>M.</given-names></name> <name><surname>Ahmad</surname> <given-names>R.</given-names></name> <name><surname>Alam</surname> <given-names>M.</given-names></name> <name><surname>Uchida</surname> <given-names>Y.</given-names></name> <name><surname>Kufe</surname> <given-names>D.</given-names></name></person-group> (<year>2011</year>). <article-title>MUC1-C oncoprotein regulates glycolysis and pyruvate kinase M2 activity in cancer cells</article-title>. <source>PLoS ONE</source> <volume>6</volume>:<fpage>e28234</fpage>. <pub-id pub-id-type="doi">10.1371/journal.pone.0028234</pub-id><pub-id pub-id-type="pmid">22140559</pub-id></citation></ref>
<ref id="B16">
<citation citation-type="journal"><person-group person-group-type="author"><name><surname>Lee</surname> <given-names>A.</given-names></name> <name><surname>O&#x00027;Rourke</surname> <given-names>J.</given-names></name> <name><surname>De Ungria</surname> <given-names>M. C.</given-names></name> <name><surname>Robertson</surname> <given-names>B.</given-names></name> <name><surname>Daskalopoulos</surname> <given-names>G.</given-names></name> <name><surname>Dixon</surname> <given-names>M. F.</given-names></name></person-group> (<year>1997</year>). <article-title>A standardized mouse model of <italic>Helicobacter pylori</italic> infection: introducing the Sydney strain</article-title>. <source>Gastroenterology</source> <volume>112</volume>, <fpage>1386</fpage>&#x02013;<lpage>1397</lpage>. <pub-id pub-id-type="doi">10.1016/S0016-5085(97)70155-0</pub-id><pub-id pub-id-type="pmid">9098027</pub-id></citation></ref>
<ref id="B17">
<citation citation-type="journal"><person-group person-group-type="author"><name><surname>Linden</surname> <given-names>S. K.</given-names></name> <name><surname>Sheng</surname> <given-names>Y. H.</given-names></name> <name><surname>Every</surname> <given-names>A. L.</given-names></name> <name><surname>Miles</surname> <given-names>K. M.</given-names></name> <name><surname>Skoog</surname> <given-names>E. C.</given-names></name> <name><surname>Florin</surname> <given-names>T. H.</given-names></name> <etal/></person-group>. (<year>2009</year>). <article-title>MUC1 limits <italic>Helicobacter pylori</italic> infection both by steric hindrance and by acting as a releasable decoy</article-title>. <source>PLoS Pathog.</source> <volume>5</volume>:<fpage>e1000617</fpage>. <pub-id pub-id-type="doi">10.1371/journal.ppat.1000617</pub-id><pub-id pub-id-type="pmid">19816567</pub-id></citation></ref>
<ref id="B18">
<citation citation-type="journal"><person-group person-group-type="author"><name><surname>Marchbank</surname> <given-names>T.</given-names></name> <name><surname>Chinery</surname> <given-names>R.</given-names></name> <name><surname>Hanby</surname> <given-names>A. M.</given-names></name> <name><surname>Poulsom</surname> <given-names>R.</given-names></name> <name><surname>Elia</surname> <given-names>G.</given-names></name> <name><surname>Playford</surname> <given-names>R. J.</given-names></name></person-group> (<year>1996</year>). <article-title>Distribution and expression of pancreatic secretory trypsin inhibitor and its possible role in epithelial restitution</article-title>. <source>Am. J. Pathol.</source> <volume>148</volume>, <fpage>715</fpage>&#x02013;<lpage>722</lpage>. <pub-id pub-id-type="pmid">8774127</pub-id></citation></ref>
<ref id="B19">
<citation citation-type="journal"><person-group person-group-type="author"><name><surname>Marchbank</surname> <given-names>T.</given-names></name> <name><surname>Freeman</surname> <given-names>T. C.</given-names></name> <name><surname>Playford</surname> <given-names>R. J.</given-names></name></person-group> (<year>1998</year>). <article-title>Human pancreatic secretory trypsin inhibitor. Distribution, actions and possible role in mucosal integrity and repair</article-title>. <source>Digestion</source> <volume>59</volume>, <fpage>167</fpage>&#x02013;<lpage>174</lpage>. <pub-id pub-id-type="doi">10.1159/000007485</pub-id><pub-id pub-id-type="pmid">9643675</pub-id></citation></ref>
<ref id="B20">
<citation citation-type="journal"><person-group person-group-type="author"><name><surname>Mavrommatis</surname> <given-names>E.</given-names></name> <name><surname>Fish</surname> <given-names>E. N.</given-names></name> <name><surname>Platanias</surname> <given-names>L. C.</given-names></name></person-group> (<year>2013</year>). <article-title>The schlafen family of proteins and their regulation by interferons</article-title>. <source>J. Interferon Cytokine Res.</source> <volume>33</volume>, <fpage>206</fpage>&#x02013;<lpage>210</lpage>. <pub-id pub-id-type="doi">10.1089/jir.2012.0133</pub-id><pub-id pub-id-type="pmid">23570387</pub-id></citation></ref>
<ref id="B21">
<citation citation-type="journal"><person-group person-group-type="author"><name><surname>McGuckin</surname> <given-names>M. A.</given-names></name> <name><surname>Every</surname> <given-names>A. L.</given-names></name> <name><surname>Skene</surname> <given-names>C. D.</given-names></name> <name><surname>Linden</surname> <given-names>S. K.</given-names></name> <name><surname>Chionh</surname> <given-names>Y. T.</given-names></name> <name><surname>Swierczak</surname> <given-names>A.</given-names></name> <etal/></person-group>. (<year>2007</year>). <article-title>Muc1 mucin limits both <italic>Helicobacter pylori</italic> colonization of the murine gastric mucosa and associated gastritis</article-title>. <source>Gastroenterology</source> <volume>133</volume>, <fpage>1210</fpage>&#x02013;<lpage>1218</lpage>. <pub-id pub-id-type="doi">10.1053/j.gastro.2007.07.003</pub-id><pub-id pub-id-type="pmid">17919495</pub-id></citation></ref>
<ref id="B22">
<citation citation-type="journal"><person-group person-group-type="author"><name><surname>McGuckin</surname> <given-names>M. A.</given-names></name> <name><surname>Linden</surname> <given-names>S. K.</given-names></name> <name><surname>Sutton</surname> <given-names>P.</given-names></name> <name><surname>Florin</surname> <given-names>T. H.</given-names></name></person-group> (<year>2011</year>). <article-title>Mucin dynamics and enteric pathogens</article-title>. <source>Nat. Rev. Microbiol.</source> <volume>9</volume>, <fpage>265</fpage>&#x02013;<lpage>278</lpage>. <pub-id pub-id-type="doi">10.1038/nrmicro2538</pub-id><pub-id pub-id-type="pmid">21407243</pub-id></citation></ref>
<ref id="B23">
<citation citation-type="journal"><person-group person-group-type="author"><name><surname>Mehla</surname> <given-names>K.</given-names></name> <name><surname>Singh</surname> <given-names>P. K.</given-names></name></person-group> (<year>2014</year>). <article-title>MUC1: a novel metabolic master regulator</article-title>. <source>Biochim. Biophys. Acta</source> <volume>1845</volume>, <fpage>126</fpage>&#x02013;<lpage>135</lpage>. <pub-id pub-id-type="doi">10.1016/j.bbcan.2014.01.001</pub-id><pub-id pub-id-type="pmid">24418575</pub-id></citation></ref>
<ref id="B24">
<citation citation-type="journal"><person-group person-group-type="author"><name><surname>Mi</surname> <given-names>H.</given-names></name> <name><surname>Muruganujan</surname> <given-names>A.</given-names></name> <name><surname>Ebert</surname> <given-names>D.</given-names></name> <name><surname>Huang</surname> <given-names>X.</given-names></name> <name><surname>Thomas</surname> <given-names>P. D.</given-names></name></person-group> (<year>2019a</year>). <article-title>PANTHER version 14: more genomes, a new PANTHER GO-slim and improvements in enrichment analysis tools</article-title>. <source>Nucleic Acids Res.</source> <volume>47</volume>, <fpage>D419</fpage>&#x02013;<lpage>D426</lpage>. <pub-id pub-id-type="doi">10.1093/nar/gky1038</pub-id><pub-id pub-id-type="pmid">30407594</pub-id></citation></ref>
<ref id="B25">
<citation citation-type="journal"><person-group person-group-type="author"><name><surname>Mi</surname> <given-names>H.</given-names></name> <name><surname>Muruganujan</surname> <given-names>A.</given-names></name> <name><surname>Huang</surname> <given-names>X.</given-names></name> <name><surname>Ebert</surname> <given-names>D.</given-names></name> <name><surname>Mills</surname> <given-names>C.</given-names></name> <name><surname>Guo</surname> <given-names>X.</given-names></name> <etal/></person-group>. (<year>2019b</year>). <article-title>Protocol Update for large-scale genome and gene function analysis with the PANTHER classification system (v.14.0)</article-title>. <source>Nat. Protoc.</source> <volume>14</volume>, <fpage>703</fpage>&#x02013;<lpage>721</lpage>. <pub-id pub-id-type="doi">10.1038/s41596-019-0128-8</pub-id><pub-id pub-id-type="pmid">30804569</pub-id></citation></ref>
<ref id="B26">
<citation citation-type="journal"><person-group person-group-type="author"><name><surname>Ng</surname> <given-names>G. Z.</given-names></name> <name><surname>Menheniott</surname> <given-names>T. R.</given-names></name> <name><surname>Every</surname> <given-names>A. L.</given-names></name> <name><surname>Stent</surname> <given-names>A.</given-names></name> <name><surname>Judd</surname> <given-names>L. M.</given-names></name> <name><surname>Chionh</surname> <given-names>Y. T.</given-names></name> <etal/></person-group>. (<year>2016</year>). <article-title>The MUC1 mucin protects against <italic>Helicobacter pylori</italic> pathogenesis in mice by regulation of the NLRP3 inflammasome</article-title>. <source>Gut</source> <volume>65</volume>, <fpage>1087</fpage>&#x02013;<lpage>1099</lpage>. <pub-id pub-id-type="doi">10.1136/gutjnl-2014-307175</pub-id><pub-id pub-id-type="pmid">26079943</pub-id></citation></ref>
<ref id="B27">
<citation citation-type="journal"><person-group person-group-type="author"><name><surname>Pitroda</surname> <given-names>S. P.</given-names></name> <name><surname>Khodarev</surname> <given-names>N. N.</given-names></name> <name><surname>Beckett</surname> <given-names>M. A.</given-names></name> <name><surname>Kufe</surname> <given-names>D. W.</given-names></name> <name><surname>Weichselbaum</surname> <given-names>R. R.</given-names></name></person-group> (<year>2009</year>). <article-title>MUC1-induced alterations in a lipid metabolic gene network predict response of human breast cancers to tamoxifen treatment</article-title>. <source>Proc. Natl. Acad. Sci. U.S.A.</source> <volume>106</volume>, <fpage>5837</fpage>&#x02013;<lpage>5841</lpage>. <pub-id pub-id-type="doi">10.1073/pnas.0812029106</pub-id><pub-id pub-id-type="pmid">19289846</pub-id></citation></ref>
<ref id="B28">
<citation citation-type="journal"><person-group person-group-type="author"><name><surname>Que</surname> <given-names>J.</given-names></name> <name><surname>Okubo</surname> <given-names>T.</given-names></name> <name><surname>Goldenring</surname> <given-names>J. R.</given-names></name> <name><surname>Nam</surname> <given-names>K. T.</given-names></name> <name><surname>Kurotani</surname> <given-names>R.</given-names></name> <name><surname>Morrisey</surname> <given-names>E. E.</given-names></name> <etal/></person-group>. (<year>2007</year>). <article-title>Multiple dose-dependent roles for Sox2 in the patterning and differentiation of anterior foregut endoderm</article-title>. <source>Development</source> <volume>134</volume>, <fpage>2521</fpage>&#x02013;<lpage>2531</lpage>. <pub-id pub-id-type="doi">10.1242/dev.003855</pub-id><pub-id pub-id-type="pmid">17522155</pub-id></citation></ref>
<ref id="B29">
<citation citation-type="journal"><person-group person-group-type="author"><name><surname>Rawla</surname> <given-names>P.</given-names></name> <name><surname>Barsouk</surname> <given-names>A.</given-names></name></person-group> (<year>2019</year>). <article-title>Epidemiology of gastric cancer: global trends, risk factors and prevention</article-title>. <source>Prz Gastroenterol.</source> <volume>14</volume>, <fpage>26</fpage>&#x02013;<lpage>38</lpage>. <pub-id pub-id-type="doi">10.5114/pg.2018.80001</pub-id><pub-id pub-id-type="pmid">30944675</pub-id></citation></ref>
<ref id="B30">
<citation citation-type="journal"><person-group person-group-type="author"><name><surname>Schroeder</surname> <given-names>B. O.</given-names></name></person-group> (<year>2019</year>). <article-title>Fight them or feed them: how the intestinal mucus layer manages the gut microbiota</article-title>. <source>Gastroenterol. Rep.</source> <volume>7</volume>, <fpage>3</fpage>&#x02013;<lpage>12</lpage>. <pub-id pub-id-type="doi">10.1093/gastro/goy052</pub-id><pub-id pub-id-type="pmid">30792861</pub-id></citation></ref>
<ref id="B31">
<citation citation-type="journal"><person-group person-group-type="author"><name><surname>Sheh</surname> <given-names>A.</given-names></name> <name><surname>Fox</surname> <given-names>J. G.</given-names></name></person-group> (<year>2013</year>). <article-title>The role of the gastrointestinal microbiome in <italic>Helicobacter pylori</italic> pathogenesis</article-title>. <source>Gut Microbes</source> <volume>4</volume>, <fpage>505</fpage>&#x02013;<lpage>531</lpage>. <pub-id pub-id-type="doi">10.4161/gmic.26205</pub-id><pub-id pub-id-type="pmid">23962822</pub-id></citation></ref>
<ref id="B32">
<citation citation-type="journal"><person-group person-group-type="author"><name><surname>Sheng</surname> <given-names>Y. H.</given-names></name> <name><surname>Hasnain</surname> <given-names>S. Z.</given-names></name> <name><surname>Florin</surname> <given-names>T. H.</given-names></name> <name><surname>McGuckin</surname> <given-names>M. A.</given-names></name></person-group> (<year>2012</year>). <article-title>Mucins in inflammatory bowel diseases and colorectal cancer</article-title>. <source>J. Gastroenterol. Hepatol.</source> <volume>27</volume>, <fpage>28</fpage>&#x02013;<lpage>38</lpage>. <pub-id pub-id-type="doi">10.1111/j.1440-1746.2011.06909.x</pub-id><pub-id pub-id-type="pmid">21913981</pub-id></citation></ref>
<ref id="B33">
<citation citation-type="journal"><person-group person-group-type="author"><name><surname>Sheng</surname> <given-names>Y. H.</given-names></name> <name><surname>Triyana</surname> <given-names>S.</given-names></name> <name><surname>Wang</surname> <given-names>R.</given-names></name> <name><surname>Das</surname> <given-names>I.</given-names></name> <name><surname>Gerloff</surname> <given-names>K.</given-names></name> <name><surname>Florin</surname> <given-names>T. H.</given-names></name> <etal/></person-group>. (<year>2013</year>). <article-title>MUC1 and MUC13 differentially regulate epithelial inflammation in response to inflammatory and infectious stimuli</article-title>. <source>Mucosal Immunol.</source> <volume>6</volume>, <fpage>557</fpage>&#x02013;<lpage>568</lpage>. <pub-id pub-id-type="doi">10.1038/mi.2012.98</pub-id><pub-id pub-id-type="pmid">23149663</pub-id></citation></ref>
<ref id="B34">
<citation citation-type="journal"><person-group person-group-type="author"><name><surname>Spicer</surname> <given-names>A. P.</given-names></name> <name><surname>Rowse</surname> <given-names>G. J.</given-names></name> <name><surname>Lidner</surname> <given-names>T. K.</given-names></name> <name><surname>Gendler</surname> <given-names>S. J.</given-names></name></person-group> (<year>1995</year>). <article-title>Delayed mammary tumor progression in Muc-1 null mice</article-title>. <source>J. Biol. Chem.</source> <volume>270</volume>, <fpage>30093</fpage>&#x02013;<lpage>30101</lpage>. <pub-id pub-id-type="doi">10.1074/jbc.270.50.30093</pub-id><pub-id pub-id-type="pmid">8530414</pub-id></citation></ref>
<ref id="B35">
<citation citation-type="journal"><person-group person-group-type="author"><name><surname>Sutton</surname> <given-names>P.</given-names></name> <name><surname>Wilson</surname> <given-names>J.</given-names></name> <name><surname>Lee</surname> <given-names>A.</given-names></name></person-group> (<year>2000</year>). <article-title>Further development of the <italic>Helicobacter pylori</italic> mouse vaccination model</article-title>. <source>Vaccine</source> <volume>18</volume>, <fpage>2677</fpage>&#x02013;<lpage>2685</lpage>. <pub-id pub-id-type="doi">10.1016/S0264-410X(00)00052-9</pub-id><pub-id pub-id-type="pmid">10781854</pub-id></citation></ref>
<ref id="B36">
<citation citation-type="journal"><person-group person-group-type="author"><name><surname>Theocharidis</surname> <given-names>A.</given-names></name> <name><surname>van Dongen</surname> <given-names>S.</given-names></name> <name><surname>Enright</surname> <given-names>A. J.</given-names></name> <name><surname>Freeman</surname> <given-names>T. C.</given-names></name></person-group> (<year>2009</year>). <article-title>Network visualization and analysis of gene expression data using BioLayout Express(3D)</article-title>. <source>Nat. Protoc.</source> <volume>4</volume>, <fpage>1535</fpage>&#x02013;<lpage>1550</lpage>. <pub-id pub-id-type="doi">10.1038/nprot.2009.177</pub-id><pub-id pub-id-type="pmid">19798086</pub-id></citation></ref>
<ref id="B37">
<citation citation-type="journal"><person-group person-group-type="author"><name><surname>Tohidpour</surname> <given-names>A.</given-names></name> <name><surname>Gorrell</surname> <given-names>R. J.</given-names></name> <name><surname>Roujeinikova</surname> <given-names>A.</given-names></name> <name><surname>Kwok</surname> <given-names>T.</given-names></name></person-group> (<year>2017</year>). <article-title>The middle fragment of <italic>Helicobacter pylori</italic> CagA induces actin rearrangement and triggers its own uptake into gastric epithelial cells</article-title>. <source>Toxins</source> <volume>9</volume>:<fpage>237</fpage>. <pub-id pub-id-type="doi">10.3390/toxins9080237</pub-id><pub-id pub-id-type="pmid">28788072</pub-id></citation></ref>
<ref id="B38">
<citation citation-type="journal"><person-group person-group-type="author"><name><surname>van Beelen Granlund</surname> <given-names>A.</given-names></name> <name><surname>Ostvik</surname> <given-names>A. E.</given-names></name> <name><surname>Brenna</surname> <given-names>O.</given-names></name> <name><surname>Torp</surname> <given-names>S. H.</given-names></name> <name><surname>Gustafsson</surname> <given-names>B. I.</given-names></name> <name><surname>Sandvik</surname> <given-names>A. K.</given-names></name></person-group> (<year>2013</year>). <article-title>REG gene expression in inflamed and healthy colon mucosa explored by in situ hybridisation</article-title>. <source>Cell Tissue Res.</source> <volume>352</volume>, <fpage>639</fpage>&#x02013;<lpage>646</lpage>. <pub-id pub-id-type="doi">10.1007/s00441-013-1592-z</pub-id><pub-id pub-id-type="pmid">23519454</pub-id></citation></ref>
<ref id="B39">
<citation citation-type="journal"><person-group person-group-type="author"><name><surname>van Dongen</surname> <given-names>S.</given-names></name> <name><surname>Abreu-Goodger</surname> <given-names>C.</given-names></name></person-group> (<year>2012</year>). <article-title>Using MCL to extract clusters from networks</article-title>. <source>Methods Mol. Biol.</source> <volume>804</volume>, <fpage>281</fpage>&#x02013;<lpage>295</lpage>. <pub-id pub-id-type="doi">10.1007/978-1-61779-361-5_15</pub-id><pub-id pub-id-type="pmid">22144159</pub-id></citation></ref>
<ref id="B40">
<citation citation-type="journal"><person-group person-group-type="author"><name><surname>Vinall</surname> <given-names>L. E.</given-names></name> <name><surname>King</surname> <given-names>M.</given-names></name> <name><surname>Novelli</surname> <given-names>M.</given-names></name> <name><surname>Green</surname> <given-names>C. A.</given-names></name> <name><surname>Daniels</surname> <given-names>G.</given-names></name> <name><surname>Hilkens</surname> <given-names>J.</given-names></name> <etal/></person-group>. (<year>2002</year>). <article-title>Altered expression and allelic association of the hypervariable membrane mucin MUC1 in <italic>Helicobacter pylori</italic> gastritis</article-title>. <source>Gastroenterology</source> <volume>123</volume>, <fpage>41</fpage>&#x02013;<lpage>49</lpage>. <pub-id pub-id-type="doi">10.1053/gast.2002.34157</pub-id><pub-id pub-id-type="pmid">12105832</pub-id></citation></ref>
<ref id="B41">
<citation citation-type="journal"><person-group person-group-type="author"><name><surname>Wang</surname> <given-names>G. P.</given-names></name> <name><surname>Xu</surname> <given-names>C. S.</given-names></name></person-group> (<year>2010</year>). <article-title>Pancreatic secretory trypsin inhibitor: more than a trypsin inhibitor</article-title>. <source>World J. Gastrointest Pathophysiol.</source> <volume>1</volume>, <fpage>85</fpage>&#x02013;<lpage>90</lpage>. <pub-id pub-id-type="doi">10.4291/wjgp.v1.i2.85</pub-id><pub-id pub-id-type="pmid">21607145</pub-id></citation></ref>
<ref id="B42">
<citation citation-type="journal"><person-group person-group-type="author"><name><surname>Wolfe</surname> <given-names>C. J.</given-names></name> <name><surname>Kohane</surname> <given-names>I. S.</given-names></name> <name><surname>Butte</surname> <given-names>A. J.</given-names></name></person-group> (<year>2005</year>). <article-title>Systematic survey reveals general applicability of &#x0201C;guilt-by-association&#x0201D; within gene coexpression networks</article-title>. <source>BMC Bioinformatics</source> <volume>6</volume>:<fpage>227</fpage>. <pub-id pub-id-type="doi">10.1186/1471-2105-6-227</pub-id><pub-id pub-id-type="pmid">16162296</pub-id></citation></ref>
<ref id="B43">
<citation citation-type="journal"><person-group person-group-type="author"><name><surname>Wykes</surname> <given-names>M.</given-names></name> <name><surname>MacDonald</surname> <given-names>K. P.</given-names></name> <name><surname>Tran</surname> <given-names>M.</given-names></name> <name><surname>Quin</surname> <given-names>R. J.</given-names></name> <name><surname>Xing</surname> <given-names>P. X.</given-names></name> <name><surname>Gendler</surname> <given-names>S. J.</given-names></name> <etal/></person-group>. (<year>2002</year>). <article-title>MUC1 epithelial mucin (CD227) is expressed by activated dendritic cells</article-title>. <source>J. Leukoc. Biol.</source> <volume>72</volume>, <fpage>692</fpage>&#x02013;<lpage>701</lpage>. <pub-id pub-id-type="doi">10.1189/jlb.72.4.692</pub-id><pub-id pub-id-type="pmid">12377938</pub-id></citation></ref>
<ref id="B44">
<citation citation-type="journal"><person-group person-group-type="author"><name><surname>Zarzecka</surname> <given-names>U.</given-names></name> <name><surname>Modrak-Wojcik</surname> <given-names>A.</given-names></name> <name><surname>Figaj</surname> <given-names>D.</given-names></name> <name><surname>Apanowicz</surname> <given-names>M.</given-names></name> <name><surname>Lesner</surname> <given-names>A.</given-names></name> <name><surname>Bzowska</surname> <given-names>A.</given-names></name> <etal/></person-group>. (<year>2019</year>). <article-title>Properties of the HtrA protease from bacterium <italic>Helicobacter pylori</italic> whose activity is indispensable for growth under stress conditions</article-title>. <source>Front. Microbiol.</source> <volume>10</volume>:<fpage>961</fpage>. <pub-id pub-id-type="doi">10.3389/fmicb.2019.00961</pub-id><pub-id pub-id-type="pmid">31130939</pub-id></citation></ref>
</ref-list>
</back>
</article>